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Abstract 
Nanoparticles are known for their unique and exceptional properties and are widely 
used in biomedical, bioelectronics, pharmacology and environmental fields. This thesis 
looks at the synthesis of iron oxide nanoparticles (Fe3O4 and γ-Fe2O3), iron oxide core-
gold shell nanoparticles (γ-Fe2O3-Au), their characterization and application in the 
development of plasma immunoglobulin immunosensor electrode as a biomarker for 
Alzheimer’s disease (AD). Iron oxide coated with gold shell was used in the 
development of the immunosensor electrode in other to improve on the sensitivity, low 
plasma immunoglobulin concentration detection, stability and reproducibility of the 
immunosensor electrode for AD monitoring and detection. This is achieved by taking 
advantage of the increased surface area obtained from combining iron oxide core and 
gold shell nanoparticles for biomolecules binding, their biocompatibility that allows 
biomolecules to regenerate and the electron conducting properties of gold nanoparticles.  
Iron oxide nanoparticles in this thesis were synthesized through oxidative alkaline 
hydrolysis of ferrous salt and the synthesis parameters altered to see how it affects the 
nanoparticles properties, structure, purity and size. The synthesized iron oxide 
nanoparticles (Fe3O4) showed changes in shape and size and also the formation of side 
products or impurities mixed with Fe3O4 nanoparticles such as alkaganeite (β-FeOOH) 
nano-rods, α-Fe2O3 (hematite) and lepidocrocite (γ-FeOOH). Gold shell nanoparticles 
average size 24 nm was formed as a shell on γ-Fe2O3 nanoparticles (50 nm) through the 
iterative reduction of chloroauric acid with hydroxylamine. The iron oxide core-gold 
shell nanoparticles with average particles size 74 nm was used in the development of the 
immunosensor electrode. The immunosensor electrode and nanoparticles were 
characterized using physical and electrochemical techniques.  
The immunosensor electrode for the direct detection of plasma immunoglobulin as 
biomarker for AD is a novel work since no work has been carried out on direct 
electrochemical detection of plasma immunoglobulin for AD. The electrode was 
developed with a view to addressing the problems currently facing present Alzheimer’s 
disease biomarkers such as being too expensive, technically challenging, rarely 
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available and inability to control repeated sampling for regular monitoring of AD. In 
developing the immunosensor electrode, depleted plasma immunoglobulin was used as 
the biomarker and polyclonal rabbit Anti-human IgA, IgG, IgM as the antibody specific 
for plasma conjugation. Gold electrode and γ-Fe2O3-Au nanoparticles were used as the 
immobilizing substrate for the immunosensor electrode. The immunosensor electrodes 
showed good response, sensitivity and reproducibility in differentiating plasma 
immunoglobulin from AD patients and control subjects up to the 8
th
 (3.91 ppm) and 5
th
 
plasma concentration (31.25 ppm) for the modified gold electrode and γ-Fe2O3-Au 
electrode respectively. The electrodes had a better linear responds to plasma 
immunoglobulin at high concentration compared to enzyme linked immunosorbent 
assay (ELISA) technique. 
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Chapter 1 
Introduction 
1.1 Motivation and aims of the research  
The advances in nanotechnology and nanoscience have made possible the use of 
nanomaterials with exceptional properties in studying, monitoring and treatment of most 
biomedical related diseases. Specifically the use of biocompatible nanoparticles (1-100 
nm) to interact between cells and molecules in our body has helped in the fabrication of 
sensors and implantable devices to regulate body functions and disease control. 
Biocompatible nanoparticles such as iron oxide and gold nanoparticles with unique 
properties have been of great interest to researchers in environmental, biomedical and 
medical fields.  
The magnetic properties of iron oxide nanoparticles, their stability when functionalized 
and their robust surface area combined with their biocompatibility, ligands affinity and 
electron transfer ability of gold nanoparticles has led to the fabrication of iron oxide 
core-gold shell nanoparticles and their application in biomedical fields such as 
biosensors fabrication, drug delivery, contrast agent in magnetic imaging, cell 
separation, disease monitoring and treatment. Iron oxide core-gold shell nanoparticles 
has been used as drug delivery carriers (Barnett et al., 2013), imaging (Menichetti et al., 
2013), biomedical platforms(Hoskins et al., 2012) protein immobilization (Liang et al., 
2009) and for disease treatment (Guo et al., 2013) 
The use of iron oxide core-gold shell nanoparticles in the monitoring, control and 
treatment of diseases has being a focal point for researchers to improve on the drawback 
experienced in most clinical and analytical diagnosis of diseases. Specifically the 
diagnosis, detection and monitoring of the progression of dementia especially 
Alzheimer’s disease (AD) in ageing people has been of great challenge since there are 
no standard reliable diagnostic test and cure for the diseases. The disease is a disease of 
the brain that often causes memory loss, confusion, inability to speak properly and cope 
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with everyday activities. It is a progressive disease that gets worse over time and 
eventually leads to death.  
The available clinical diagnostic technique such as the use of radio tracers and lumber 
puncture are very expensive and challenging. The uses of biomarkers as a supportive 
measure to aid the diagnosis and monitoring of AD diseases have been encouraged by 
the National Institute of Ageing and Alzheimer’s Association (McKhann et al., 2011). 
Biomarkers for the detection of cerebrospinal fluids (CSF) proteins such as increase in 
levels of amyloid beta proteins (Aβ 40) and (Aβ 42) observed in AD patients has been 
developed (Sunderland et al., 2005), although the CSF biomarkers still faces the 
problem of extracting the fluid from the brain which is challenging. 
The use of blood plasma proteins such as immunoglobulin (Ig), as biomarker for 
monitoring AD has been encouraging and also has removed the difficulties experience 
in extracting fluids from the brain for analysis since blood plasma can easily be 
extracted from the body and use. Plasma immunoglobulin have been used as a 
biomarker in enzyme linked immunosorbent assay (ELISA) for monitoring AD and also 
plasma amyloid beta proteins and tau proteins have been used as biomarkers too for AD 
(Hye et al., 2006; Mukaetova-Ladinska et al., 2012). Although this method shows 
increase in immunoglobulin or amyloid protein levels in AD compared to normal 
subjects, the method is still complicated and takes long time for sampling and result 
analysis. 
This dissertation seeks to use gold electrode, iron oxide core-gold shell nanoparticles in 
developing electrochemical immunosensors electrodes using plasma immunoglobulin as 
biomarker for the monitoring of AD in patients. This will help in solving the setback 
experienced in the ELISA method and CSF biomarkers techniques, since 
immunosensors are easy to handle, highly sensitive and can run many samples within 
short time intervals. 
The specific goal of this PhD dissertation is: 
1. Synthesize iron oxide nanoparticles through oxidative alkaline hydrolysis of 
ferrous salt and the effect of synthesis parameters on the nanoparticles and their 
possible side products or impurities. 
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2. Synthesize iron oxide core-gold shell nanoparticles and the effect of temperature 
and agitation on polyethyleneimine (polymer) adsorption on iron oxide 
nanoparticles during iron oxide-gold shell formation. 
3. The use of gold electrode as an immobilizing platform for depleted plasma 
immunoglobulin as biomarker for AD immunosensor. 
4. The use of iron oxide core-gold shell nanoparticles as immobilizing substrate for 
depleted plasma immunoglobulin as biomarker for AD immunosensor. 
1.2 Nanomaterial Overview 
Nanomaterials are materials with nano-scale dimension (1-100 nm) or materials with at 
least one dimension in nanoscale and the others in microscopic scale. These materials 
possess novel properties due to their unique size and shape that are advantageous 
compared to their bulky nature (Kreyling et al., 2010). Nanomaterials are the motivating 
factor in nanotechnology which deals with the use of the nanoscale properties of 
materials to design, characterize and produce devices. Nanomaterials are often prepared 
from materials such as are polymers, metals, oxides, carbon, semiconductors and 
magnetic materials. They can be shaped into different forms based on their application 
such nanoparticles, nanowires (diameters 10
-9
 metres), nano-crystals (single crystalline 
structure with at least one ≤ 100 nm) and clusters (quantum dots), nanotubes (carbon 
materials) and dendrimers (nano-size polymers) (Luo et al., 2006).  
Nanomaterials has been of great interest in biomedical applications and in 
biosensor/immunosensor  fabrication, by taking advantage of their unique properties 
such as their surface structures, optical, electronic, catalytic, magnetic, thermal, 
biocompatibility and chemical properties (Welch and Compton, 2006). These materials 
improve the biocompatibility, stability, sensitivity and reproducibility of biosensors and 
immunosensors. Among the different nanomaterial used for biosensor/immunosensor 
applications, nanoparticles of metal are of great interest. This is due to their 
biocompatibility to biomolecules which allows biomolecules to regenerate, their ability 
to act as catalyst in electrochemical reactions, ability to enhance electron transfer 
between biomolecules and electrode surfaces and their ability to act as labels for 
biomolecules and also as reactants (Welch and Compton, 2006).  
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1.3 Nanoparticles 
Nanoparticles are particles in nanoscale forms or particles with at least one dimension 
less than 100 nm (Kreyling et al., 2010). They are of great interest due to their wide 
variety of potential applications in biomedical, optical, and electronic/bioelectronics 
fields. Nanoparticles for sensor applications can be formed from metals, semiconductor, 
polymer and oxide materials and each play different roles in different sensing systems. 
Metal nanoparticles such as gold, silver and platinum are often used as an electronic 
wire to aid electron transfer in biosensor applications , oxides nanoparticles such as iron 
oxide are used for biomolecules immobilization due to their biocompatibility and large 
surface area while semiconductor nanoparticles are often used as labels or tracers (Luo 
et al., 2006). Among the numerous nanoparticles used for biosensor/immunosensor 
fabrication iron oxide nanoparticles and gold nanoparticles have received great interest 
due to their intriguing properties. 
1.4 Iron oxide nanoparticles 
Iron oxide nanoparticles are nanoscale magnetite (Fe3O4) or maghemite (Fe2O3) 
particles often referred to as magnetic nanoparticles due to their magnetic properties. 
They are cost-effective and possess unique properties such chemical stability, 
biocompatibility, non-toxicity, effective specific power absorption rate and ability to be 
chemically functionalized and stable in solution of physiological pH (pH 7.3-7.4). 
These properties and their strong magnetic properties, high separation efficiency, and 
high specific surface area makes them useful in the fabrication of DNA and protein 
biosensors ((Li et al., 2011c) and for other biomedical applications such as magnetic 
resonance imaging, drug delivery, hyperthermia therapy and cell separations. 
Magnetite (Fe3O4) also referred to as tri-irontetraoxide is the most widely used form of 
magnetic nanoparticles because of its biocompatibility and high magnetization values. It 
is an unstable iron oxide that is sensitive to oxidation and also ferrimagnetic at room 
temperature. Its structure is composed of oxygen anion and iron cation in octahedral or 
tetrahedral interstitial sites forming a cubic closed packed arrangement (Teja and Koh, 
2009) as shown in Figure 1.1. Magnetite contains both iron II ions (Fe
II
)
 
and iron III 
ions (Fe
III
) in an inverse cubic spinel structure with the Fe
II
 ions in the octahedral site 
and half Fe
III
 ions in octahedral and half in tetrahedral site (Goon et al., 2010). The 
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stoichiometric ratio of Fe
2+
 and Fe
3+
 cation in magnetite is 1:2 under a non-oxidizing 
free oxygen environment (Goon et al., 2010).  
Maghemite (γ-Fe2O3) also referred to as iron III oxide is the completely oxidized form 
of magnetite or iron II deficient magnetite. It is a ferrimagnetic iron oxide at room 
temperature, unstable at high temperature and loses its magnetization with time 
(Dronskowski, 2001). It contains three quarter of iron III cation in the tetrahedral site 
and the rest in the octahedral site. It has similar cubic close packed arrangement with 
oxygen anions like magnetite.  The tetrahedral sites of maghemite are filled while 
cationic vacancies appear on the octahedral site. The occurrence of the vacancies is due 
to the migration of cations through the lattice frame work of magnetite during oxidation 
and in turn maintains the charge balance in the formation of maghemite (Jolivet et al., 
2004). The two forms of iron oxide can be represented mathematically as: 
         
  [         ]                                 1.1 
              
  [             ]                   1.2 
The brackets represent the octahedral sites and the V denotes vacancies that occurred in 
the octahedral sites.  . 
 
Figure 1.1 Crystal structure of magnetite 
Although the two major forms of iron oxide in magnetic nanoparticles are magnetite 
and maghemite, iron oxides also exist in other forms due to its polymorphic nature. The 
two polymorphs forms of iron oxide are the anhydrous (oxides) which includes 
maghemite (γ- Fe2O3), magnetite (Fe3O4), hematite (α-Fe2O3), wustite (FeO) with 
magnetite or with both ferrous and ferric iron , and the hydrous form (oxy hydroxides) 
which often contain excess water e.g. goethite (α-FeOOH), lepidocrocite (γ-FeOOH) 
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and akaganeite (β-FeOOH), of which the goethite is the most stable of the iron oxy 
hydroxides polymorphs (Snow et al., 2011). 
1.5 Magnetic and physical properties 
The magnetic properties of iron oxide nanoparticles are determined by factors such as 
their size, shape, temperature, pressure composition and chemical phase present. Most 
materials including magnetic iron oxide nanoparticles experience magnetic induction B 
in the presence of an external magnetic field of strength H as shown in equation 1. 3 
                                          1.3 
Where    the permeability of free space and M is the magnetization of the material. 
Magnitization (M) is the magnetic moment per unit volume of the material.  Bulk 
magnetic materials consist of domains with different magnetization and the number of 
domains decreases as the material becomes smaller resulting to single domain at a 
characteristic size (dC) as shown in Figure 1.2. The net magnetization of the domains is 
usually less compared to when all the atomic moment in the individual domains are 
aligned. But often the magnetization of all the domains may not be aligned in the 
presence of a magnetic field and this leads to decrease in the net magnetization as 
shown in Figure 1.3 
 
 
 
                                
(a)                                         (b)                                                     (c)                         
Figure 1.2 Magnetic moment in bulk (a) reduced bulk (b) and single domain materials (c) 
 
 
(a)                                                        (b) 
 
                        
                        H = 0                                                                             H    
Figure 1.3 Magnetic moment in bulk (a) absence of magnetic field (b) presence of magnetic field 
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The volumetric susceptibility (χ) of the domains to an external magnetic field of 
strength H is a dimensionless number as shown in equation 1.4 and varies from one 
magnetic material to another. 
                                                                        1.4 
Based on the arrangement and composition of atoms in the domains, magnetic 
nanoparticles or materials can exhibit different forms of magnetism such as 
diamagnetism, paramagnetism, ferromagnetism and super-paramagnetism.  
Iron oxide nanoparticles orbital have 4 unpaired electrons from its 3d orbitals 
(1s22s22p63s23p63d64s2) that can move freely and are capable of aligning in direction that 
result in net dipole moment (magnetic field) in the presence of external magnetic field. 
If the alignments of the unpaired electrons in the nanoparticles are parallel to the 
magnetic field, they are referred to as paramagnetic particles. This type of particles or 
materials show small repulsion from an external magnet with positive susceptibility and 
their magnetic properties ceases upon the removal of the external magnet.  
The disappearance of the magnetic properties in paramagnetic materials or nanoparticles 
in the absence of a magnetic field is due to thermal motions which make the electrons to 
align randomly or fluctuate yielding a net magnet dipole moment of zero. The transition 
temperature beyond which the material due to thermal motion becomes weak and losses 
its magnitization is called Curie temperature TC for ferromagnetic and ferrimagnetic 
materials and Neel temperature TN for antiferromagnetic materials. 
 
When particles or materials exhibit permanent magnetic dipole in the presence or 
absence of a magnetic field or have spins moving in the same direction and contributing 
to the net magnetization, they are referred to as ferrimagnetic or ferromagnetic 
materials. Ferromagnetic particles shows large and positive susceptibility to magnetic 
fields and the magnetic properties of the particles are stable upon removal of the 
external magnet and are also referred to as magnet. Situations where the atoms in the 
different sub-lattice of the material point in different directions to yield a net magnetic 
moment of zero, they are referred to as anti-ferrimagnetic particles. The ordering of 
atoms in anti-ferrimagnetic material disappears at the Neel temperature above which the 
material is paramagnetic. 
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Diamagnetism occurs when the velocity of paired electrons around the atomic nuclei of 
materials changes and creates a dipole moment in the presence of an external magnetic 
field.  Diamagnetic materials have weak repulsion in the presence of an external 
magnetic field with a negative susceptibility, and their magnetic properties cease upon 
removal of the field.  All materials undergoes diamagnetic effect but the effect are less 
in the presence of paramagnetic or ferrimagnetic effect.  
Materials or particles with size less than 10 nm exhibit super-paramagnetic behaviour 
which occurs when the materials randomly flip direction during magnetization under the 
influence of temperature and in the absence of a magnetic field, it takes a longer time 
more than the Neel relaxation time (time between two flips) to measure the 
magnetization of the nanoparticles thus, their magnetization appears to be in average 
zero. The thermal fluctuations that occurs on the average length of time between 
random flips in the direction of magnetization is described by Neel-Arrhenius equation 
1.5 
                                                            (
  
   
)                                         1.5 
where    is the average length of time between each flip,    is the length of time or 
attempted time (typically between 10
-9
 and 10
-10 
seconds) characteristics of the material, 
K is the magnetic anisotropy density of the nanoparticle, V is the nanoparticle volume , 
kB is the Boltzmann constant, KV is the energy barrier associated with magnetization 
and T is the temperature. In situation where   is shorter than   , the nanoparticles will 
become ferrimagnetic even though the material is below its Neel temperature. Super-
paramagnetic nanoparticles have significant thermal energy even though the material is 
below the Neel temperature. They are single domain particles with no hysteresis loop 
during magnetization as shown in Figure 1.4 (B). 
Hysteresis loop are observed in ferromagnetic materials with magnetic strength M when 
an external magnetic field of strength H is applied as shown in Figure 1.4 (A). The 
magnetization M of ferromagnetic material increases with H until a saturation value Ms. 
Ferromagnetic materials forms hysteresis loop because the different domains that makes 
up the bulk ferromagnetic material do not return to their initial orientation upon 
decrease of the magnetic field after attaining saturation magnetization (Teja and Koh, 
2009). Thus, at the point where H reaches zero, remnant magnetization (MR) is observed 
9 
 
and requires coercive force field (HC) in the opposite direction of the applied magnetic 
field to remove.  
. 
  
 
                                           
    
                                                                                                                                
Figure1.4 Magnetization curve showing M as a function of applied magnetic field H for (A) 
ferromagnetic (B) super-paramagnetic materials 
The magnetic and physical properties of magnetite and maghemite are summarized in 
table 1.1 (Teja and Koh, 2009). 
 
Property                              Magnetite                       Maghemite 
 
Molecular formular                 Fe₃O₄                               γ-Fe₂O₃ 
 Density (g/cm³)                       5.18                                   4.87 
 Melting point (°C)                 1583-1597                             - 
Hardness                                  5.5                                     5.0 
Type of magnetism                Ferromagnetic                  Ferrimagnetic 
Curie temperature (K)             850                                    820-986 
Ms at 300K (A-m²/kg)             92-100                               60-80 
   
   (KJ/mol)                          -1012.6                              -711.1 
Crystallographic system         Cubic                                Cubic or tetrahedral 
Structural type                        Inverse spinel                    Defect spinel 
Space group                            Fd3m                                P4₃32(cubic); P    2 (tetragonal) 
Lattice parameter (nm)            a =0.8396                       a = 0.83474 (cubic); 0.8347, c =  
                                                                                        2.501 (tetragonal) 
 
Table 1.1 Physical and magnetic property of magnetite and maghemite 
H 
 
M 
MS M
R
 
H
C
 
 
H 
M 
(A) (B) 
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1.6 Synthesis of iron oxide magnetic nanoparticles 
Iron oxide magnetic nanoparticles can be synthesized through various synthetic 
methods with each method producing nanoparticles with different sizes, morphology, 
chemical composition and magnetic properties. The common routes for synthesizing 
iron oxide nanoparticles are co-precipitation, thermal decomposition, sol gel, 
hydrothermal reactions, microemulsions, flow injection and sonochemical methods. 
1.6.1 Co-precipitation 
This is the simplest and most common method of synthesizing super-paramagnetic and 
paramagnetic iron oxide nanoparticles (Fe3O4 or γ- Fe2O3). It involves ageing mixtures 
of iron salts (ferric and ferrous chloride) in an aqueous medium based on stoichiometric 
ratio 2:1 (Fe
3+
/Fe
2+
) in the absence of oxidizing oxygen. This result in the formation of 
Fe3O4 nanoparticles at higher pH values 8 and 14 (Jolivet et al., 2004) and further 
undergoes oxidation in the presence of oxygen to form maghemite (γ- Fe2O3). The 
reaction can be written as: 
                                                            1.6 
         
            
                                        1.7 
1.6.2 Thermal decomposition 
This method produces iron oxide nanoparticles through the decomposition of organic 
iron salt such as iron acetylacetonate [Fe(acac)3], iron pentacarbonyl Fe (CO)5 and iron 
carboxylates at high temperature (250-350
O
C) (Sharma and Jeevanandam, 2013) in an 
organic solution. The process sometimes requires the use of complicated iron salts, 
ligands and inert conditions (argon and nitrogen atmosphere). Iron oxide nanoparticles 
(super-paramagnetic or paramagnetic) synthesized through this method are highly 
monodispersed with narrow size distribution. The disadvantage with this method is that 
the synthesized nanoparticles can only dissolve in nonpolar solvent making its 
biomedical applications limited.  
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1.6.3 Microemulsion  
This is a thermodynamically stable method of synthesizing nanoparticles. It involves the 
thermodynamic dispersion of two immiscible liquids usually water and oil in the 
presence of a surfactant.  This results in the formation of droplets of water in oil (w/o) 
or oil in water (o/w) stabilized by the surfactant when small amount of oil or water are 
used respectively. The nano-droplets can take different shapes such as spherical 
(inverted), cylindrical micelles to lamellar phases coexisting with the predominant oil or 
aqueous phase. The size of the droplets can be controlled by changing the water or oil to 
surfactant ratio in the nanometre range. These nano-droplets can be used to obtain size 
and shape controlled iron oxide nanoparticles (super-paramagnetic or paramagnetic). 
Water in oil microemulsion technique has been used to synthesize mono-dispersed 
spherical maghemite nanoparticles with higher saturation magnetization (Vidal-Vidal et 
al., 2006; Chin and Yaacob, 2007). The disadvantage with this method is the 
aggregation of the nanoparticles that requires several washing process and stabilization 
despite the use of surfactant. 
1.6.4 Hydrothermal synthesis 
This method is used to grow highly crystalline iron oxide nanoparticles in a sealed 
medium. It involves crystallization of nanoparticles from high temperature (130-250
O
C) 
aqueous solution at high vapour (0.3-04 MPa) in a sealed container by applying wet 
chemical synthesis routes (e.g. sol-gel, co-precipitation etc.) that meets these conditions. 
It is also a convenient way of synthesizing iron oxide nanostructures such as iron oxide 
hollow spheres or iron oxide nanocubes. It is also more advantageous compared to the 
microemulsion and thermal decomposition methods 
1.6.5 Sol gel-method 
This is a wet chemical technique that is used to synthesize nanostructured metal oxides. 
It involves the introduction of hydroxyl groups and subsequent condensation of 
molecular precursors into colloidal solution (sol) or nanometric particles that act as the 
precursor for the formation of a gel of either discrete particles or network polymer. This 
process is often carried out at room temperature thus further heat treatment is required 
to obtain the desired crystalline state of the particles. The particles growths are 
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determined by concentration of the salt precursors (iron salt), agitation, pH, temperature 
and solvent. This technique is advantageous in that particles with specified structures 
can be synthesized and the particles sizes can easily be controlled. It also allows for the 
synthesis of pure amorphous phases of the particles, monodispersed particles and the 
formation of core-shell. 
1.6.6 Flow injection 
This is a reactor based route for the synthesis of iron oxide nanoparticles under laminar 
or plug flow conditions. The process involves continuous or segmented mixing of 
reactants and iron precursor in a capillary reactor under plug flow or laminar flow 
conditions to form iron oxide nanoparticles. The method allows for the synthesis of 
reproducible narrow size nanoparticles due to the flow conditions, and better control of 
the process. This method has been used to synthesize narrow size super-paramagnetic 
magnetite nanoparticles of sizes 2-7nm (Salazar-Alvarez et al., 2006). 
1.6.7 Sonochemical 
This method uses the chemical effect of ultrasound to synthesize iron oxide 
nanoparticles from organic iron salts. The process involves the formation, growth and 
rapid collapse of bubbles (cavities) in liquid during ultrasound (sonolysis). The rapid 
collapse of the cavities results in the formation of localized hot spots at high 
temperatures (5000K) (Suslick, 1990) which allows for the conversion of iron salt into 
nanoparticles. The nanoparticles growth is controlled through the use of organic 
capping agents either polymers or structural.  
1.7 Applications of iron oxide nanoparticles 
Iron oxide nanoparticles are widely used in biomedical applications such as magnetic 
resonance imaging (MRI), Hyperthermia therapy, drug delivery, magnetic recording 
media, ferrofluids and biosensors fabrication. The application of the nanoparticles for 
biomedical and other bioengineering largely depends on the nanoparticles specific size 
with narrow particle size distribution that allows for their uniform physical and 
chemical properties, shape, characteristics and magnetic properties. 
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1.7.1 Magnetic resonance imaging (MRI) 
MRI is a medical imaging technique that makes use of a magnetic field and pulses of 
radio wave energy to picture organs and structures inside the body. Super-paramagnetic 
iron oxide nanoparticles (Fe3O4) core coated with polymer for colloidal stabilization are 
used as contrast agent for in vivo MRI. The nanoparticles differentiate between healthy 
and disease tissue when a strong magnetic field and radio waves are applied. The 
biocompatibility and stability of the iron oxide nanoparticles over time during MRI, 
makes MRI a better medical imaging technique compared to X-ray computer 
temography (CT) where there is an exposure to ionizing radiation. Super-paramagnetic 
and paramagnetic  iron oxide nanoparticles have been used in magnetic resonance 
imaging of cancer, tissues and tumours (Ris et al., 2010; Zou et al., 2010; Chung et al., 
2011; Ishigami et al., 2011; Lee et al., 2012; Yoo et al., 2012). 
 
1.7.2 Hyperthermia therapy 
Hyperthermia therapy is the application of slight higher temperatures to body tissues in 
order to damage or kill cancer cells. Super-paramagnetic iron oxide nanoparticles are 
used as therapeutic agents for cancer treatment. During the treatment, the nanoparticles 
are exposed to alternating magnetic field and are used to heat tumour cells to 
temperatures (41-45
O
C) that completely damages the tumour cells while the normal 
tissue cell can be regenerated.  Super-paramagnetic iron oxide nanoparticles has been 
used in hyperthermia analysis and treatment (Kobayashi, 2011; Silva et al., 2011; Bae et 
al., 2012; Amarjargal et al., 2013). 
1.7.3 Magnetic recording media 
Mono-dispersed small size maghemite nanoparticle doped with colbalt to improve its 
coecivity and storage are the most common material in recording and data storage 
applications such as magnetic disc, video tapes and high bias audio tapes. The data 
storage application takes advantage of the chemical and physical stability and 
switchable magnetic state of maghemite nanoparticles, while for recording data, the 
doped quality of maghemite and colbalt such as resistance to corrosion, resistance to 
temperature changes, high coecivity and high remanence are advantageous. 
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1.7.4 Drug delivery 
Super-paramagnetic iron oxide nanoparticle with special surface coatings that are 
biocompatible and non-toxic can be used for in vivo drugs delivery to specific site in the 
body with the aid of an external magnetic field without damaging cells or tissues. The 
drugs can be covalently attached to functional groups on surface of the iron oxide 
nanoparticles and delivered with the appropriate local concentration with minimal 
overall dosage and side effect. Magnetite iron oxide nanoparticles has been used to aid 
delivery of cancer drugs (Marcu et al., 2013; Omidirad et al., 2013; Zhang et al., 2013).   
1.7.5 Ferrofluids 
Ferrofluids are small size magnetic particles suspended in a fluid either water or organic 
solvent. The small size nature of the particles allows for the stability of the fluids and 
also reduces the effect of precipitation, charge and surface chemistry that may occur. 
Ferrofluids have no net magnetic moment but are strongly magnetized in the presence 
of a magnet. Super-paramagnetic iron oxide (Fe3O4) nanoparticles ferrofluids has been 
used as seals in space applications and also for sealing computer disk unit (Teja and 
Koh, 2009). 
1.7.6 Biosensor application 
Iron oxide nanoparticles have found great interest in biosensor application. The 
biocompatibility of iron oxide nanoparticles, its low toxicity, and large surface-to-
volume ratio coupled with strong super-paramagnetic properties aids the delivery, 
effective immobilization and regeneration of bioactive molecules such as enzymes. 
Various glucose base enzyme biosensors has been developed and other enzyme 
biosensors using iron oxide nanoparticles as immobilization matrix (Kaushik et al., 
2008; Chauhan and Pundir, 2011; Li et al., 2011b). 
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1.8 Gold nanoparticles and its properties 
Gold generally is a metal with a shiny metallic yellow colour and standard atomic 
weight of 196.9665gmol
-1
, an electronic configuration of [Xe]4f
14
5d
10
6s
1
 and electron 
per shell of 2, 8,18 , 32, 18, 1 (Yates, 2000). The most common gold compounds are 
auric chloride (AuCl3) and chloroauric acid (HAuCl4). Gold nanoparticles or 
nanospheres are basically colloid gold of 2 nm to 100 nm in diameter created when gold 
ions (Au
3+
) are turned into neutral atoms (A
0
).There are different synthetic route for the 
synthesis of gold nanoparticles such as citrate-induced reduction of boiling aqueous 
Au
3+
 (Hien Pham et al., 2008; Nguyen et al., 2010; Li et al., 2011a), colloidal Au 
surface-catalysed reduction of Au
3+ 
by hydroxylamine (Brown and Natan, 1998; Lyon 
et al., 2004), sonolysis (Zhang et al., 2006; Zhang et al., 2010), electrodeposition of 
gold nanoparticles in electrolytic solution containing gold salt or acid (Mohanty, 2011) 
and block polymer mediated growth of gold nanoparticles (Sakai and Alexandridis, 
2005). The sizes and colour of the nanoparticles is determined by the type of synthesis 
route and variations in concentration of synthesis parameters. The nanoparticles colours 
depends on the size of particles formed, with deep red colour for nanoparticles less than 
100nm and blue/purple colour for larger particles. .  
Gold nanoparticles also exist in other forms such as nano-shells, nano-rods and nano-
cage based on their sizes, shape and physical properties. The synthesis of these forms of 
gold nanoparticles depends on their need for specific applications. Gold nanoparticles or 
other gold forms do not react with air, acids and most regents but dissolve in aqua regia 
(mixture of freshly prepared concentrated nitric acid and hydrochloric acid in ratio 1:3), 
mercury and alkaline solution of cyanide. 
Gold shell nanoparticles are non-toxic in nature, biocompatible and have excellent 
conductivity which enables them to act as electron pathways or mediators between 
proteins and electrode surfaces in biosensor and immunosensor applications. The high 
surface area and biocompatible nature of gold nanoparticles enables them to facilitate 
high enzyme loading and also to retain their bioactivity (Saxena et al., 2011). Gold 
nanoparticles have strongly enhanced optical properties which makes them suitable for 
cancer therapy (Huang and El-Sayed, 2010).  
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The optical properties of gold nanoparticles result from their ability to absorb and 
scatter light orders of magnitude which is a characteristic mostly found in noble metals. 
This strong light absorption is due to coherent oscillation of conduction band electrons 
also known as surface plasmon oscillation caused by interaction with an 
electromagnetic field (El-Brolossy et al., 2008; Huang and El-Sayed, 2010). The 
optimal point of the amplitude of the oscillation at a specific frequency is referred to as 
surface plasmon resonance (SPR). The nature of the surface plasmon resonance and the 
width of the plasmon absorption band depends on the nanoparticles sizes. Gold 
nanoparticles have surface plasmon resonance band in the visible region around 520 nm 
(Huang and El-Sayed, 2010). Nanoparticles with very small size (e.g. 2 nm) do not 
show surface plasmon bands and damp surface plasmon resonance is observed when 
particles are less than 10nm.  Increasing nanoparticles sizes forces the surface plasmon 
resonance wavelength to red shift with increased intensity and band broadening occurs 
when the nanoparticle are greater than 100 nm. The band broadening is due to the 
dominant contributions from higher order electron oscillations. 
 
1.9 Gold nanoparticles synthesis 
Gold nanoparticles can be synthesized through different synthetic routes but the most 
common method applied in biomedical and biosensor applications are the colloid and 
electrodeposition techniques.  
1.10 Colloid gold technique 
Colloidal gold are nanometer size gold particles suspended in fluids such as water or 
organic liquids. Different methods can be applied in the synthesis of colloidal gold and 
the resulting gold particle size and properties depends greatly on the method of 
preparation .This in turn determine the gold nanoparticles colour, their mode of 
functionalization and applications in various field. The most common colloidal gold 
synthesis techniques are the Turkevish, Brust, Perrault and Martin methods. 
1.10.1 Turkevish technique 
This is a simple technique that was pioneered by John Turkevish and his co-workers in 
1951 (Kimling et al., 2006) before being modified by various researchers . The method 
17 
 
simply involves reacting small amounts of sodium citrate solution in boiling chloroauric 
acid solution. The method is used to synthesized mono-dispersed spherical gold 
nanoparticles with size range 10-20 nm. The citrate acts as reducing, stabilizing and 
capping agent for the gold nanoparticles and is responsible for the gold colloid surface 
negative charge. Altering the amount of citrate ions in this method i.e. using smaller 
amount of citrate in the solution results in the formation of large gold nanoparticles size 
up to 190 nm (Kimling et al., 2006) with less mono-dispersity. 
1.10.2 Brust Method  
This is an organic route for the synthesis of gold colloid that was first used by Mathias 
Brust and co-worker (Brust et al., 1994). The method involves reacting  chloroauric 
acid solution with organic solution that are immiscible with water such as toluene 
solution containing tetraoctylammonium bromide (TOAB) and sodium borohydride 
(NaBH4). The toluenes act as reducing agent and the NaBH4 act as anti-coagulant 
agents. TOAB functions as a stabilizing agent and also as transfer catalyst between the 
liquid-liquid phases in the system. TOAB is known to have poor binding affinity to gold 
and often leads to the aggregation of the colloid gold nanoparticles with time. Therefore 
modification of this method with stronger covalent binding and stabilizing agent such as 
thiol has been used to in synthesizing gold nanoparticles within the range 5-6 nm in 
organic liquids  (Manna et al., 2003). 
1.10.3 Perrault Method  
This is an organic method of synthesizing colloid gold nanoparticles through the use of 
hydroquinone (benzene-1,4-diol or quinol) as reducing agent. The method involves 
synthesizing gold seeds through citrate reduction and forming aqueous solution with the 
gold seed and chloroauric acid (HAuCl4) and then using hydroquinone as the reducing 
agent in forming gold nanoparticles. This method produces gold nanoparticles of size 
range 30-250 nm (Perrault and Chan, 2009). 
1.10.4 Martin Method  
This method produces gold nanoparticles by simply reducing chloroauric acid in water 
with sodium borohydride without the need for a stabilizing agent. Gold nanoparticles 
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synthesized through this method are stable, nearly mono-dispersed with size distribution 
of 3.2-5.2 nm (Martin et al., 2010).  
1.11 Electrodeposition method 
This is an electrochemical technique of synthesizing gold nanoparticles and the most 
promising methods compared to the other techniques. It is a binder free, simple, less 
expensive and easy to carry out method of synthesizing gold nanoparticles. It involves 
the application of electrical potential between a conducting electrode and a counter 
electrode in an electrolytic solution of gold salt or acid (HAuCl4). This results in the 
formation or deposition of gold nanoparticles on the surface of the working electrode 
and sometimes the liberation of gas due to the type of redox reaction taking place. It 
produces gold nanoparticles with controlled morphology, size and composition  and this 
properties can easily be manipulated by simply adjusting the operating conditions 
(Mohanty and Koucianos, 2006).  
1.12 Gold nanoparticles functionalization  
Functionalization of nanoparticles plays important role in the stability, functionality, use 
and biocompatibility of the nanoparticles. This in turn preserves the nanoparticles 
properties and any bound biological molecules on it. Functionalized gold nanoparticles 
can be used as building blocks for the attachment of biomolecules, catalysis, core-shell 
nanoparticles synthesis, surface engineering, bioelectronics sensors and for in-vivo 
therapeutic applications. Gold nanoparticles are strongly covalently bound to self-
assembled monolayer (SEM) surfaces through functional groups such as thiol (-SH), 
amines (-NH2), cyanide (-CN) or polymers  
Gold nanoparticles well functionalized have been used in different biosensor and 
electrochemical sensors applications. High sensitive and stable glucose biosensors has 
been fabricated for blood glucose detection using gold nanoparticles as the 
immobilizing substrate due to its biocompatibility and as an electron pathway for the 
flow of electron between redox solution and proteins (German et al., 2010; Chen et al., 
2011; Wang et al., 2011). Electrochemical sensors and immunosensors for 
antibody/antigen conjugation has been fabricated using gold nanocomposite electrodes 
(Chen et al.; Che et al., 2009; Yang et al., 2009; Jaganathan and Ivanisevic, 2011). The 
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effectiveness and efficiency of these sensors comes from the biocompatibility and 
electron transfer ability of gold nanoparticles. 
1.13 Biosensors 
Biosensors are devices that make use of biological sensing materials (proteins, enzymes, 
micro-organisms, tissues etc.) to monitor, detect and transmit biological information 
through a transducer into signals. The two basic component of a biosensor is the 
biological sensing materials or bioreceptor which monitor and detect molecular changes 
and a transducer which transform the changes observed by the bioreceptor into signals. 
The changes from the bioreceptor transformed into signal might be due to changes in 
pH, heat transfer, electron transfer etc. Sometimes a signal amplifier or processor is 
used to amplify the signal and read as result. The basic characteristics of biosensors that 
determine how effective the biosensor can predict physical events taking place are the 
biosensor sensitivity, response time, selectivity, linearity, detection limit, repeatability 
and reproducibility. 
Biosensor sensitivity is the ability of a biosensor to response to the change when a 
material is been investigated. It also determines the usefulness of the biosensor in 
specific applications and is often expressed as the ratio of the output signal to the input 
signal. The response time of a biosensor is the time it takes the biosensor to attain a 
steady state position when carrying out measurement from the onset of change in the 
analyte concentration. It is often referred to as the time it takes a biosensor to reach 95% 
response during investigation (Wang et al., 2006). The selectivity of the biosensor is the 
ability of the biosensor to minimally detect interferences from chemicals during 
measurements. The interference determines the selectivity of the biosensor and if the 
interference is minimal during measurement, the biosensor is said to be more selective 
and the result more accurately measured. Biosensors selectivity depends solely on 
applied bio-receptor and transducers.  
The point where the biosensor attains maximum linear value in its calibration curve is 
referred to as the linearity of the biosensor. This is normally achieved by measuring the 
increasing or decreasing response when the concentration of the analyte is varied during 
measurement.  When no significant change in the response of the biosensor is observed 
20 
 
during analyte investigation, the biosensor is said to have reached its detection limit or 
limit of the linear range at low concentration. The repeatability of a biosensor deals with 
the ability of the biosensor to repeat the same result when a sample is re-run or repeat 
results that will be closely related to a similar result from a different run. The 
reproducibility of the biosensor determines how effective the biosensor can reproduce 
its previous result if re-run in another laboratory operated by different workers. It also 
determines the commercial viability of the biosensor.  These characteristics are also 
applicable in the different types of biosensors. 
Biosensors are classified either by their detection mode or the type of biological 
recognition elements used. In terms of the detection mode or transduction, they are 
classified as electrochemical, calorimetric, piezoelectric and photometric biosensors. In 
terms of the type of bioreceptors, they are classified as enzyme electrodes biosensors for 
enzymes, Immunosensors for antibody and antigen detection, DNA sensors (DNA), and 
microbial sensors for organelles or microbial cell.  
1.14 Immunosensors and immunoassay 
Immunoassays uses antibody as specific recognition reagent to detect analyte (antigens). 
The specific binding of an antibody to an antigen are classified into two formats, 
homogenous immunoassay and the heterogeneous immunoassay. The homogeneous 
immunoassay assay format does not require physical separation of the antibody-antigen 
bound complexes from unbound antigen molecules. The heterogeneous immunoassay 
requires separation of the unbound immune reagent (antigen) from the antibody-antigen 
bound complexes by washing them out of the system. In this immunoassay format, 
antibody-antigen bound complexes are bound to a solid substrate which allows for the 
retention of the molecule of interest as the unbound once are washed off. The 
heterogeneous assays are more reliable, versatile, sensitive and more specific (Ju et al., 
2011). 
Solid substrates for the heterogeneous immunoassay are made of biocompatible 
materials and are often prepared with excess immunological elements (antigen or 
antibodies). Immobilization of the antigen or antibodies on the substrate vary from 
substrate to substrate, and the orientation of the antibodies and its optimum density 
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plays important role in achieving optimal antigen-antibodies reaction and minimal 
destruction of the paratope on the substrate (Luppa et al., 2001). Immobilization 
techniques such as physical adsorption, covalent bonding and embedding are often used 
on heterogeneous immunoassay format. The two most common heterogeneous 
immunoassay strategies are competitive and sandwich methods.  
In competitive immunoassay sample antigens and labelled antigens compete for limited 
binding site of the antibody immobilized onto a substrate and the bound label signal 
detected after washing off the unbound antigens. The detected signal is inversely 
proportional to the antigen concentration in the sample (Ju et al., 2011). In sandwich 
immunoassay the antigens are captured by a highly specific primary antibody 
immobilized onto a substrate followed by the binding of the captured antigen with a 
labelled secondary antibody which acts as tracer and provide a signal that is directly 
proportional to antigen concentration in the sample after washing off excess tracer. The 
antigen in sandwich immunoassay must have at least two antigenic epitope capable of 
binding to the two different antibodies. Monoclonal or polyclonal antibodies are either 
used as capture or detection antibodies in Sandwich systems. But the polyclonal 
antibody is most preferable in order to bind as much of the antigen as possible.  
 
Immunosensor is a type of biosensor that detects antibody-antigen interaction and relay 
these complementary interactions between the antibody and antigen through a 
transducer as signal. The working principle of immunosensor is the same as the working 
principles applied in solid phase immunoassay, where antibody or antigens are 
immobilized on the sensor surface. The sensitivity and specificity of the immunosensors 
are determined by the affinity and specificity of the antibody- antigen and the level of 
background noise from the transducer (Morgan et al., 1996). The use of immunosensors 
to analyse extensive range of samples such as drugs, hormones, pollutants and diseases 
with quick and highly sensitive immunological response have led to increased interest 
in its manufacture. A typical immunosensor set up is shown in Figure 1.5. 
There are two categories of immunosensors based on their mode of detection, direct and 
indirect immunosensors. Direct immunosensors detects directly the antibody-antigen 
interactions without the use of labels while the indirect immunosensors uses a separate 
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labelled species such as enzymes or fluorescent to aid the detection of the antibody-
antigen interactions. Indirect immunosensors are less affected by non-specific binding 
phenomena, but direct immunosensors have advantage over the indirect once because of 
its simplicity and ability to carry out real time monitoring of samples (Rahman et al., 
2007).  
 
 
 
 
Figure 1.5 Typical immunosensor set up with antigens and antibodies (receptor) immobilized onto 
solid sensor surface (transducer). 
Immunosensors can also be classified into four different types based on the type of 
transducer applied and signal result. The four basic types of immunosensors are: 
electrochemical (potentiometric, amperometric, or conductimetric), mass (piezoelectric 
or acoustic), heat (calorimetric) and optical immunosensors. All these type of 
immunosensors can be run as direct or indirect immunosensors. Among these different 
types of immunosensors, the electrochemical immunosensor is known for its high 
sensitivity, high detection speed, easy handling and fabrication (Sun et al., 2011). 
1.15 Electrochemical immunosensors 
Electrochemical immunosensors uses electrochemical transducer to detect and measure 
the immunochemical reaction between an antibody and a specific antigen. The 
immunochemical reactions results in the generating or depleting of electrons or ions on 
the surface of an electrode. These types of immunosensors are highly sensitive, less 
expensive, easy to operate and have a high selectivity which makes them easily 
acceptable and applicable compared to other types of immunosensors. Electrochemical 
immunosensors can be classified into three categories namely: potentiometric, 
amperometric and conductimetic based on their operating principles. 
 
 
      
Signal 
Antibody 
Antigen 
Transducer 
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1.15.1 Potentiometric immunosensors 
This type of immunosensor measures the potential resulting from the selective binding 
of ions to an electrode or sensing surface due to changes in the ionophoric properties 
resulting from antibody-antigen conjugation. The potentials generated are measured by 
a working and reference electrode both in contact with a solution and it is proportional 
to the activity of ions present in the solution but logarithmic with concentration as 
shown in Nerst equation in equation 1.8 and 1.9. This forms the basis for the fabrication 
of the ion-selective electrodes (ISE), in which ions present in a sample are selectively 
bound to electrode surface and a charge separation occurs between the sample and the 
electrode surface which is then measured.  
                      +  
  
  
 In 
[  ]
[   ]
                                                                        1.8                                                   
Where E is the electrode potential, EO is the standard electrode potential, [Ox] and 
[Red] are the concentration of the oxidized and reduced forms of the system, F is 
faraday constant and n is the number of moles of electron transferred in the cell 
reaction. For the case of ionic concentration, the concentration ( ) is replaced by the 
activity of ions ( );  
                                                                                                               1.9 
Where, y represents the activity coefficients.  
Sometimes field effect transistor (FET) which allows for the detection and conversion 
of any charges that are built up on the electrode surface into measurable response 
without depleting the current or electrode are incorporated with the ISE (Morgan et al., 
1996). This has led to the fabrication of an advance ion sensitive field effect transistor 
(ISFET) which is more sensitive and selective with minimal interference of signal. 
1.15.2 Amperometric immunosensors 
Amperometric immunosensors measure the intensity of current flow generated when 
antibody-antigen electrochemical reactions occurs at a forced or constant potentials. The 
intensity of the current measured is proportional to the concentration of the antibody-
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antigen immune-complex being investigated (Morgan et al., 1996). This immunosensor 
makes use of a working electrode either as anode or cathode and reference electrodes 
for the detection of the redox reaction or immunochemical reaction taking place due to 
antibody- antigen conjugation.  
Most available amperometric immunosensors uses electrochemical active labels directly 
or product from an enzymatic reaction to facilitate the electrochemical reaction of 
analyte at the electrode surface. This makes it difficult for the fabrication of direct 
amperometric immunosensor since most proteins analyte for amperometric detection 
cannot act as redox couples in electrochemical reactions (Luppa et al., 2001).  Despite 
this disadvantage, this type of immunosensors have linear analyte sampling  range 
which results in its excellent sensitivity compared to the logarithmic relationship found 
in the potentiometric system (Luppa et al., 2001). 
1.15.3 Conductimetric/capacitive immunosensors 
This type of immunosensor measures changes observed in electrical conductivity or 
capacitance in a solution at constant voltage due to biochemical reaction which 
produces or consumes ions. The production or consumption of ions changes the overall 
conductivity of the solution which is then measured. This type of sensors is designed 
with the bioactive materials e.g. enzymes, antibodies, proteins attached to a noble metal 
surface or electrodes such as gold, or platinum and changes in conductance that occur in 
the solution containing the samples are measured  by applying an electric field. 
1.16 Piezoelectric or acoustic immunosensor 
This type of immunosensors generates acoustic wave through the oscillation of 
piezoelectric crystals at high frequency (30-200 MHz) when an alternating voltage is 
applied across inter-digital electrodes. The immobilization of biological recognition 
element on the crystal produces a change in the resonance frequency or a decrease of 
the acoustic wave and the change in the velocity of the acoustic wave is recorded by a 
second inter-digital electrode as signal. The change in velocity recorded is proportional 
to the concentration of the analyte of interest. This type of immunosensors is limited in 
their applications because of the effect of factors such as temperature, pressure and 
surface conductivities which can alter the acoustic wave properties. 
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1.17 Calorimetric immunosensors 
This type of immunosensors also referred to as thermal immunosensors makes use of 
heat sensing transducer or thermistors to detect the changes in temperature of a 
biological analyte immobilized on it or biological analyte in solution. The biological 
analyte in solution might be due to enzymatic catalysed reaction giving out heat or 
antibody action in detecting specific antigen. The results are often read as analyte 
concentration in the solution. This type of immunosensors is widely used in determining 
analyte concentrations in fermentation and environmental analysis. 
1.18 Optical immunosensors 
Optical immunosensor uses optical transducer to detect the change in the intensity of 
light absorbed by certain materials which might be reactants or products from biological 
and chemical systems. The materials are capable of absorbing fluorescence, 
luminescence, bioluminescence and chemiluminescence light depending on their 
surface. Optical immunosensor can be direct sensing without the use of labels such as 
epllipsometry, surface plasmon resonance or indirect sensing which makes use of 
enzymes, antibodies or other biological materials to generate light absorbing products. 
1.19 Antibodies 
Antibodies also referred to as immunoglobulin (Ig) are glycoprotein produced by 
plasma cells (B cells) that bind specifically to foreign molecules (antigen) or 
immunogen. Antibodies can be polyclonal or monoclonal. Polyclonal means that the 
antibodies come from clones of separate B-cells and different antibodies in this group 
react with different antigen determinant.  Monoclonal antibodies are from one clone of 
B-cells and reacts with one specific antigen. The monoclonal antibodies are highly 
specific and has better sensitivity compared to the polyclonal antibodies 
Structurally antibodies are composed of two identical light chains and two identical 
heavy chains linked together by disulphide bonds. The heavy and light chains are 
further divided into two regions based on the variability of the amino acid sequence in 
the chains into variable light chains (VL), constant light chains (CL), variable heavy 
chains (VH) and constant heavy chains (CH) as shown in the Figure 1.6 (Kumagai etal., 
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2010). The antibody has a hinge region which allows for its flexibility therefore forming 
a Y shape molecule. The structure is also divided into two fragments, the Fab (fragment 
antigen-binding) fragment which is the antigen combining site of the antibody and the 
Fc (fragment crystallisable) fragments which has the ability to fix to cell surface and are 
easily crystalized. They contain the heavy chains CH2 and CH3 domains and 
carbohydrates are attached to the CH2 domains in most immunoglobulin and sometimes 
in other regions. 
     
Figure 1.6 (a) Generalized structure of immunoglobulin (IgG) and (b) its three dimension structure 
Immunoglobulin are divided into five classes based on the differences in their amino 
acid sequence and the number of domains in the constant regions of the heavy chains 
namely: IgG (gamma heavy chains), IgM (mu heavy chains), IgA (alpha heavy chains), 
IgD (delta heavy chains) and IgE (Epsilon heavy chains). The IgM and IgG antibodies 
primary functions is to respond to invading foreign substance, IgA protects mucous 
membranes, IgE protects against parasites while no specific function of IgD is known.  
Among the classes of immunoglobulin, the IgG is the most versatile and extensively 
studied because of its ability to carry out all the functions of immunoglobulin. 
Immunoglobulin can also be classified into subtypes based on the differences in amino 
acid sequence in the constant region of the light chain as Kappa light chains (κ) and 
Lambda light chains (λ).  
 
 
 
 
(a) 
 
 
(b) 
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1.20 Antibody-Antigen binding 
The main function of antibody is the binding of an antigen and protecting of the host. 
The binding of an antigen to antibody is highly specific and antigen binds to an 
antibody through its antigenic determinant (epitope). The epitope binds the antigen 
binding site in antibody (paratope) located in the Fab fragment section of the antibody 
which contains the VL and VH chains. The binding of antigen epitope and antibody 
paratope occurs only when they both have the same combination of VL and VH chains. 
This also determines the binding strength of the epitope and paratope (affinity). Specific 
binding of an antibody and antigen is held together by non-covalent bonds including 
electrostatic force, hydrophobic attraction, hydrogen bonding and Van der Waals 
interaction between the antigen and the amino acids of the binding site (Ju et al., 2011). 
1.21 Immobilization of antibody-antigen on substrate 
The type of immobilization technique employed for antibody/antigen conjugation plays 
important role in determining the sensitivity, stability, reproducibility and effectiveness 
of an immunosensor or immunoassay. The orientation of the antibody on the solid 
substrate is of great importance because it determines the availability of antigen binding 
sites (paratope) for antigen conjugation which in turn affects the effectiveness of the 
immunosensor. Antibody is said to be properly oriented when the Fc region with no 
antigen binding site is immobilized onto a solid surface (Lee et al., 2013). Random 
orientation of the antibody or the binding of antibody active site Fab on solid substrate 
result in lower antigen binding capacity. Antibody binding or immobilization technique 
can be divided into two namely: physical and chemical immobilizations. 
1.21.1Physical immobilization method 
Physical immobilization of antibody onto a solid substrate is a cheaper and simple way 
of immobilizing antibodies to an insoluble matrix.  The antibodies are directly adsorbed 
onto the surface of water insoluble carriers or substrate. This method results in the 
denaturation and random immobilization of the antibody which in turn lowers the 
availability of the antibody active site for antigen conjugation.  Physical immobilization  
results in the fabrication of immunosensors with low sensitivity and stability due to 
weak binding force involved such as Van der Waal’s force, hydrogen bond etc. 
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1.21.2Chemical immobilization  
Chemical immobilization involves binding proteins or antibody onto a solid substrate 
through the formation of covalent bonds. This method allows for the specific orientation 
of the antibody on a solid substrate which increases the antigen binding ability. This in 
turn increases the sensitivity, stability and effectiveness of the immunosensor or 
immunoassay. Functional groups such as amino, hydroxyl, thiol, carboxyl groups etc. 
are used as chemical cross-linkers to create strong covalent bond with the antibody onto 
solid substrate. Despite the advantages of the chemical immobilization technique 
compared to the physical method, the chemical immobilization technique also has some 
setback. The immobilization method is a complex procedure and can damage the 
proteins or antibody active site through induced crosslinking of antibodies to antibodies. 
This reduces the availability of antigen binding sites and leads to loss of antibody 
activities. 
1.22 Research question and hypothesis 
How can we improve on the sensitivity, reproducibility, stability and selectivity of AD 
biomarkers as a supportive measure in the clinical diagnosis of AD, specifically the use 
of plasma immunoglobulin as biomarkers? 
Research has shown that the use of biomarkers from cerebrospinal fluids or plasma can 
detect changes in the concentration of amyloid beta proteins (Aβ 40 and 42) and 
neuronal cell line proteins such as tau and phospho-tau proteins in AD patient compared 
to non-AD patient. The use of plasma immunoglobulin as biomarker in ELISA 
technique for AD monitoring has also shown changes in the concentration of plasma 
immunoglobulin in AD patient compared to AD patients treated with cholinesterase 
inhibitor. Despite this developments these biomarkers still faces the problem of 
controlling repeat sampling, technically challenge, complex analysis, high cost and still 
not proven to effectively detect and monitor the progression of AD.  
The development of direct immunosensor electrode that will detect directly the 
conjugation of plasma immunoglobulin (antigen) with specific antibody immobilized on 
the surface of gold electrode and the use of iron oxide core-gold shell nanoparticles as 
immobilizing substrate, will be a cheaper, faster, sensitive, reproducible and more 
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reliable way of detecting and monitoring AD progression. The immunosenor when 
developed can also be incorporated into portable devices for online measurement of the 
early onset and late onset monitoring of AD progression. 
1.23 Thesis organization 
There are three project chapters in this thesis work with the exception of chapter one, 
two, six and seven. Each project chapters have different goals and focus, but the 
nanoparticles synthesized from the first two project chapters were used to achieve the 
goal of the last project chapter. 
Chapter one of this dissertation gives background knowledge of immunosensors, 
immunoassay, nanomaterials specifically iron oxide-gold shell nanoparticles, their 
synthesis, properties and applications in biomedical fields. It also looks into the problem 
faced with the diagnosis and monitoring of the progression of Alzheimer’s disease in 
patients through the use of CSF biomarkers, plasma biomarkers and plasma ELISA 
methods. It also looks at the question and hypothesis of existing AD biomarkers and 
gives the reason why plasma immunoglobulin biomarker immunosensor will be a better 
and reliable option compared to the other methods. 
Chapter two of this thesis looks into the state of art equipment used in the 
characterization of iron oxide nanoparticles and gold nanoparticles synthesized and also 
for the fabricated depleted plasma immunosensor electrode. Physical characterization 
and electrochemical characterization of the nanoparticles were carried out. The physical 
characterization techniques include X-ray diffraction (XRD), X-ray photoelectron 
spectroscopy (XPS), scanning electron microscopy (SEM), transmission electron 
microscopy (TEM) and UV-Vis spectroscopy. The electrochemical characterization 
technique of the nanoparticles and immunosensor electrode was carried out through the 
use of cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). 
The project in chapter three describe the synthesis of magnetite iron oxide nanoparticles 
(Fe3O4) through oxidative alkaline hydrolysis of ferrous salt (iron II sulphate) and the 
effect of synthesis parameters such as temperature, salt concentration, hydroxyl 
concentration and synthesizing under the influence of revolution per minute on the 
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nanoparticles. It also looks at the type of impurity or by-products that accompany the 
synthesized iron oxide nanoparticles by altering these parameters. 
The project in chapter four looks at the formation of iron oxide core-gold shall 
nanoparticles (Fe2O3-Au Nps) by synthesizing maghemite iron oxide nanoparticles (γ-
Fe2O3) from the oxidation of Fe3O4. Gold shell nanoparticles were subsequently formed 
on the Fe2O3-Au Nps through the iterative reduction of chloroauric acid with 
hydroxylamine as reducing agent. This chapter also look at the role of 
polyethyleneimine (PEI) a polycation used in stabilizing and capping of the 
nanoparticles. Specifically the effect of temperature and agitation on polyethyleneimine 
(PEI) adsorption on iron oxide nanoparticles and how it affects the formation or 
attachment of gold nanoparticles on the surface of the iron oxide nanoparticles in the 
formation of iron oxide core-gold shell nanoparticles. 
Project chapter five looks at the fabrication of depleted plasma immunoglobulin 
immunosensor electrode for AD detection and monitoring. The plasma immunoglobulin 
(Ig) was used as the antigen while anti-human immunoglobulin (polyclonal rabbit Anti-
human IgA, IgG, IgM) as the specific antibody to the antigen. Firstly the plasma 
immunoglobulin biomarker immunosensor electrode was developed using gold 
electrode surface as the immobilizing platform and secondly iron oxide-gold shell 
nanoparticles synthesized in chapter four was used as immobilization substrate for the 
antibody/antigen conjugation on the gold electrode. Depleted plasma samples 
containing immunoglobulin as the major constituent from AD patient and control 
subjects where used for the analysis. The two different immunosensor for AD was 
compared with similar samples carried out through the use of ELISA method with UV-
Vis spectroscopy analysis. 
Chapter six of this thesis work looks at the general conclusion obtained from the results 
and analysis of the three project chapters (3, 4 and 5) and possible recommendations to 
improve on the results. Chapter seven is the appendices section of this thesis work.   
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Chapter 2 
Physiochemical analytical techniques 
This chapter looks at the state of art equipment used in the characterization of the 
nanoparticles (Fe3O4, Fe2O3-Au) and immunosensor electrode and their basic principle, 
uses and mode of operation. The characterization of the nanoparticles is based on both 
physical and electrochemical techniques. The physical technique looks at the 
composition, structure, crystallography, conductivity and optical properties of the 
nanoparticles.  The electrochemical technique looks at the electrochemical properties of 
the nanoparticles such as electron transfer ability, resistance to charge transfer, reaction 
kinetics, surface modification and double layer capacitance. 
2.1 Physical characterization techniques 
2.1.1 X-ray diffraction 
This is an analytical technique in crystallography widely used in measuring the 
molecular structure, atomic structure, chemical bonds and defects found in crystals. This 
technique is often used in biochemistry, chemistry, chemical engineering etc. to 
determine the structure of DNA, protein, inorganic compounds and variety of 
molecules. Its working principle is based on the use of x-ray beams to bombard crystal 
sample at suitable angles resulting in reflected or diffracted beams from the crystalline 
atoms in different directions. The combination of the angle of diffraction beam and their 
intensities are then used as a measure to determine the composition of the crystal or 
their lattice spacing.  
Crystalline materials have atoms arranged in regular patterns and each unit cell of the 
crystals contains smallest volume element that describe the crystals.  When an x-ray 
electromagnetic beam is bombarded through the closely spaced lattice in crystal 
samples, the electrons surrounding the atoms of the crystals oscillates at the same 
frequency with the incident beam resulting in reflected or diffracted beam composed of 
scattered rays that is characteristic of the atoms in the crystal ('Fundamentals of 
Diffraction,' 2009) as shown in Figure 2.1.  
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Incident ray 1 and 1’ reaches the crystals and makes an angle theta with the crystal 
plane resulting in reflected rays 2 and 2’ which comes from series of parallel planes 
inside the crystals and their orientation and interplaner spacing are defined by the 
integers or miller indices h, K, l (notations used to identify planes in crystal lattice) at 
angle 2 theta. The difference in path length 1 to 1’ and 2 to 2’is an integral number of 
wavelengths (λ). The spacing of the crystal is determined by using the Bragg’s law as 
shown in equation 2.1 
                                                                                                         2.1 
Where λ is the wavelength of incident ray beam, n is an integer and d is the distance 
between atomic layers in a crystal.  
 
 
 
 
 
 
 
 
Figure 2.1 Typical x-ray reflection 2 and 2’resulting from incident ray 1and1’ on a crystal sample. 
The size of the crystallite is related with the broadening of peak in the diffraction 
patterns and can be determined by using the shape factor in Scherrer equation as shown 
below; 
                                            
  
     
                                                           2.2                         
where 𝛫 is the shape factor,   is the x-ray wavelength, 𝛽 is the line broadening at half 
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the maximum intensity in radians,   is the Bragg’s angle and   is the mean size of the 
crystalline in ordered domains. 
The equipment used for x-ray diffraction analysis is called the x-ray deffractometer and 
its basic components includes an x-ray tube, detector, sample holder, goniometer circle 
or measuring circle, scatter slit, receiving slit, soller slit, θ and 2θ indicator, and a filter 
or monochromator as shown in Figure 2.2A and B (Connolly, 2007). 
     
  
Figure 2.2 A and B shows the component of a diffractometer and diffractometer beam path θ/2θ 
mode respectively. 
The x-ray deffractometer works in scanning range of θ-2θ or θ-θ where the incident and 
diffracted beam both form the same angle θ with the surface of a flat sample while the 
diffracted beam forms an angle 2θ with the incident beam. The x-ray radiation is 
produced in a sealed vacuum tube when high energy electrons strike the anode of a pure 
metal. Often used is Copper (Cu) x-ray tubes and this generates cu radiations with 
different wavelength of which Cu (Kα) is the strongest with wavelength approximately 
A 
B 
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1.54 angstroms (Å). The Cu (Kα) radiation goes to the goniometer circle where the 
sample is placed in a holder, and  where series of parallel plates (collimating slit, soller 
slit) arranged parallel to the plane of goniometer circle combined with scattered slit, 
receiving slit arranged perpendicular to the goniometer circle creates parallel incident 
beam of x-rays that strikes the sample. The resulting diffracted beam from the sample 
passes through receiving slit located at the same distance from the sample and the 
detector end and through the scattered slit which reduces the background before being 
filtered off copper radiation (Kβ) by a filter of monochromator.  
The beam then passes through a soller slit before entering the detector where data on the 
sample are recorded. The quality of the data from the x-ray depends on the nature and 
energy of the radiation, resolution of the instrument, sample preparation and the 
physical and chemical composition of the sample ('Powder Diffractometry,' 2009). 
2.1.2 X-ray photoelectron spectroscopy (XPS) 
X-ray photoelectron spectroscopy is a surface chemical analysis technique that 
determines the elemental composition, empirical formula, chemical state, core electrons 
and corresponding binding energy of materials. Materials are known to have atoms in 
their surfaces with characteristic binding energy that is not necessarily equal to the 
ionization energy of their electron. During an x-ray photoelectron spectroscopy analysis, 
x-ray beam are used to bombards sample surface and the energy of the x-ray photon is 
completely adsorbed by the core electron of atoms in the sample. At larger photon 
energy (   ), the core electrons will escape from the atom and out of the top 0 to 10 nm 
surface of the materials (Hofmann, 2013).  The emitted electrons possess kinetic energy 
   called photoelectron and the corresponding binding energy of these core electrons is 
mathematically expressed by Einstein in equation 2.3 and 2.4. Equation 2.5 indicates 
the absence of work function which can be compensated artificially. 
                                                   2.3 
                                                   2.4 
                                                          2.5 
Where    is the x-ray photon energy,      is the kinetic energy of photoelectron which 
can be measured by the energy analyser and   is the work function induced by the 
analyser or spectrometer about 4~5eV.  
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Figure 2.2 shows a schematic diagram of typical x-ray photon electron equipment which 
consists of a fixed x-ray radiation source, an energy electron analyser and a high 
vacuum chamber. X-ray beams are emitted from the x-ray radiation source and directed 
towards the sample in the high vacuum chamber. The radiation causes the emission of 
photoelectrons on the surface of the sample when bombarded and the vacuum chamber 
allows the emitted photoelectrons to be analysed without interference from gas phase 
collision. The emitted electrons are then dispersed inside the electron analyser based on 
their kinetic energy through the use of an electric field between two hemispherical 
surfaces. This in turn measures the flux of emitted electrons of a particular energy 
which can be used to identify the sample. The most common x-ray radiation source used 
in XPS analysis are magnesium (Mg Kα radiation) with photon energy (  ) of 1253.6 
eV and aluminium (Al Kα radiation) with photon energy of 1486.6 eV. 
 
Figure 2.3 Schematic diagrams showing the major component of XPS equipment 
The energy level diagram for x-ray photoelectron spectroscopy analysis is shown in 
Figure 2.4. It shows how the emitted electrons due to the photon energy moves through 
the different electron shells or principal energy levels (K, L, M and N) from K closest to 
the atom nucleus to the outer N and out of the material being analysed. 
 
 
 
 
Figure 2.4 Energy level diagrams for x-ray photoelectron spectroscopy 
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2.1.3 Scanning electron microscopy (SEM) 
This is an electron scanning technique that uses directed beams of electrons to produce 
images of an analyte at the surface. It is used to analyse the composition, surface 
topography and electrical conductivities of sample at high vacuum, low vacuum and in 
wet conditions. It operates by scanning the surface of the sample with high energy beam 
of electrons in a raster scan pattern, and the electrons interacts with atoms of the sample 
producing signals that gives information about the sample shape, composition and 
electrical conductivities.  
Samples in scanning electron microscopy are detected in three different basic modes 
based on the emitted electrons from the atoms of the sample when strike by electron 
beams. The modes are: (a) the emission of secondary electrons from the surface of 
atoms and the number of secondary electron emitted is a function of the angle between 
the surface and the beam which allows for the imaging of tilt in the sample, (b) the 
emission of back scattered electrons which is the reflection of the electrons back to the 
direction they came from. The back scattered electron mode allows for the gathering of 
information about the distribution of element in the sample and (c) the emission of 
characteristics X-ray from the atoms surface due to the striking electron beam and this 
gives information about the composition and abundance of element in the sample. 
Figure 2.5 shows a schematic diagram of SEM equipment, the equipment is composed 
of an electron gun, two or more electromagnetic lens, vacuum system, scanning system 
which includes fine probe and scan coil, a detector and electronic control (TV or 
computer).  The electron gun generates and accelerates electrons at energies around 0.1-
30keV (Goldstein et al., 2003).  The electron beam passes through the lenses which 
creates a small focused electron probe on the sample placed in a vacuum. The focused 
probe of electrons is scanned across the sample surface in a raster pattern with the aid of 
the scanning coil. The electrons strike the sample surface and up to a depth of 
approximately 1µM at different points generating electromagnetic radiations as signals. 
Selected portion of the generated electromagnetic radiation which includes the 
secondary or back scattered electrons are picked up by the detector system and 
amplified as signal on a TV or computer screen.  The image produced on the screen or 
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cathode ray monitor is directly related to each point the electron beam strikes on the 
sample (Egerton, 2011) and give rise to the linear magnification in SEM. The linear 
magnification is mathematically related to the raster length of the screen or cathode ray 
tube and the raster length on the sample as shown in equation 2.6. 
   
 
 
                                                 2.6 
Where M is the magnification, L is the raster’s length of the monitor and I the raster’s 
length on the sample surface. Samples are analysed in SEM either at low magnification 
or high magnification depending on the information needed.  
 
Figure 2.5 Typical SEM equipment operation and components 
2.1.4 Transmission electron microscopy (TEM) 
Transmission electron microscopy is an electron microscopy technique that is used to 
characterize samples structure, defects, composition and crystallographic nature. 
Samples are analysed in TEM when beam of electrons are emitted from an electron 
source at low wavelength which interacts with the sample and forms an image of the 
sample. The sample is then magnified with lenses and projected to an imaging detector.  
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TEM working principles is the same as that of light microscopy but is a thousand times 
better than the light microscopy due to the lower wavelength of electrons which allows 
for detailed analysis of samples compared to the use of light in the light microscopy. 
The principle involves the release of electron from an electron source when the cathode 
of the source is heated up by current and the electrons accelerated by a high voltage (50-
150kV) at the anode up through vacuum. The electrons are confined by passing through 
two condenser lenses which also determines their brightness and through the condenser 
aperture before hitting the sample surface in vacuum. The electrons pass through the 
sample forming elastically scattered beam (transmitted beam) which then passes 
through the objective lens and objective aperture. The objective lens forms the sample 
image display and with selected area of the aperture the elastically scattered electrons 
are collected to form image on the microscope. The electron beams from the objective 
aperture then passes through sets of magnifying lens consisting of first and second 
intermediate lenses which control the magnification of the image and a projector lens 
which projects the image on a screen or monitor as shown in Figure 2.6 (Williams and 
Carter, 2009b). 
Different type of images can be formed in TEM based on the selected aperture and type 
of electrons selected. Dark field images are formed when the objective aperture selects 
diffracted beam due to scattered electrons and bright field images are formed when the 
objective aperture selects unscattered electrons. The wavelength of the electrons 
determines the resolution of the TEM, thus the shorter the electron waves the higher the 
power of resolution. The power of resolution is also a function of the quality of lens in 
the system, specifically the objective lens ability to manage the image (Williams and 
Carter, 2009a) and the sample preparation method. Other microscopic analytical 
techniques such as energy diffractive X-ray (EDX), electron energy loss spectrum 
(EELS) and energy filtered transmission electron microscopy (EFTEM) can also be 
carried out with the TEM. 
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Figure 2.6 Schematic diagrams of the TEM components 
2.1.5 UV-VIS Spectroscopy  
This is a chemical analytical technique that is used to determine quantitatively the 
presence of different analytes in solution. Analytes such as metal ions (noble or 
transition), biomolecules, organic compounds with high degree of conjugations or 
charge transfer complex compounds in solution can be analysed with UV-spectroscopy. 
UV-Vis spectroscopy deals with the absorbance of light wavelength by the atoms of a 
molecule which result in the excitation of electrons in the atoms from the ground state 
to the excited state within the ultraviolet and visible region of an electromagnetic 
spectrum.  When light wavelength is absorbed by the atoms, some of the light are 
reflected or transmitted and these result in the change in the colour observed during 
sample analysis. The more the absorbed light wavelength, the more concentrated the 
solution and the darker the colour.  
For metal ions in solution it involves the excitation of the d electrons from the ground 
state to the excited state when visible light is absorbed and the resulting colour of the 
solution also depends on the type of ligands or anions present. Organic compounds can 
absorb either ultraviolet or visible electromagnetic radiations lights depending on their 
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degree of conjugation. The absorbance of light in the solution can be used to 
quantitatively determine the concentration of the absorbing species in solution 
according to Beer Lambert Law.  The law state that the absorbance of a solution is 
directly proportional to the concentration of the absorbing species in the solution and 
the path length (Rodger, 2013) as shown in equation 2.7. The law does not hold a 
universal relationship for the concentration and absorbance of all substances. 
           
  
 
                                2.7 
Where A is the absorbance measured, Io is the intensity of incident light at a given 
wavelength, I is the intensity transmitted, b is the path length through the sample, c the 
concentration of the absorbing species, ε is the molar absorptivity or extinct coefficient 
and T is the transmittance.  
UV-Spectroscopy analysis focuses on the absorption from the ultraviolet (200-380 nm), 
visible (280-780 nm) and infrared radiation (0.78-300 µM) regions of the 
electromagnetic radiation spectrum. The electromagnetic radiation spectrum is made up 
of gamma rays, x-ray, ultraviolet, visible, near infrared, infrared, microwave and radio 
wave each having different wavelength and affects the electronic configuration of atoms 
in different ways when absorbed. UV-Spectroscopy equipment is called a 
spectrophotometer and it works by measuring the intensity of light passing through a 
sample I and compares it to the intensity of light before it passes through the sample Io. 
It is basically composed of five basic parts, light source, sample holder (transparent 
cuvette), monochromator (prism or grating), and a detector as shown in Figure 2.7. 
                                                           
 
 
 
Figure 2.7 Schematic diagram of the component of UV-Vis spectrometer           
The light source (e.g. tungsten filaments (300-2500 nm)) generates lights which passes 
through a monochromator (prism) and then separated into different wavelengths. The 
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light separated into different wavelength then passes through the aperture which selects 
a single wavelength that goes through the sample (liquid) in a cuvette. The light passes 
through the sample and some are absorbed by species and also transmitted which is 
detected by a detector (photodiode or photomultiplier tubes) that allows the intensity of 
light reaching it to be measured as a function of wavelength. The result is then 
amplified by a processor and recorded. 
2.2 Electrochemical techniques 
The electrochemical techniques used in this thesis work for the characterization of the 
nanoparticles are cyclic voltammetry (CV) and electrochemical impedance spectroscopy 
(EIS) 
2.2.1 Cyclic voltammetry 
Cyclic voltammetry is a potentiodynamic electrochemical technique used in studying 
and analysing the electrochemical properties of analyte in a solution and their redox 
potentials. It is often the first electrochemical technique carried out in the study of the 
electrochemical properties of analyte in solution. It involves the application of potential 
between a working electrode and a reference electrode in a solution (electrolytic) 
containing analyte and then measuring the current between the working and a counter 
electrode. The current of the working electrode is then plotted against the applied 
potential forming a cyclic voltammogram trace as shown in Figure 2.8.  
The cyclic voltammogram trace shows the reduction of analyte due to the application of 
a negative initial potential resulting in cathodic peak current scan( Ipc) and a 
corresponding cathodic peak potential (Epc) at point C. The potential reaches a 
switching potential (D) which has enough voltage that causes the oxidation of the 
analyte to an anodic peak current (Ipa) and corresponding anodic peak potential (Epa) at 
point F. The anodic peak current is attained when all the analyte at the surface of the 
working electrode is completely oxidized. The oxidation and reduction of analyte on the 
electrode surface results from the movement of electrons across the electrode surface 
(Stojek, 2010). The redox potential (E
o
) of the analyte represents the potential where the 
reduced analyte or species equals the oxidized species and is obtained at half the height 
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of the cathodic peak and anodic peaks (Scholz, 2010) as shown in equation in equation 
2.8. 
   
          
 
                           2.8 
Cyclic voltammetry analysis also ramps time (scan rate) against the working electrode 
potential measured against a reference electrode forming a reversible wave form as 
shown in Figure 2.9. The waveform is scanned forward negatively with greater potential 
at point (a) and the current keeps increasing as the potential reaches the analyte 
reduction potential ends at lower potential point (d) where the analyte is depleted. Point 
d is the switch potential and the reverse scan which is the re-oxidation of the analyte 
starts and ends at point (g). The forward scan of the waveform produces current peak for 
analyte reduction within scanned potential range and the reverse shows the analyte 
oxidation and the scan direction can be changed depending the type of analyte, thus for 
analyte that undergoes oxidation first, the scan potential will be positive first before 
reduction. 
 
Figure 2.8 Typical cyclic voltammogram curve showing the cathodic and anodic peak currents and 
potentials. 
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Figure 2.9 Typical cyclic voltammetry potential wave form. 
Cyclic voltammetry equipment is composed of a three electrode system made up of 
working electrode, a reference electrode (calomel or Ag/AgCl) and a counter electrode 
(platinum), a potentiostat, measurement cell and a recording device (computer system). 
The operation simply involves the placement of analyte in an electrolytic solution in cell 
with three electrode set up and then applying a potential between the reference electrode 
and the working electrode with the aid of a potentiostat. The corresponding current is 
automatically measured between the working electrode and the reference electrode as 
shown in Figure 2.10 (Rico et al., 2009). 
 
Figure 2.10 Schematic diagram of electrochemical cell with three electrode system 
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2.2.2 Electrochemical impedance spectroscopy (EIS) 
Electrochemical impedance spectroscopy is used to measure a system response to 
varying frequencies. This allows for the characterization of electrode processes, 
complex interface, charge transfer resistance determination, double layer capacitance 
and ohmic resistance (electrolyte resistance) of the system. Also information on the 
general electrochemical processes and reaction kinetic involved in the processes can be 
obtained. The EIS principle is based on the opposition or resistance of alternating 
current (impedance) flowing in a system under investigation over range of frequencies 
and the result is plotted on a Nyquist plot or Bode plot.  
The Nyquist plot displays the real component of the impedance against the imaginary 
component of the impedance in EIS experiment. In the Nyquist plot a semi-circle arc is 
formed on the real axis at high frequencies (high kHz range) which shows the resistive 
displacement caused by electrolyte impedance (Yeu et al., 1991). The plot is dominated 
by processes occurring at or very close to an electrode surface. When an electrode is 
modified with a layer of nanoparticles or film, the film resistance (RF) is in series with 
the charge transfer resistance (RCT) at high frequencies at the real axis. The impedance 
of the film is the difference between when film is present on the electrode surface and 
the absence of film on the electrode surface (Yeu et al., 1991). In the absence of any 
major difference, the electrolyte is said to have effectively penetrated the film and the 
film resistance can be considered negligible (Armstrong et al., 1986).  
The semi-circle arc can also be formed at lower frequencies due to the parrallel effect of 
the charge transfer resisitance of the redox process and double layer capacitance at he 
electrode surface (Deslouis et al., 1989). 
 
Figure 2.11 (A) shows typical Nyquist plot for an electrode modified with a layer of 
film. It shows the real (Z’) and imaginary parts (Z’’) component of the impedance, 
electrolyte resistance (RS), immobilized film resistance (RF), resistance to charge 
transfer (RCT), low frequency capacitance (CLF) and frequency w.  
The semi-circular arc appearance in the Nyquist plot can be explained through the use 
of Randles equivalent circuit in Figure 2.11 (B) for simple charge transfer as shown in 
the reaction in equation 2.9  
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Figure 2.11 (A) Schematic diagram of  Nyquist plot (B) Randles circuit showing RS, CDL, RCT and 
ZW 
 
                                                              2.9 
separating the in phase and out of phase component of impedance, gives: 
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Where R is gas constant, T is temperature, F is faraday constant, n is the number of 
electron involved, A is the electrode area, W is the frequency of applied pertubation and 
σ is the warburg coefficient. For a limiting situation where W moves towards zero (W        
0), the real and imaginary part of the impedance is writing as: 
               
 
 
                                          2.13 
         
 
                                                 2.14 
When W moves towards infinity (W        ), the real and imaginary component of the 
impedance becomes: 
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Therefore at high frequencies, the imaginary impedance displayed in the y axis of the 
Nyquist plot becomes very small but gradually increases as the frequency diminshes. 
Further decrease in frequency causes more current to flow through the charge transfer 
(RCT) component of the equivalent circuit and the contribution from CDL decreases 
gradually to a minimum point corresponding to the second intercept of the semicircle in 
the x axis as shown in Figure 2.10 (A). This intercept at a lower frequency of the 
semicircle arc is the sum of the charge transfer resistance (RCT) and solution resistance 
RS. The charge transfer resistance can be calculated by subtracting the solution 
resistance obtained from the high frequency intercept from the low frequency intercept.  
 
The EIS experimental procedure involves placing a three electrode system comprising 
of the working electrode (electrode of interest), reference electrode and a counter 
electrode in an electrolyte solution. Applying a voltage through a potentiostat to the 
working electrode with a small sinusoidal amplitude e.g.10 mV waveform, and this AC 
(alternating current) potential perturbation drives the redox processes (if any) at the 
electrode surface. The resulting amplitude and phase angle from the AC current are then 
measured and used in calculating the real and imaginary components of the impedance 
displayed in the Nyquist plot (Martin et al., 1989). The impedance is calculated as the 
ratio of the applied sinusoidal voltage to the sinusoidal current that flows between the 
counter and working electrodes as a result of the applied voltage (Ehret et al., 1997).  
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The Randle circuit which is an equivalent circuit of resistors and capacitors that passes 
current with the same amplitude and phase angle that the real cell does under a given 
excitation as shown in Figure 2.10 (B) is used to predict the performance of the 
electrochemical cell or EIS experimental set up. It also describes the recorded 
impedance spectrum at high to medium frequencies when the EIS experiment is run at 
the formal potential of redox couple present (Lindholm, 1990).  In the Randle circuit RS 
is the electrolyte resistance, CDL is the double layer capacitance, RCT is the charge 
transfer resistance and ZW is the Warburg impedance.  
 
The CDL results from a separation of charge in space due to the asymmetry that occurs 
when a metal-solution interphase is formed. ZW is the Warburg impedance (ZW) caused 
by mass transport limitation by diffusion and it gives rise to a constant phase angle of 
45° (π/4) as shown in the Nyquist plot Figure 2.10 (A). The ZW occurs in EIS 
experiment if the reaction is dominated by partial or complete mass transport control by 
diffusion. The CDL, RCT and ZW are placed in parallel positions in the circuit because the 
current passing through the working electrode is the sum of the individual contributions 
from these processes. The RS is placed in series position in the equivalent circuit since 
all the current must pass through the uncompensated solution resistance (Ehret et al., 
1997). RS and CDL are nearly ideal circuit elements but RCT and ZW which are 
components of the faradaic impedance changes with frequency because they are not 
ideal (Ehret et al., 1997). Therefore in real experiment a much more complex behaviour 
is expected due to coupling between faradaic and double layer charging processes.  
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Chapter 3 
Nature of Magnetite Nanoparticles Synthesized by Direct Oxidative 
Alkaline Hydrolysis of Iron II sulphate by varying synthesis 
parameters 
3.1 Introduction 
Iron oxide nanoparticles magnetite (Fe3O4) or maghemite (γ-Fe2O3) are widely used in 
medical and biomedical applications such as in hyperthermia therapy, drug delivery and 
magnetic resonance imaging (Gupta and Gupta, 2005; Gupta et al., 2007; Jain et al., 
2008) . There use depends on their sizes, nature, stability and purity which are 
influenced by their mode of synthesis. This in turn affects their magnetic properties, 
potency and sensitivity in their applications e.g. resonance imaging. There are different 
synthetic route for the synthesis of iron oxide nanoparticles, such as sol gel, 
sonochemical reactions, hydrothermal reactions, co-precipitation, microemulsions, flow 
injection and electro spray method.(Laurent et al., 2008) .It is important that the method 
chosen for the nanoparticles synthesis leads to mono-dispersed particles domains which 
are easy to characterize with controllable properties. These types of particles are mostly 
desirable in biomedical applications compared to the poly-dispersed domain. The type 
of synthesis route also affects the nanoparticle sizes, shape, structural defects and degree 
of impurities. The method also should be reproducible and industrially scalable without 
complex purification processes.   
Magnetite nanoparticles (Fe3O4) in this dissertation were synthesized through direct 
oxidative alkaline hydrolysis of iron II sulphate salt. The process simply involves 
reacting iron II salt with a strong base (e.g. sodium hydroxide) in the presence of a mild 
reducing agent (potassium nitrate) to form iron (II) hydroxide. The iron (II) hydroxide 
formed is heated and undergoes anaerobic oxidation by the protons of water to form 
magnetite and molecular hydrogen (Schikorr reaction). The chemical reaction for the 
synthesis of magnetite and Schikorr reaction are shown in equation 3.1 and 3.2.  
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                                                     3.1. 
                                                               3.2 
Magnetite (Fe3O4) is known to be an unstable iron oxide and easily undergoes oxidation 
in the presence of oxygen to form maghemite (γ-Fe2O3) as shown in equation 3.3 
(Rebodos and Vikesland, 2010). The process of oxidation involves the iron II cation 
(Fe
2+
) in the octahedral site of magnetite being oxidized to iron III cation (Fe
3+
) creating 
cationic vacancies which helps to maintain the charge balance in maghemite.  
       
 
 
     
             
                      3.3 
Most often stabilizers are used during magnetite nanoparticles synthesis to improve the 
mono-dispersity and stability of the particles. This section of the dissertation will be 
based on the synthesis and characterization of magnetite using polyethyleneimine (PEI) 
a polycation as stabilizing agent. 
Within the past decade and recently, authors have published works on the synthesis of 
iron oxide nanoparticles (Fe3O4) through oxidative alkaline hydrolysis of iron II 
sulphate salt. Most attention has been focussed on the synthesis of desired Fe3O4 
nanoparticles sizes, stabilization and application of the nanoparticles in various fields. 
But not much work has been done on the type of likely side products (iron oxides) or 
impurities that may accompany the formation of iron oxide nanoparticles by varying 
synthesis parameters using this method. 
Recently 50 nm cubic shaped average size iron oxide nanoparticles (Fe3O4) were 
successfully synthesized using the oxidative alkaline hydrolysis of ferrous ions at 90
o
C 
(Goon et al., 2010). Murbe and co-workers (Mürbe et al., 2008) showed that oxidative 
alkaline hydrolysis of ferrous ion at 90
o
C allowed the synthesis of large size magnetite 
nanoparticles with cubo-octahedral morphologies. They also showed that complete 
oxidation of the nanoparticles was achieved at temperatures 300
o
C and the degree of 
oxidation depends on the particle sizes. 
Hexagonal Fe3O4 nano-plates of thickness 10-15 nm with side length of 150-200 nm 
were successfully synthesized through oxidative alkaline hydrolysis of ferrous ion at 
50 
 
90
o
C (Ma et al., 2013). Their research was focused on how ethylene glycol affects the 
size and shape of the nano-plates. Verges and co-workers synthesized Fe3O4 
nanoparticles with different sizes by varying synthesis parameters (salt concentration, 
hydroxyl concentration and ethanol concentration) at 90
o
C using oxidative alkaline 
hydrolysis of ferrous ion. They showed that increasing salt concentration increases the 
nanoparticles sizes and shape with maximum particle size of 300 nm. Changes in 
hydroxyl iron concentration and the presence of ethanol results in the formation of 
smaller particles. No other iron oxide phase was detected during synthesis. The effect of 
temperature changes and synthesis under the influence of revolution per minute on the 
sizes and shape of the nanoparticles were not studied. 
Oxidative alkaline hydrolysis of ferrous ion was also used by Sugimoto and co-worker, 
who showed that dramatic change in particle size and morphology, was determined by 
the iron salt concentration. Sharp pH change from iron II salt concentration and 
hydroxyl ion affects the formation mechanism of the particles (Sugimoto and Matijević, 
1980). They also reported that synthesizing the particles at 80
o
C is much slower than 
90
o
C, but gave crystals with same modal diameters with broader size distribution than 
the system aged at 90
o
C. No analysis was carried out by the group on the effect of 
higher temperatures and synthesis under the influence revolution per minutes on the 
nature of nanoparticles. 
3.2 Aims 
The aims of this work is to synthesis magnetite (Fe3O4) nanoparticles through oxidative 
alkaline hydrolysis of iron II sulphate salt and explore the effect of synthesis 
temperature, iron salt concentration, hydroxyl concentration and revolution per minute 
on the nature and purity of iron oxide nanoparticles (Fe3O4 Nps). Polyethyleneimine 
(PEI) was used as a stabilizing agent and X-ray diffraction, X-ray photoelectron 
spectroscopy and transmission electron microscopy were used in characterizing the 
nanoparticles. 
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3.3 Experimental 
3.3.1 Materials and chemicals 
Polyethyleneimine (branched 25000mw), iron II sulphate heptahydrate >99%, were 
purchased from Sigma Aldrich (Dorset UK), sodium hydroxide 97%, and potassium 
nitrate 99% were from Alfa Aesar (Lancashire UK). All chemicals were used as 
received without further purification. Solutions were prepared using Millipore deionised 
water. 
3.3.2 Synthesis of iron oxide core/polyethyleneimine nanoparticles (Fe3O4-PEI NPs) 
Iron oxide nanoparticles (Fe₃O₄ Np) were synthesized following a method by Goon and 
co- workers with some modification (Goon et al., 2009). Different concentration of iron 
(II) sulphate heptahydrate (0.0035-0.2M) were added into 80ml of deionized water 
containing PEI (500mgl
-1
) in a 250ml round bottom flask after sparging for 20 minutes. 
Potassium nitrate (10ml, 2M) was added followed by the addition of sodium hydroxide 
(10ml, 1M). This results in the formation of iron (II) hydroxide which was heated for 2 
hours at 90
0
C while constantly sparging the system with nitrogen. Black precipitate of 
iron oxide nanoparticles was formed and washed several times with deionised water. 
The nanoparticles were finally suspended in 80ml of deionised water at pH 6-7. The 
procedure was repeated but by varying the heating temperature (50°C, 90°C and 
150°C), heating at 90°C with different revolution per minute (200, 500 and 1500) and 
varying hydroxyl ion concentrations (0.001M, 0.01M, 0.1M, 1.0M and 2.0M). 
3.3.3 Characterization of the iron oxide/PEI nanoparticles 
X-ray diffraction pattern of nanoparticles were obtained using PANalytical X’pert Pro 
MPD, powered by Philips PW 3040/60 x-ray generator fitted with X’celerator and using 
Cu Kα radiation with wavelength of 1.54180Å to determine the crystalline structure of 
the nanoparticles. The nature and core electrons of the Fe3O4 nanoparticles were 
obtained by x-ray photoelectron spectroscopy (XPS) with Thermo Scientific K-α 
monochromated small spot x-ray Photoelectron Spectrometer system. Transmission 
electron microscopy analysis (TEM) was carried out with Philips CM200 FEGTEM 
field emission gun TEM/STEM with supertwin objective lens. 
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3.4 Results and Discussion 
3.4.1 Physical properties of nanoparticles synthesized by varying iron salt 
concentration 
FeSO4       KNO3        NaOH        Temp        PEI        XRD       TEM       Shape                                    
(M)             (M)             (M)            
o
C             mgl
-1
      (nm)       (nm) 
 
 0.0035         2.0              1.0              90            500           57            58          cubic 
 0.017           2.0              1.0              90            500           62            66          cubic 
0.025           2.0              1.0              90            500           50            50          cubic 
0.035           2.0              1.0              90            500           70            72          cubic 
0.068           2.0              1.0              90            500           216          565        hexagonal 
0.1               2.0              1.0              90            500           192             -           - 
0.2               2.0              1.0              90            500           76            78          shapeless 
 
Table 3.1Fe3O4 nanoparticles synthesized by varying iron II sulphate concentration 
Synthesizing Iron oxide (Fe3O4) nanoparticles by varying the salt concentration as 
shown in table 3.1, showed that the nanoparticles changes in sizes and shape as the salt 
concentration varies. This might be due to the fluctuations in the pH (5-6) of the system 
caused by large changes in salt concentration. Slight changes in the pH of the reacting 
system are known to affect the nanoparticles sizes and shapes (Sugimoto and Matijević, 
1980; Vergés et al., 2008). The largest nanoparticles sizes was observed when the salt 
concentration was increased to 0.068M and the nanoparticles sizes start decreasing with 
further increase in salt concentration. Although there is a large difference between the 
crystallite nanoparticles sizes as analysed by the XRD compared to the TEM results for 
the large particles formed at 0.068M FeSO4. This might be due to aggregation of the 
nanoparticles over the length of time it took for the TEM analysis to be carried out. It 
might also result from poor stabilizing effect of polyethyleneimine on larger 
nanoparticles during synthesis.  
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 (a)   (b) 
 (c)   (d) 
(e)    (f) 
 (g)   (h) 
Figure 3.1 Effect of excess iron II salt on Fe3O4 synthesis and paramagnetic behaviour and nature 
before and after magnetic separation (a) and (b) 0.025M, (c) and (d) 0.2M, (e) and (f) 0.3M, (g) and 
(h) 0.5M  
Figure 3.1 showed that increasing the salt concentration to 0.2M and above (0.3M and 
0.5M) results in less paramagnetic effect or no visible paramagnetic effect of the 
nanoparticles at room temperature. Paramagnetism is the ability of a material to be 
attracted to an external magnet and losing the magnetic property upon removal of the 
external magnet. The observed less or no visible paramagnetic effect at higher salt 
concentration is as a result of the presence of β-iron oxy hydroxide nano-rods also 
known as alkaganeite (β-FeOOH) mixed with the formed iron oxide nanoparticles.  The 
β-FeOOH nano-rods are brownish in colour and have Neel temperatures that lie close to 
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room temperature thus making them less paramagnetic or antiferrimagnetic under 
ambient conditions .The antiferromagnetic behaviour of β-FeOOH nano-rods also 
increases with increasing iron salt concentration in the mixture. The TEM images in 
Figure 3.2 shows that the nanoparticles have cubic shape at lower salt concentration, 
hexagonal shape at 0.068M and not well defined shape 0.2M mixed with β-FeOOH 
nano-rod. The average size distribution of the nanoparticles from TEM analysis shows 
that nanoparticles did not have broad size distribution as shown in Figure 3.3. 
 (a)  (b) (c)  
(d)   (e)  (f)  
Figure 3.2 TEM images of Fe3O4 nanoparticles synthesized at different FeSO4 concentration (a) 
0.0035M FeSO4, (b) 0.017M FeSO4 (c) 0.025M FeSO4 (d) 0.035M FeSO4 (e) 0.068M FeSO4 (f) 0.2M 
FeSO4 
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 (a) (b) 
 (c) (d)
(e)  (f) 
Figure 3.3 Size distribution of Fe3O4 nanoparticles synthesized at different FeSO4 concentration (a) 
0.0035M FeSO4, (b) 0.017M FeSO4 (c) 0.025M FeSO4 (d) 0.035M FeSO4 (e) 0.068M FeSO4 (f) 0.2M 
FeSO4 
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Figure 3.4 XRD analysis of Fe3O4 synthesis by varying iron II sulphate concentration (a) 0.0035M 
FeSO4, (b) 0.017M FeSO4 (c) 0.025M FeSO4 (d) 0.035M FeSO4 (e) 0.068M FeSO4 (f) 0.1M (g) 0.2M 
FeSO4 
The XRD analysis in Figure 3.4 shows diffraction peaks of iron oxide (Fe3O4) 
nanoparticles synthesized at the different iron salt concentrations. The diffraction peaks 
represented by the miller index (111), (220), (311), (222), (400), (422), (511), (440), 
and (611) can be indexed to the face-centered cubic structure of magnetite (Fe3O4) 
according to joint committee of powder diffraction standards (JCPDS) number 00-019-
0629. The presence of diffraction peak (b-200) at lower angle for sample (g) prepared 
with 0.2M FeSO4 indicates the presence of β-FeOOH.  
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Figure 3.5 Fe3O4 nanoparticles XPS analysis (a) 2p core electrons (b) 1s core electrons of O2 
Figure 3.5a shows the XPS analysis for magnetite nanoparticles synthesized without 
excess salt concentration (0.025M FeSO4). It shows the characteristic doublet for iron 
base compounds indicating the presence of 2p core electrons (Fe 2p3/2 and 2p1/2). The 
arrows shows the presence of iron II cation (Fe
2+
) at binding energies of 710.18eV, 
713.38eV and 721.78eV and iron III cation (Fe
3+
) at 718.08eV confirming the formation 
0
10000
20000
30000
40000
50000
60000
70000
80000
695 700 705 710 715 720 725 730 735 740 745
C
p
s 
Binding energy (eV) 
Fe2+ (710.18eV) 
Fe3+ sat (718.08 eV) 
Fe2+  (721.78eV) 
Fe2+ sat (713.38eV)  
 
__  Shirley bacground 
__   Iron doublet showing Fe2+ cation at 710.18eV 
---  Iron doublet showing  Fe2+ cation at 713.38eV 
-.-   Iron doublet showing Fe3+ cation at 718.08eV 
---  Iron doublet showing Fe2+ cation at 721.78eV 
 
Shirley background 
a 
0
20000
40000
60000
80000
100000
120000
520 525 530 535 540 545 550
C
p
s 
Binding energy (eV) 
O 1S 
Oxide (529.63eV) 
Oxide (530.48eV) 
b 
Shirley background 
58 
 
of magnetite (Fe3O4) nanoparticles. Figure 3.5b also shows that the 1s core electron of 
oxygen in Fe3O4 nanoparticles results only from oxides in the nanoparticles at lower 
binding peak of 529.58eV and 530.48eV.  
3.4.2 Physical properties of nanoparticles synthesized by varying base (NaOH) 
concentration 
FeSO4       KNO3        NaOH        Temp        PEI        XRD       TEM       Shape                                    
(M)            (M)             (M)              
o
C            mgl
-1
      (nm)       (nm) 
 
 0.025         2.0             0.005             90              500         19             20          shapeless 
 0.025         2.0             0.01               90              500         26             26          s/spherical 
0.025         2.0             0.1                 90              500         40             44           cubic 
0.025         2.0             1.0                 90              500         50             51           cubic 
0.025         2.0             2.0                 90              500         60             64           cubic 
 
Table3.2 Fe3O4 nanoparticles synthesized by varying base concentration  
Iron oxide nanoparticles synthesized by varying the OH
- 
concentration results in the 
formation of smaller nanoparticles (super-paramagnetic and paramagnetic) with broader 
size distribution at lower OH
-
 concentrations.  The nanoparticles sizes increases with 
lesser size distribution and the shape changes from shapeless form to cubic as the OH
-
 
concentration increases as shown in table 3.2. 
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 (c)    (d) 
  (e)   (f) 
     (g)    (h)                                                                                                  
Figure 3.6 TEM images of Fe3O4 nanoparticles synthesized at (a) 0.005M NaOH (b) size 
distribution of Fe3O4 Nps at 0.005M (c) 0.01M NaOH (d) size distribution for 0.01M NaOH (e) 1M 
NaOH (f) 1M NaOH size distribution (g) 2M NaOH (h) 2M size distribution. 
        
Figure3.7 Images of Fe3O4 nanoparticles synthesized with (A) 0.005M, (B) 0.01M and (C) 1M 
NaOH respectively 
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Figure 3.6 shows the TEM images of nanoparticles synthesized with the different base 
concentrations and their size distribution. Nanoparticles synthesized with 0.005M and 
0.01M NaOH have broader size distribution (1-40 nm) and 1-50 nm respectively. The 
average particle size is 20 nm for 0.005M NaOH with no preferred particles shape and 
26 nm for 0.01M NaOH with spherical shape. Nanoparticles synthesized with 0.1M, 1M 
and 2M NaOH had cubic shape with less size distribution. The average particle size is 
44 nm, 51nm and 64 nm respectively from the TEM images. Figure 3.7 A, B and C after 
magnetic separation and removal of supernatant shows that only small quantity of iron 
oxide nanoparticles can be synthesized in the presence of lower hydroxyl concentrations 
(0.005M and 0.01M) compared to higher concentration (C). This can be attributed to the 
insufficient hydroxyl groups present that can convert the iron salt to iron oxide 
nanoparticles. This phenomenon can be explained from the stoichiometric relationship 
between iron salt to NaOH concentration in the formation of iron oxide nanoparticles in 
equation 3.1.The equation shows that two moles of NaOH is needed to react with one 
mole of iron salt to form magnetite nanoparticles. 
 
Figure3.8 XRD analysis of Fe3O4 synthesis by varying hydroxyl ion concentration (a) 0.005M (b) 
0.01M (c) 0.1M (d) 1M and (e) 2M 
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Figure 3.8 shows the XRD analysis of iron oxide nanoparticles synthesized with the 
different NaOH concentrations. The diffraction peaks for samples a, b, c, d, and e can be 
indexed to the face centred cubic structure of magnetite except for peak (a-012). It was 
observed from the XRD diffraction spectra the disappearance of the miller index 111 
peaks at 0.005M (a) and 0.01M (b) concentrations. This indicates the absence of large 
size crystals nanoparticles at these concentrations. The 111 diffraction peaks are used in 
identify the presence of large-size crystal in samples, it can also result from the 
preferred orientation effects of the nano-crystal during preparation. 
The presence of diffraction peaks (a-012) for iron nanoparticles synthesized with 2M 
NaOH shows that other form of iron oxide hematite (α-Fe2O3) in trace amount was 
formed. The small letter a attached to the miller index is used to differentiate this peak 
from the magnetite peaks.  
3.4.3 Physical properties of nanoparticles synthesized by varying revolution per 
minute 
FeSO4       KNO3        NaOH        Temp        PEI        RPM       XRD                                           
(M)             (M)             (M)            
o
C             mgl
-1
    (rmin
-1
)     (nm) 
 
 0.025           2.0                 1.0             90            500         200          74           
 0.025           2.0                 1.0             90            500         500          65           
0.025           2.0                 1.0             90            500        1500         50    
 
Table 3.3 Fe3O4 nanoparticles synthesized by varying revolution per minute  
Iron oxide nanoparticles synthesized by varying the revolution per minute showed that 
the nanoparticles crystallite sizes increased with decrease in revolution per minute as 
shown in table3.3. It was observed that XRD spectrum for Fe3O4 at 500 and 1500 
revolution per minutes contains some diffraction peaks that shows the presence of small 
amount of α-Fe2O3 and iron oxy hydroxide (γ-FeOOH) also known as Lepidocrocite 
present in the nanoparticles as shown in Figure 3.9. The presence of Lepidocrocite at 
diffraction peak 011 denoted by L-011  is due to the oxidation of iron II hydroxide 
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(Fe(OH)2) leading to mixed ferric and ferrous ions in solution and the formation of 
magnetite (Snow et al., 2011). Lepidocrocite is known to be paramagnetic at room 
temperature and antiferromagnetic at its Neel temperature of 77K  with slightly smaller 
band gap than goethite at 2.2eV (Hall et al., 1995). The formation of small amount of α-
Fe2O3 (hematite) at the lower angle might be as a result of larger multiplet splitting of the 
high spin state 2p3/2 core electrons during synthesis of Fe3O4 nanoparticles caused by 
higher revolution per minute.  
 
Figure 3.9 XRD analysis of Fe3O4 synthesis at (a) 200, (b) 500 and (c) 1500 revolution per minute  
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Figure 3.10 XPS analysis Fe3O4 synthesis with and without revolution per minute  
 
Figure 3.10 shows the XPS analysis of the nanoparticles synthesized at higher 
revolution per minute compared to magnetite nanoparticles synthesized without 
revolution per minute. It corroborates the result from the XRD analysis that the α-Fe2O3 
(hematite) formed is as a result of multiplet splitting of the high spin core electrons 
causing the broadening of the Fe2p peaks as indicated by arrow for magnetite 
synthesized with revolution per minute. 
The Multiplet splitting of high spin state core electrons is known to be a characteristics 
step for α-Fe2O3 formation.(Mills and Sullivan, 1983; Nasibulin et al., 2009). It is a 
phenomenon associated with photoelectron peaks caused by an unpaired valence 
electrons present giving rise to exchange interactions which affect differently the 
remaining spin-up or spin-down core electrons. In the case of the high spin states the 
phenomenon is heightened, thus for high spin states of Fe
II
 and Fe
III
 a broadening of the 
Fe2p peaks due to unresolved multiplet splitting is observed. 
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3.4.4 Physical properties of nanoparticles synthesized by varying synthesis 
temperature 
FeSO4       KNO3        NaOH        Temp        PEI          XRD                                                       
(M)             (M)            (M)            
o
C             mgl
-1
        (nm) 
 
 0.025           2.0                1.0            50            500           55                      
 0.025           2.0                1.0            90            500           51                       
0.025           2.0                1.0            150          500           52                                               
 
Table 3.4 Fe3O4 nanoparticles synthesized by varying synthesis temperature 
Synthesizing iron oxide nanoparticles by varying the synthesis temperatures does not 
really affect the size of the nanoparticles as shown in table 3.4. The XRD diffraction 
pattern of the nanoparticles in Figure 3.11 showed the nanoparticles peaks can be 
indexed to the face centred cubic structure of magnetite for samples a, b and c except 
for the appearance of diffraction peak a-012 at lower angle planes around 24
o
 (Hou et 
al., 2007) for increased synthesis temperature 150
o
C. This peak indicates the presence 
of α –Fe2O3 (hematite) which is a more stable iron III oxide. This might result from the 
oxidation of Fe3O4 at higher temperature (150°C).  
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Figure 3.11  XRD analysis Fe3O4 synthesized by varying synthesis temperatures (a) 50°C, (b) 90°C 
and (c) 150°C  
 
4.0 Conclusion 
 
This work shows that iron oxide nanoparticles (Fe3O4) were successfully synthesized 
through oxidative alkaline hydrolysis of ferrous ion and that synthesis parameters affect 
the nature and purity of the nanoparticles. Changing iron salt concentration affects the 
size and shape of the nanoparticles and salt concentration up to 0.2M and above results 
in less paramagnetic effect of the nanoparticles due to the formation of alkaganeite (β-
FeOOH) nano-rods mixed with iron oxide nanoparticles. Hydroxyl ion concentrations 
(0.005M and 0.01M) results in lesser conversion of iron salt to nanoparticles with the 
formation of smaller nanoparticles (super-paramagnetic and paramagnetic) with broad 
size distribution. Increasing hydroxyl concentration results in the formation of cubic 
shaped paramagnetic Fe3O4 nanoparticles with less size distribution and traces of α-
Fe2O3 formed at 2M NaOH.  
Synthesis temperature does not affect the Fe3O4 nanoparticles sizes, but synthesizing the 
nanoparticles at temperature150
o
C results in the formation of trace amount of hematite 
(α-Fe2O3) mixed with Fe3O4 nanoparticles.  Iron oxide nanoparticles synthesized 
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through revolution per minutes (RPM) showed that the Fe3O4 nanoparticles sizes 
increases with decreasing RPM, but the nanoparticles synthesized at higher RPM 
contains small amount of α-Fe2O3 and lepidocrocite (γ-FeOOH) as impurities. 
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Chapter 4 
The Effect of temperature and agitation on polyethyleneimine 
adsorption on iron oxide magnetic nanoparticles in the synthesis of 
iron oxide-Au core-shell nanoparticles 
4.1 Introduction 
Iron oxide nanoparticles are known for their cost effectiveness and unique properties 
such chemical stability, biocompatibility, non-toxicity, effective specific power 
absorption rate, strong magnetic properties, high separation efficiency and high specific 
surface area which makes them useful in various field applications. These properties 
become limited in use due to the aggregation of iron oxide nanoparticles with time 
during synthesis and applications especially in biomedical and biosensor/immunosensor 
applications. Biomedical applications such as in vitro magnetic separation (particles 
sizes >50 nm) and in vivo analysis (particles sizes <50 nm) require the use of iron oxide 
nanoparticles with narrow size distribution and surface coating with biocompatible 
materials at physiological pH (pH 7.3 to 7.4 in which body cells can survive and 
function best). The surface modification of these nanoparticles is necessary for the full 
utilization of the magnetic property of iron oxide nanoparticles and also to adjust the 
zeta potential of the ferro fluid to zero at physiological pH.  
The use of electrostatic stabilization of nanoparticles through the creation of 
electrostatic repulsion of similarly charges surfaces due to an electric double layer 
around the particles (Kim et al., 2003) is one of the most efficient and practical ways for 
the surface modification of iron oxide nanoparticles.   
Magnetic iron oxide nanoparticles are known to be isoelectric at a pH of 7(Vergés et al., 
2008; Daou et al., 2009), indicating that they are only stable at high or low pH values 
thus requiring surface modification through the use of organic or inorganic stabilizers. 
In synthesizing Iron oxide nanoparticles organic stabilizers (natural or synthetic) such as 
dextran, starch, gelatin, chitosan, poly (ethyleneglycol) (PEG), poly(vinyl alcohol) 
(PVA), poly(lactide acid) (PLA), aliginate, polymethylmethacrylate (PMMA), 
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polyacrylic acid (PAA), and inorganic stabilizers (silica, metal, non-metal, metal oxides 
and sulphides) have been used to functionalize the nanoparticles. Among the synthetic 
organic stabilizers used in functionalizing iron oxide nanoparticles, polyethyleneimine 
(PEI) is known to be effective in stabilizing, preventing aggregation of iron oxide 
nanoparticles and as capping agent in formation of iron oxide core gold shell 
nanoparticles for biomedical applications. 
In recent years great deal of research has been focused on ways of improving the use 
and application of Iron oxide nanoparticles in in-vivo and bioelectronics applications. 
Iron oxide nanoparticles coated with gold shell serve as excellent platform for the 
construction of biosensors, immunosensors and other biomedical and environmental 
applications. The presence of gold shell on iron oxide nanoparticles increases the 
nanoparticles surface area, electrical conductivity and biocompatibility for the 
conjugation of proteins, enzymes, antibodies and deoxyribonucleic acid (DNA). The 
magnetic properties of iron oxide nanoparticles allows for the control of the iron oxide-
Au shell nanoparticles with external magnetic force to specific targets in in-vivo 
biomedical applications such as drug delivery and cell separation. Iron oxide-gold shell 
nanoparticles often used in biomedical or biosensor analysis are either magnetite coated 
gold shell (Fe3O4-Au) or maghemite coated gold shell (Fe2O3-Au). 
Research have shown that it is easier to synthesize maghemite coated gold shell (Fe2O3-
Au) compared to magnetite coated gold shell (Fe3O4-Au) because Au
3+
 reduces 
preferentially onto γ-Fe2O3 surfaces compared to Fe3O4 (Lyon et al., 2004), although 
the reasons for the disparity in the deposition is not known since Fe3O4 and γ-Fe2O3 
have very close lattice parameters (a=0.840 and 0.835nm respectively). 
Iron oxide core-Au shell nanoparticles has been successfully used in fabricating DNA 
sensors (Li et al., 2011c; Loaiza et al., 2011), immobilization of biomolecules (Tamer et 
al., 2013), enzyme glucose biosensor (Li et al., 2011b), catalysis (Wu et al., 2010), 
protein immunosensors (Liang et al., 2009) and as contrast agents(Kim et al., 2009).  
4.2 Polyethyleneimine 
PEI also known as polyaziridine is an organic molecule that exists in two forms, linear 
and branched forms. Linear PEI contains two methyl groups and a secondary amine and 
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is a solid at room temperature with melting point of 73-75
 O
C. It is soluble in methanol, 
chloroform, ethanol at low pH and in hot water. Branched PEI is a polycation with 25% 
primary, 50% secondary and 25% tertiary amino groups as shown in Figure 4.1. It is 
water soluble polyamine, a liquid at room temperature with melting and boiling points 
of 59-60
O
C and 250
O
C respectively and is normally synthesized from its monomer in 
the presence of a catalyst.  
                                
Linear PEI       Branched PEI 
Figure 4.1 Chemical structure of linear and branched PEI 
 
Branched PEI is synthesized in different molecular weight suitable for the stabilization 
of different sizes of iron oxide nanoparticles. In solution during synthesis of iron oxide 
nanoparticles the negatively charged iron oxide nanoparticles binds electrostatically 
with the positively charge PEI to form a stabilizing polyelectrolyte layer. This enhances 
the iron oxide stability due to the steric hindrance and electrostatic repulsion between 
the iron oxide nanoparticles as a result of PEI coatings (Goon et al., 2010; Zhou et al., 
2010). 
Polyethyleneimine forms stable complex with metal ions at pH 4-12 due to the high 
amount of amine-nitrogen it contains that can donate electrons and chelate metal ions 
(Maketon and Ogden, 2009). The presence of the amine groups also allow for the easy 
modification of polyethyleneimine to act as coating on inorganic materials, carriers for 
enzymes immobilization and the neutralization of excess anionic colloidal charges 
mostly found in acidic and neutral pH conditions .  
Researches have been carried out on the use of PEI as stabilizing and capping agent for 
nanoparticles.  Goon and co-workers (Goon et al., 2010) studied the adsorption of PEI 
on iron oxide nanoparticles (Fe3O4) by varying PEI concentration from 0-50mgl
-1
 at 
80
O
C. They showed that increased PEI concentration, increases the amount of PEI 
adsorbed on the surface of iron oxide nanoparticles due to the greater number of PEI 
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chains present and it also increases the electrophoretic mobility of the particles. The 
nanoparticles were found to be most stabilized at 50mgl
-1
 and lower or higher 
concentrations of PEI results in nanoparticle aggregation.  In a separate research, they 
also found out that by varying PEI concentration from 0-4gl
-1
 at 60
O
C, the maximum 
amount of PEI adsorbed on iron oxide nanoparticles ( average particles size 50 nm) was 
0.88μg PEI per cm3 particles surface by measuring the solution organic carbon content 
since PEI is the only source of carbon (Goon et al., 2009).  
Zhou and co-workers stabilized and coated iron oxide nanoparticles (40 nm) with gold 
shell using 5gl
-1
 PEI at 60
o
C for protein detection (Zhou et al., 2010) although the 
molecular weight of the PEI used depends on the size of the nanoparticles. Wang et al, 
controlled the aggregation of iron oxide nanoparticles by agitating the nanoparticles at 
room temperature with different amount of 5% mass per mass (m/m) PEI solution 
(Wang et al., 2009). Jin-jun and co-workers coated iron oxide nanoparticles with PEI by 
stirring the nanoparticles with PEI at room temperature for the selective removal of 
cadmium ion from blood (Jin et al., 2012). Also Yiu et al., coated iron oxide 
nanoparticles with PEI by heating the nanoparticles with PEI at 130
o
C for possible 
neutral cell transplantation therapies (Yiu et al., 2012).  
PEI was used to improve the stability and sensitivity of glucose biosensor up to 200% 
by reacting PEI and glucose oxidase at room temperature (Qian et al., 2004). The result 
showed that the response of the glucose biosensor increases as PEI concentration 
increases up to 2.5% (w/v) PEI before decreasing. The biosensor stability was 
dramatically increased with reduced detection limit due to PEI ability to prevent the 
oxidation of the enzyme’s sulfidic groups.  
Although many studies have been carried out on iron oxide magnetic nanoparticles 
synthesis, there have not been systematic studies on the effect of heating temperature on 
PEI coating. Temperature is a crucial factor for the amount of PEI adsorption on 
nanoparticle surface and therefore will affect the stability and capping effect of PEI in 
gold coating process when preparing gold shell iron oxide core magnetic nanoparticles. 
The more PEI adsorbed on the surface of the iron oxide nanoparticles, the higher the 
electrostatic attachment of gold shell nanoparticles which in turn improves the electron 
transfer properties of the nanoparticles when used for biosensor/immunosensor 
fabrication.  
71 
 
In this thesis work biopolymer chitosan was used as a coating film for the 
immobilization of the nanoparticles (iron oxide core-gold shell) on to the surface of an 
electrode for the electrochemical characterization of the nanoparticles. 
4.3 Chitosan 
Chitosan is a natural linear polysaccharide derived by deacetylation (DA) of chitin 
found in the shells of crustacea such as crab, shrimp, and crawfish. Chitin is associated 
with proteins and therefore, high in protein contents. The deacetylation of chitin 
involves removing the acetyl groups found in the molecular chain of chitin, resulting in 
the formation of chitosan with a high degree chemical reactive amino group (-NH2). 
Chitin and chitosan have similar chemical structures but the difference is the absence of 
the acetyl groups (CH3-CO) found in chitin.  Chitosan is composed of randomly 
distributed β-(1-4)-linked D-glucosamine (deacetylated unit) and N-acetyl-D-
glucosamine (acetylated unit). The structure of chitin and chitosan are shown in Figure 
4.2.   
                
                                CHITIN                                               CHITOSAN 
Figure 4.2 Structures of chitin and chitosan 
 
Chitosan is non-toxic, biodegradable and biocompatible polymer which has made its 
application widely accepted in field such as pharmaceutical and biomedical industries 
for enzyme immobilization and purification, wastewater treatment in chemical plants 
and in food industries for food formulations as binding, gelling, thickening and 
stabilizing agent (Knorr, 1984). Chitosan possesses unique properties including the 
ability to form films, optical structural characteristics and much more. Chitosan also 
possesses a positive ionic charge, which gives it the ability to chemically bind with 
negatively charged fats, lipids and bile acids (Sandford, 1992). 
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4.4 Aims 
The aim of this chapter is to synthesize iron oxide core-gold shell nanoparticles and to 
study the effect of different heating temperatures (25
O
C, 40
 O
C, 60
 O
C, 80
 O
C and 100
 
O
C) and agitation on polyethyleimine adsorption on magnetic iron oxide nanoparticles 
(50 nm) and in the formation of gold shell nanoparticles. Comparisons between 
different temperatures were based on electrochemical techniques using cyclic 
voltammetry (CV) and electrochemical impedance spectroscopy (EIS). It demonstrates 
a simple electrochemical method on characterization of the effect of temperature and 
PEI adsorption in nanoparticles synthesis. Physical characterization of iron oxide core-
gold shell nanoparticles where carried out with x-ray diffraction, x-ray photoelectron 
spectroscopy, scanning electron microscopy and transmission electron microscopy. 
Electrochemical characterizations were carried out using cyclic voltammetry and 
electrochemical impedance spectroscopy after immobilizing the iron oxide core-gold 
shell nanoparticles with chitosan on an electrode surface.  
4.5 Experimental 
4.5.1 Materials and chemicals 
Polyethyleneimine (branched 25000 mw), iron II sulphate heptahydrate >99%, Chitosan 
powder (deacetylated chitin) were purchased from Sigma Aldrich (Dorset UK), sodium 
hydroxide 97%, sodium citrate 100%, hydrogen tetrachloroauric acid 100% (HAuCl4), 
Sodium borohydride powder 98% (NaBH4) and Hydroxylamine hydrochloride (99%), 
tetramethylammonium hydroxide pentahydrate (TMAOH) and potassium nitrate 99% 
were from Alfa Aesar (Lancashire UK). All chemicals were used as received without 
further purification. Solutions were prepared using Millipore deionised water. 
4.5.2 Synthesis of 50nm average size oxidized iron oxide nanoparticles (γ-Fe2O3Nps)  
0.025M FeSO4 was added to 80ml of deionized water in 250ml round bottom flask after 
sparging for 20 minutes. Potassium nitrate (10ml, 2M) was added followed by the 
addition of sodium hydroxide (10ml, 1M). The mixture was sparged constantly and 
heated for 2 hours at 90
0
C. The black precipitate of iron oxide nanoparticles formed was 
washed several times with deionised water and dispersed in 80ml deionised water with 
concentration 2.4gl
-1 
at pH 6-7. The precipitate was separated with magnet and washed 
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once with 250ml of TMAOH (0.1M) solution and separated with a magnet. The 
precipitate was further washed with 250ml of HNO3 (0.01M) and separated with 
magnet. Finally the precipitate was dispersed in 250ml of HNO3 (0.01M) and heated at 
90-100
o
C with stirring until the colour turns brown (Hien Pham et al., 2008). The 
oxidized particles were separated with magnet and washed twice with deionised water 
and dispersed in 250ml of TMAOH (0.1M).    
4.5.3 Synthesis of iron oxide core/ gold seed nanoparticles (γ-Fe2O3-Au seed NPs) 
Gold seed (3 nm) nanoparticles were deposited on the oxidized iron oxide by a modified 
method from Zhou and co-workers (Zhou et al., 2010). 5ml of TMAOH stabilized γ-
Fe2O3 nanoparticles were stirred for 30 minutes in 50ml of 5gl
-1
 PEI to exchange 
absorbed OH
-
 ions with PEI ions and separated with an external magnet. The particles 
were rinsed with deionised water to pH 6-7 and dispersed in 50ml of 5gl
-1
 PEI by 
sonicating for 5 minutes before heating for 1 hour at 60
o
C. The nanoparticles were 
separated with magnet and the supernatant discarded and washed severally with 
deionised water to pH 6-7. 
The nanoparticles were then dispersed in 90ml of deionised water and sonicated for 5 
minutes followed by the addition of 1ml of 1% HAuCl4 acid and stirred for another 5 
minutes. 2ml of sodium citrate (38.8mM) solution was added and stirred for 2 minutes. 
Finally 1ml of freshly prepared 0.075 wt. % of sodium borohydride (NaBH4) in 1ml of 
38.8mM sodium citrate was added and the system stirred for 2 hours. This allows for 
the direct deposition of gold seeds on the surface of the iron oxide nanoparticles.  
The iron oxide-gold seed nanoparticles (γ-Fe2O3-Au seed NPs) formed were separated 
with magnet and washed to a pH of 6-7 with deionised water to remove excess gold 
seed. The nanoparticles were then dispersed in 50ml of 5gl
-1
PEI solution and heated at 
60
o
C for 1 hour to form Fe2O3- Au seed-PEI nanoparticles (Fe2O3- Au seed-PEI). After 
heating, the nanoparticles were separated with magnet and rinsed to a pH of 6-7 with 
deionised water. 
4.5.4 Synthesis of iron oxide core/gold shell nanoparticles (Fe2O3-Au shell NPs) 
Gold shells were formed on the iron oxide gold seeds nanoparticles through iterative 
reduction of chloroauric acid with hydroxylamine chloride as the mild reducing agent. 
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Iron oxide-Au seed nanoparticles with PEI layers (Fe2O3- Au seed-PEI) were dispersed 
in 110ml of NaOH (0.01M) and agitated for 5 minutes followed by the addition of 
0.5ml of 1% chloroauric acid and 0.75ml of hydroxylamine with vigorous stirring. The 
reaction was allowed to proceed for ten minutes followed by subsequent iteration of 
0.5ml chloroauric acid and 0.25ml of hydroxylamine for the 2
nd
, 3
rd
, 4
th
, and 5
th
 
iterations with ten minutes intervals between iterations (Goon et al., 2009; Zhou et al., 
2010). The process was repeated twice for a total of ten iterations and the iron oxide 
gold shell nanoparticles (Fe2O3- Au shell) were then washed twice with water, once 
with HCl (1M) and rinse with water. Figure 4.3 shows a schematic diagram for the iron 
oxide core-gold shell nanoparticles synthesis process. The concentration of the gold 
shell formed is 0.000254moll
-1
 and thickness 24 nm based on calculation from the 
absorbance peaks. 
 
 
                                                                                     
 
 
Figure 4.3 Schematic diagrams for the synthesis of Fe2O3-Au shell nanoparticles                       
4.5.5. Preparation of nanoparticles modified electrodes with chitosan 
Chitosan glassy carbon electrode (GC-CHIT) was formed by dropping 10 micro-litres 
(µL) of 0.2wt.% of chitosan solution on a polished glassy carbon electrode (0.071cm
2
) 
and allowed to dry in air. The 0.2 wt. % Chitosan solution was prepared by dissolving 
0.2g of deacetylated chitosan powder in 100ml of acetic acid (0.05M) and the mixture 
stirred for three hours. Iron oxide-TMAOH-chitosan modified glassy carbon electrode 
(GC-Fe2O3-TMAOH-CHIT) was prepared by first adding 1ml of TMAOH stabilized 
Fe2O3 nanoparticles in 2ml of chitosan (0.2wt.%) solution and sonicated for 3 minutes 
to form a mixture. Then 10 µL of the mixture was deposited on a cleaned glassy carbon 
electrode and allowed to dry in air. 
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Iron oxide-PEI-chitosan modified electrodes (GC- Fe2O3-PEI-CHIT) was prepared by 
adding 1ml of iron oxide PEI nanoparticles obtained from stirring TMAOH stabilized 
iron oxide nanoparticles with PEI and then heating the nanoparticles in the presence of 
5gl
-1
PEI at 60
o
C as described in section 4.5.3., in 2ml of 0.2wt% chitosan solution and 
sonicated for 3 minutes. Then 10 µL of the mixture was deposited on a cleaned glassy 
carbon electrode and allowed to dry in air. Finally iron oxide core-gold shell modified 
electrode (GC- Fe2O3-PEI-Au-CHIT) was prepared by adding 1ml of iron oxide-gold 
shell nanoparticles in 2ml chitosan solution and sonicated for 3 minutes. 10 µL of the 
mixture was then deposited on a clean glassy carbon electrode and allowed to dry in air. 
4.5.6 Synthesis of iron oxide nanoparticles (Fe2O3 /PEI NPs) at different 
temperatures 
2.4gl
-1 
Fe3O4 solution at pH 6-7 prepared in section 4.5.2 was separated with a magnet 
and the precipitate washed with 250ml of HNO3 (0.01M). The precipitate was dispersed 
in 250ml of 0.01M HNO3 and heated at 90-100
o
C until the solution colour turned to 
brown (Hien Pham et al., 2008). The oxidized nanoparticles were separated with 
magnet and washed twice with deionised water and dispersed in 250ml 
tetramethylammonium hydroxide (TMAOH). Then 5ml of TMAOH stabilized Fe2O3 
nanoparticles were stirred for 30 minutes in 50ml of 5gl
-1
 PEI to exchange absorbed 
OH
-
 ions with PEI ions and separated with an external magnet. The particles were 
rinsed to pH 6-7 with deionised water and dispersed in 50ml of 5gl
-1
 PEI by sonicating 
for 3 minutes. For synthesis at 25
o
C, the particles were allowed to stabilize in the PEI 
solution for 1 hour without stirring and the others were heated for 1 hour at 40
o
C, 60
o
C, 
80
o
C and 100
o
C respectively. 
4.5.7 Preparation of iron oxide-PEI (Fe2O3 /PEI) modified electrodes at different 
temperatures 
Iron oxide/polyethyleneimine modified glassy carbon electrodes (GC- Fe2O3-PEI-
CHIT) were prepared by adding 1ml of iron oxide/PEI nanoparticles in 2 ml of 0.2 wt.% 
chitosan (CHIT) solution and sonicated for 5 minutes. 10µl of the mixture was pipetted 
on a clean glassy carbon electrode and allowed to dry in air. This process was repeated 
for iron oxide-PEI nanoparticles synthesized at the different temperatures (25
 o
C, 40
 o
C, 
60
 o
C, 80
 o
C and 100
 o
C). 
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4.5.8 Instrumentation and characterization of the nanoparticles 
The synthesized nanoparticles were characterized using physical and electrochemical 
characterization techniques. Physical characterization of the nanoparticles were carried 
out using Philips XL 30 environmental scanning electron microscopy (ESEM) operated 
at 20kV to determine the surface morphology of the particles. X-ray diffraction pattern 
of the nanoparticles were obtained using PANalytical X’pert Pro MPD, powered by 
Philips PW 3040/60 X-ray generator fitted with X’celerator and using Cu Kα radiation 
with wavelength of 1.54180Å to determine the crystalline structure of the nanoparticles. 
UV-Vis spectroscopy analysis of nanoparticles was carried out using Jenway 6705 
model UV-VIS Spectrometer to detect the presence of gold shell nanoparticles on the 
iron oxide core-Au shell composite nanoparticles and their surface Plasmon resonance 
and band. Transmission electron microscopy (TEM) was carried out with Philips 
CM200 FEGTEM field emission gun TEM/STEM with supertwin objective lens. The 
TEM was used in analysing the shape, size and morphology of the iron oxide core-Au 
shell nanoparticles. 
Electrochemical characterizations of the nanoparticles electrode were carried out using 
cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). CV 
analysis was obtained with Ecochemie BV PGSTAT 302 Autolab (Netherland) in 0.1M 
phosphate buffer (pH 7.4) containing 5mM ferrocyanide/ferricyanide [Fe (CN) 6]
4-/3-
 at a 
scan rate of 50mV/s. The cyclic voltammetry (CV) allows for the determination of 
changes on the electrode behaviour after modification with nanoparticles and the ability 
of the nanoparticles to allow the flow of electrons between the probe solution and 
electrode surface. 
EIS analysis was carried out with Ecochemie BV PGSTAT 302 Autolab (Netherland)  
in 0.1M phosphate buffer (pH 7.4) containing 5mM ferrocyanide/ferricyanide [Fe (CN) 
6]
4-/3-
 in ratio 1:1 by applying an open circuit potential with amplitude 5mV in frequency 
range 0.01Hz-10kHz. EIS analysis was carried out on the modified electrodes to obtain 
information on the opposition or resistance (impedance) to alternating current of the 
electrodes modified with the different stages of the nanoparticles. The resistance 
determines the movement of electrons of the redox probe (ferrocyanide/ferricyanide) at 
the electrode interface. A three electrode cell with a 3mm diameter (area 0.07cm
2
) 
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glassy carbon electrode (GCE) as working electrode, Ag/AgCl (3M NaCl, 0.208V vs 
SHE) as the reference electrode and a platinum wire as the counter electrode was used 
for the analysis. 
4.6 Result and discussion 
4.7 Physical properties of nanoparticles 
4.7.1 Paramagnetic effect of iron III oxide (γ-Fe2O3), iron oxide/gold shell 
nanoparticles (γ-Fe2O3-Au shell) and their XPS analysis 
     
     
Figure 4.4 (a) Fe2O3 nanoparticles stabilized in TMAOH before and after magnetic separation (b) 
Fe2O3 -Au shell before and after magnetic separation 
Figure 4.4a shows that iron III oxide (maghemite) displayed paramagnetic behaviour in 
the presence of an external magnetic field and gradually re-disperse back in solution in 
the absence of the magnet.  It was also observed in Figure 4.4b that despite coating the 
iron oxide with gold shell, the nanoparticles still maintained paramagnetic effect. This 
indicates that the magnetic property of the iron oxide nanoparticles is not affected by the 
formation of gold shell on its surface, and the combined properties of the iron oxide-
gold shell nanoparticles can effectively be applied.  
(a) 
(b) 
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Figure 4.5 Fe2O3 nanoparticles XPS analysis (a) 2p core electrons (b) 1s core electrons of O2 
Figure 4.5a shows the characteristic doublet of iron based compounds showing the 2p 
core electrons for maghemite (γ-Fe2O3). The doublets shows peaks indicated by the 
arrows which can be assigned to iron III cation (Fe
3+
) at 710.08eV, 712.28eV and a 
characteristic satellite peak at 717.28eV. These peaks are characteristics of maghemite 
which contains only iron III oxidation states (Goon et al., 2010). The appearance of 
satellite peaks at 717.28eV in the oxidized samples as shown in Figure 4.5a indicates 
the presence of iron III. The satellite peak results from an incident x-ray photon which 
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gives up a discrete portion of its energy to the excitation of a second electron rather than 
imparting its quantum of energy to the primary (Mills and Sullivan, 1983; Yamashita 
and Hayes, 2008). Figure 4.5b shows the XPS spectra for oxygen 1s core electron 
present in the nanoparticles. The scan shows characteristics oxide peaks at 529.63eV 
and 530.48eV confirming the presence of only oxides in the iron oxide nanoparticles 
sample (γ-Fe2O3) and no hydroxyl species (iron oxy- hydroxide).  
 
 
Figure 4.6 XPS analysis of Au shell on Fe2O3 nanoparticles (a) 4f core electrons of Au (b) 1s core 
electrons of O2 
0
10000
20000
30000
40000
50000
60000
70000
75 80 85 90 95 100
C
p
s 
Binding energy (eV) 
Au o 4f 7/2 (84eV) 
Au o 4f 5/2 (87.38eV) 
Shirley background 
0
10000
20000
30000
40000
50000
60000
515 520 525 530 535 540 545
C
p
s 
Binding energy (eV) 
O 1S Oxy hydroxide (531.81eV) 
Water  (532.7eV) 
Water  (533.42eV) 
Shirley background 
(b) 
(a) 
80 
 
Figure 4.6a shows the XPS analysis of Fe2O3 –Au shell nanoparticles indicating the 
presence of 4f core electrons of Au resulting from the formation of Au shell on the iron 
oxide nanoparticles. The 4f core electrons of Au was observed at binding energies of 
84eV and 87.38eV corresponding to 4f7/2 and 4f5/2 core electrons respectively. The 
presence of the 4f peaks indicates that gold shell was deposited on the iron oxide 
nanoparticles. The 1s core electron of oxygen in the Fe2O3 –Au shell nanoparticles 
observed at binding energy 531.81eV, might be attributed to the presence of iron oxy 
hydroxide resulting from chemisorption of water on the air exposed surfaces of the 
nanoparticles or the presence of non-stoichiometric surface oxygen atom which can still 
be observed in samples not exposed to air (Rodríguez Nieto et al., 2009). The higher 
binding energy peaks at 532.7eV and 533.42eV can be attributed to the presence of 
water on the nanoparticles during gold shell formation or the sample not completely 
dried before XPS analysis. The XPS analysis in Figures 4.5 and 4.6 confirms the 
presence of the components that make up iron oxide core and gold shell nanoparticles, 
indicating that iron oxide core-gold shell were formed during synthesis. 
 
 
Figure 4.7 UV-Vis spectra for Fe2O3, Au seed, Fe2O3-Au 5
th
 iteration and Fe2O3-Au 10
th
 iteration 
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Figure 4.8 UV-Vis spectra for Fe2O3/Au shell formation showing the 5 iteration steps 
The optical properties of the as-prepared nanoparticles (γ-Fe2O3, Fe2O3 –Au shell) was 
analysed with the aid of UV- Vis spectroscopy. In Figure 4.7 a featureless spectra was 
observed for iron oxide (Fe2O3) nanoparticles indicating the absence of surface plasmon 
resonance.  The gold seed nanoparticles showed the presence of surface plasmon 
resonance peak at 512 nm indicating the formation of approximately 3 nm gold seed 
nanoparticle. The sizes of the gold seed nanoparticles were determined based on UV-
Vis spectra analysis following a method as reported by Haiss and co-workers (Haiss et 
al., 2007).  
The formation of Fe2O3-Au shell nanoparticles using the iterative reduction of 
chloroauric acid with hydroxylamine was done for both 5 iteration and 10 iteration 
steps. It was observed that during the 5 iterative steps, the amount of the gold shell on 
the iron oxide nanoparticles increases resulting to a blue shift of the surface plasmon 
resonance in the UV-Vis spectra to 556 nm wavelength. Increasing the iteration process 
to 10 iterations, result in further blue shift in the UV-Vis spectra to 546 nm. The 10 
iteration steps allows for the almost 100% coverage of the iron oxide nanoparticles with 
gold shell compared to the 5 iteration process as shown in ESEM results in Figure 4.9.  
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Figure 4.8 shows that the surface plasmon resonance peaks wavelength decreases as the 
iteration steps increases from 578 nm, 574 nm, 565 nm 558 nm and 556 nm for 1
st
, 2
nd
, 
3
rd
, 4
th
 and 5
th
 iterations respectively, thus increasing the amount of gold nanoparticles 
on the iron oxide core nanoparticles surface. The size of the Au shell nanoparticles on 
the iron oxide was estimated to be approximately 25 nm after the 10
th
 iteration based on 
UV-Vis spectra analysis which was further corroborated with the XRD results of 24 nm 
in Figure 4.10.  
       
       
Figure 4.9 (a) Fe2O3  (b) Fe2O3 –Au shell 5 iterations (c) Fe2O3 –Au shell 10 iteration (d) TEM of 10 
iteration  
Figure 4.9 (a), (b) and (c) shows the ESEM analysis of the Fe2O3, Fe2O3 –Au shell gold 
shell nanoparticles after 5 iterations, Fe2O3 –Au shell gold shell nanoparticles after 10 
iterations and TEM image of Fe2O3 –Au shell gold shell nanoparticles after 10 iterations  
respectively. Figure 4.9a shows the iron oxide nanoparticles  with no gold shell formed 
as control and Fig, 4.9b shows that the nanoparticles where partially coated with gold 
shell after 5 iterations as reflected in the bright image due to the conductive property of 
gold compared to Fig 4.9a. Figure 4.9c shows that the nanoparticles where fully covered 
(a) (b) 
(c) 
1000 nm 1000 nm 
1000 nm 
(d) 
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with gold shell. Although the Fe2O3 –Au shell nanoparticles after 10 iterations looks 
clustered together, this might be as a result of the nanoparticles not finely grounded 
before ESEM analysis and also due to low magnification of the ESEM during analysis. 
Figure 4.9d shows the TEM images of the iron oxide-Au shell nanoparticles showing 
the presence of gold shell on the iron oxide nanoparticles. The TEM resolution is 
different from the ESEM because of its detail analysis. The gold shell nanoparticles are 
the dark spots particles on the iron oxide nanoparticles as shown in the TEM analysis, 
although the TEM could not show how the gold shell is placed on the iron oxide 
nanoparticles surface. The TEM analysis also shows little fraction of the iron oxide 
nanoparticles not covered with gold shell, but the XRD result in Figure 4.10 indicates 
that the iron oxide nanoparticles were almost 100% covered with gold shell. 
 
Figure 4.10 XRD analysis of (a) γ-Fe2O3 (b) Fe2O3-Au shell nanoparticles at 5 iterations (c) Fe2O3-
Au shell nanoparticles at 10 iterations  
Figure 4.10a shows the X-ray diffraction patterns for maghemite (γ-Fe2O3) 
nanoparticles synthesized using 0.025M FeSO4.The diffraction peaks (111), (220), 
(311), (222), (400), (422), (511), (440) and (622) can be indexed to the face centre cubic 
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structure of maghemite which has similar crystallographic nature as magnetite (Fe3O4). 
The average particle size of γ-Fe2O3 NPs was calculated to be approximately 50 nm 
using peaks (311), (440), (222) and (511) with the Scherrer equation. 
Figure 4.10b and c shows the Fe2O3-Au shell nanoparticles synthesized from 5 and 10 
iteration processes respectively. The diffraction peaks at 2θ = 38.2o, 44.4o, 64.6o, 77.5o 
and 81.7
o 
denoted with Au, can be indexed to (111), (200), (220), (311), and (222) of 
gold in a cubic phase. It was observed that after 5 iteration steps, diffraction peaks for 
maghemite were still present in the sample (b) with reduced intensity. This indicates 
that the maghemite nanoparticles where not fully covered with gold shell. Figure 4.10c 
shows that after 10 iteration processes in repeated sequence, the maghemite 
nanoparticles were fully covered with gold shell indicated by the disappearance of the 
maghemite peaks. The gold nanoparticles after 10 iterations have an average particles 
size of 24 nm and the total particle size for the iron oxide core- gold shell nanoparticles 
is 74 nm.  
4.8 Electrochemical properties of the nanoparticles 
Electrochemical characterization of the nanoparticles was carried out to determine the 
electrochemical properties of the nanoparticles when modified on an electrode. This 
shows how good the nanoparticles at different stages of modification can allow the flow 
of electrons between the probe solution and the surface of a modified electrode, and 
their biocompatibility to biomolecules.  
Figure 4.11 shows the cyclic voltammogram trace of the nanoparticles at different 
stages modified on a glassy carbon electrode (GCE). The cyclic voltammogram trace is 
the plot of the working electrode current against applied potential in a cyclic 
voltammetry (CV) analysis. The results shows a well-defined oxidation and reduction 
peaks caused by the Fe
3+
/Fe
2+
 redox couple for all the modified electrodes for both 
forward and reverse scans. The highest oxidation and reduction peaks of the Fe
3+
/Fe
2+
 
redox couple was observed when the glassy carbon electrode was modified with Fe2O3-
PEI-CHIT nanoparticles at 0.27V and 0.18V respectively. This is attributed to the 
synergy between iron oxide and PEI and the ability of PEI to reduce electron transfer 
resistance in solutions due to its polycationic nature (Tan et al., 2007).  
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The electrode modified with Fe2O3-PEI-Au-CHIT nanoparticles showed the second 
highest oxidation and reduction peaks at 0.28V and 0.15Vrespectively compared to 
Fe2O3-TMAOH-CHIT and CHIT modified electrodes. 
 
4.11 Cyclic voltammogram of nanoparticles modified electrodes in a 5mM 
ferrocyanide/ferricyanide [Fe(CN)6]
4-/3-
 solution containing 0.1M PBS at a scan rate of 50mV/s 
 
This can be attributed to the ability of gold nanoparticle to act as an electron path way 
allowing the flow of electrons between the redox couple and the surface of the 
electrodes and also due to the synergetic effect of the composite film formed with iron 
oxide/PEI. The electrode modified with chitosan (CHIT) also showed a well-defined 
oxidation and reduction peaks lower than that of Fe2O3-PEI-CHIT and Fe2O3-PEI-Au-
CHIT nanoparticles, but higher than Fe2O3-TMAOH-CHIT modified electrodes. This 
indicates that a layer of chitosan was formed on the GCE and that chitosan blocked the 
movement of electrons to the electrode surface. The reason why the chitosan modified 
electrode has higher oxidation and reduction peaks compared to Fe2O3-TMAOH-CHIT 
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modified electrode is because of the OH
-
 ion present in TMAOH which further blocks 
the flow of electrons between redox couple and electrode surface. 
 
Figure 4.12 Nyquist plot of nanoparticles modified electrodes in in 5mM potassium 
ferrocyanide/ferricyanide ([Fe(CN)6]
4-/3
) solution in ratio 1:1 containing 0.1M PBS (pH 7.4) 
applying an open circuit potential with amplitude 5mV in frequency range 0.01Hz-10kHz. 
 
Figure 4.12 shows the Nyquist plot of the nanoparticles modified electrodes in an EIS 
analysis. The plot shows the real component of impedance plotted against the imaginary 
component. The semicircle portion in the Nyquist plot represents the electron transfer 
limiting process at higher frequencies while the linear portion represents the diffusion 
limited process. 
The result showed that the glassy carbon electrode modified with Fe2O3-PEI-CHIT 
nanoparticles had the lowest charge or electron transfer resistance (Rct) of 268Ω which 
can be attributed to the presence of PEI in the composite. PEI is known to reduce charge 
transfer resistances due to its polycationic nature that neutralizes any negative charges 
developed by composite (Tan et al., 2007). This is followed next by the electrode 
modified with Fe2O3-PEI-Au-CHIT with resistance to charge transfer of 584Ω. This is 
lower compared to the electron transfer resistance of CHIT (881Ω) and Fe2O3-
TMAOH-CHIT (900Ω) modified electrodes. This shows the presence of gold shell on 
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the iron oxide/PEI nanoparticles and also the decrease in resistance can be attributed to 
the ability of gold nanoparticles in the composite to act as a conducting pathway 
between the electrode and electrolyte promoting electron transfer of the redox probe 
towards the electrode surface.  
The modified electrode with chitosan (CHIT) shows a high interfacial resistance (an 
increase in the diameter of the semicircle) towards electron transfer of about 881Ω. This 
shows the composite film blocked the electron transfer of the electrochemical probe 
caused by the presence of non-conducting chitosan. The resistance to electron transfer 
was further increased when the glassy carbon electrode was modified with Fe2O3-
TMAOH-CHIT to 900 Ω. This is attributed to the presence of the negative charge 
hydroxyl group (OH
-
) in the TMAOH which further increases the charge transfer 
resistance and prevents the flow of electrons. There was no difference observed in the 
solution resistance Rs (152Ω) for the modified electrodes at their formal potentials. 
4.9 Effect of temperature and agitation on PEI adsorption on iron oxide 
nanoparticles and gold shell formation 
  
 
 
 
 
Figure 4.13 (a) ESEM image of Fe2O3 nanoparticles (b) TEM image of Fe2O3 nanoparticles   
The ESEM and TEM images of (γ-Fe2O3) nanoparticles are shown in Figure 4.13. The 
ESEM image in Figure 4.13a showed the as-prepared γ-Fe2O3 nanoparticles and the 
TEM in Figure 4.13b indicated that the nanoparticles are cubic in shape with average 
particle size of 50 nm.  
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4.9.1. Electrochemical analysis on PEI adsorption in iron III oxide/PEI nanoparticle 
preparation at various heating temperatures 
 
Figure 4.14 Electrochemical characterisation of Fe2O3-PEI at different temperatures (a) cyclic 
voltammograms (b) EIS Nyquist plots 
Figure 4.14a shows the cyclic voltammogram of the modified electrodes with PEI at 
different temperatures. The result showed that PEI is well adhered to the surface of γ- 
Fe₂O3 nanoparticles at 40
O
C compared to 25
O
C and heating at 60, 80 and 100 for 1 
hour. The nanoparticles heated with PEI at 40
 O
C had the highest oxidation and  
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reduction peaks at 0.3V and 0.15Vrespectively as shown in the cyclic voltammograms 
(Fig.4.14a) followed by 25
 O
C, 60
 O
C and the lowest at100
 O
C when the solution turned 
oily. This is an indication that more of the PEI is adhered or adsorbed electrostatically 
onto the surface of the Fe₂O3nanoparticles at 40
 O
C compared to the other temperatures. 
The high increase in the oxidation and reduction current of the modified electrode with 
Fe₂O3-PEI at 40
 O
C is due to the presence of more PEI molecules attached to the surface 
of the iron oxide nanoparticles, which reduces the electron transfer charges between the 
probe solution and the electrode surface thus, increasing the oxidation and reduction 
peaks. This result is further verified with the electrochemical impedance spectroscopy 
(EIS) results shown in Figure 4.14b showing the ohmic resistance (Rs) which includes 
the ohmic resistance of solution and the coating layer, and the charge transfer resistance 
(Rct). It was observed that the lowest ohmic resistance was obtained at 25
 O
C followed 
by 40
 O
C which had the lowest charge transfer resistance. The temperatures and their 
corresponding ohmic and charge transfer resistance are shown in Table 4.1 
Fe2O3-PEI nanoparticles        Charge transfer resistance         Ohmic resistance  
heating temp. (
o
C)                             (Ohm)                                       (Ohm) 
 
       25                                                     76                                              177 
       40                                                     38                                              268 
      60                                                    104                                             280 
      80                                                    128                                             302 
      100                                                  207                                             388                        
 
Table 4.1 Fe2O3-PEI nanoparticles at different temperature ohmic and charge transfer resistance 
The result shows that change in temperatures affects the ohmic resistance and as the 
heating temperature of PEI on iron oxide nanoparticles increases, the charge transfer 
resistance increases. This also indicates that the polycationic nature of PEI which 
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neutralizes any negative charge that tends to increase charge transfer resistance 
diminishes with increasing temperatures on the surface of the iron oxide nanoparticles. 
A repeat of the experiment carried out showed similar result with 40
 O
C showing better 
PEI adsorption on iron oxide nanoparticles compared to the other temperatures. The 
reason for this observation might be that 40
 O
C favoured the electrostatic interaction 
between positively charges PEI molecule and negatively charged iron oxide 
nanoparticles. Error bar analysis carried out as shown in Figure 4.15 for the first and 
second run experiment showed minimal errors from the average peak current data as 
indicated by the vertical upper and lower error bars for the different temperatures. This 
indicates that the experiment is reproducible.
 
Figure 4.15 Error bar analysis of average peak current against temperatures 
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4.9.2 Effect of agitation on PEI adsorption 
 
 
Figure 4.16 Effects of agitation: on PEI adsorption on Fe2O3 nanoparticles at room temperatures 
with and without stirring (a) cyclic voltammograms (b) EIS Nyquist plots 
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Comparison was made between stirring iron oxide nanoparticles with PEI at room 
temperature for 1 hour and the unstirred process at room temperature. It was observe 
from the cyclic voltammetry results shown in Figure 4.16a that the nanoparticles 
(Fe2O3-PEI) obtained by stirring PEI with iron oxide had the higher oxidation and 
reduction peaks at 0.25V and 0.19V respectively for the redox couple compared to the 
unstirred process. This result is corroborated with the EIS analysis shown in Figure 
4.16b and the results in Table 4.2 which showed that the stirred nanoparticles had lower 
charge transfer resistance compared to the unstirred synthesis. 
This can be attributed to the stirring process which enables the random mixing of the 
iron oxide nanoparticles with PEI molecules, resulting in an increased PEI ion attached 
on the surface of iron oxide nanoparticles due to increased electrostatic attraction 
between the negatively charged iron oxide and positively charged PEI.  
The EIS results (Figure 4.16b) also showed that the ohmic resistance (Rs) is slightly 
affected at room temperature compared to large variation observed when the particles 
were heated at increased temperatures as shown in Table 4.1. This indicates that PEI 
synthesized at room temperature and at 40⁰C had less opposition to the flow of 
electrons of a probe solution due to increased polycationic nature of PEI at this 
temperatures on the iron oxide nanoparticles. Higher heating temperatures results in 
opposition to flow of electrons as the PEI polycationic nature diminishes and the 
solution turns oily. 
Fe2O3-PEI nanoparticles        Charge transfer resistance         Ohmic resistance  
at room temp. (
o
C)                             (Ohm)                                       (Ohm) 
 
       25  (stirred)                                    44                                              171 
       25  ( not stirred)                             76                                              177 
 
 
Table 4.2 Fe2O3-PEI nanoparticles at room temperature ohmic and charge transfer resistance 
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4.9.3 UV-VIS Spectroscopy analysis of Fe2O3-PEI/Au shell nanoparticles at the 
different temperatures 
 
 
Figure 4.17 UV-Vis spectra for Fe2O3-PEI/Au shell formation after 5 iteration step (a) at different 
heating temperatures (b) stirred and unstirred process at 25⁰C 
The optical properties of the Fe2O3-PEI nanoparticles at the different temperatures 
coated with gold shell was analysed with the aid of UV- Vis spectroscopy and the 
results is shown in Figure 4.17. The formation of Fe2O3-PEI–Au shell nanoparticles was 
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achieved after five iterations through the iterative reduction of chloroauric acid with 
hydroxyl amine (Lyon et al., 2004), (Goon et al., 2009). The results in Figure 4.17a 
shows that after 5 iteration steps for each temperature, the size and amount of gold shell 
on the surface of the iron oxide nanoparticles increases resulting to a blue shift of the 
surface plasmon resonance in the UV-Vis spectra. The blue shift indicates an increase in 
gold shell formation to the iron oxide nanoparticles. The shift in surface plasmon 
resonance is most observed at 40
o
C as the ratio of gold to iron oxide increases with peak 
wavelength of 548 nm followed by 25
o
C (553 nm), 60
o
C (562 nm) and the lowest at 
100
o
C (584 nm). This result indicates the presence of more positively charged PEI ions 
on the iron oxide nanoparticles at 40
o
C that can act as capping agents for gold shell 
formation. 
The UV- spectra (Figure 4.17b) showed that stirred nanoparticles at 25
 o
C had higher 
absorbance and surface plasmon resonance peak at 550 nm compared to the unstirred 
nanoparticles 553 nm. This indicates that agitating PEI with iron oxide nanoparticles at 
room temperature favoured capping capability of the PEI in the attachment of gold shell 
nanoparticles.  
A paper has been published by me on this topic the effect of temperature and agitation 
on polyethyleneimine adsorption on iron oxide magnetic nanoparticles in the synthesis 
of iron oxide-Au core-shell nanoparticles in the journal of Advance Science, 
Engineering  and Medicine, volume 6, number 5 (pp 531-537) (2014). The copy of the 
paper is shown in the appendices in chapter seven. 
 
4.10 Conclusions 
In conclusion iron oxide core-gold shell nanoparticles where successfully synthesized. 
The gold nanoparticles after 10 iterations have an average particles size of 24 nm and 
the total particle size for the iron oxide core- gold shell nanoparticles is 74 nm. The 
nanoparticles showed good electro-catalytic properties towards redox probe with Fe2O3-
PEI having the highest oxidation and reduction peaks and least charge transfer 
resistance followed by the gold coated iron oxide nanoparticles due to the electron 
transfer ability of gold. It was also found that temperature places a major role in the 
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adsorption of PEI on iron oxide nanoparticles and the ability of PEI to act as capping 
agents in the formation of gold shell on the iron oxide nanoparticles.  
The result showed that 40
o
C is most favourable for PEI adsorption on iron oxide 
nanoparticles and favours the capping properties of PEI in the formation of iron oxide 
core/gold shell nanoparticles. The result also indicates that the polycationic nature of 
PEI on iron oxide nanoparticles diminishes as the heating temperature increases which 
is reflected in the reduced electrochemical properties observed at 100
o
C compared to 
40
o
C. Also the ohmic resistance of iron oxide/PEI nano-composite is affected with 
increased heating temperatures above 40
o
C. At room temperature synthesis, the stirred 
iron oxide/PEI nanoparticles showed better electrochemical properties compared to the 
unstirred process due to the agitation which encouraged better electrostatic attraction 
between the negatively charge iron oxide nanoparticles and positively charged PEI ions. 
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Chapter 5 
Plasma immunoglobulin biomarker immunosensor for Alzheimer’s 
disease 
5.1   Introduction 
Alzheimer disease (AD) is a physical disease of the brain and the major cause of 
dementia which is a group of symptoms such as loss of memory, confusion, problems 
with speech and understanding that occur when the brain is affected by diseases in 
ageing people. The disease result in the death of nerve cells in particular regions of the 
brain, and shrinking of the brain as gaps develop in the temporal lobe and hippocampus, 
which are responsible for storing and retrieving new information. It also affects the 
production of acetylcholine which is an important chemical in the brain. AD is a 
progressive disease that gets worse over time and leads to death if not properly 
managed.  The level of progress of the symptoms depends on the affected individual. 
The diagnosis of Alzheimer’s disease has been of great challenge since there is no 
reliable diagnostic test and cure for the disease, but drugs such acetylcholinesterase 
inhibitors (donepezil hydrochloride, galantamine and rivastigmine) has been used to 
temporarily alleviate some of the symptoms (Mukaetova-Ladinska et al., 2012). The 
diagnosis of AD is often based on clinical ground and neuropsychological assessment of 
dementia (Dubois et al., 2007). Clinical analysis of the disease detects treatable 
conditions which might have similar symptoms to dementia such as depression, chest 
and urinary infections, severe constipation, vitamin and thyroid deficiencies and brain 
tumors. It identifies possible causes of confusion in patients, such as poor sight or 
hearing; emotional changes and upsets, such as moving or bereavement; or the side-
effects of certain drugs or combinations of drugs. It also gives patient time to access 
advice, information and support (emotional, practical and financial) from social 
services, voluntary agencies and support groups and plan and make arrangements for 
the future. 
To improve on the clinical diagnosis accuracy of AD the use of one or more biomarker 
as supportive measures for structural or molecular neuroimaging of AD, particularly 
analysis of cerebrospinal fluid (CSF) such as amyloid-β (A β) or tau proteins was 
recommended by the National Institute of Ageing and Alzheimer’s Association 
97 
 
guidelines (McKhann et al., 2011). Most studies on AD markers have been focused in 
CSF (fluid that baths the brain) which reflects more of the metabolic state of the brain 
(Sunderland et al., 2005). CSF contains amyloid beta proteins (Aβ 1-40) and 
hydrophobic (Aβ 1-42) which are peptide produced from amyloid β-protein precursor 
(βAPP) through successive cleavage from protolytic enzymes β and γ secretases.  
Amyloid beta proteins are the main focus of AD pathology especially (Aβ 40) and (Aβ 
42). CSF biomarkers have shown reproduced decreases in (Aβ 42) levels in CSF and 
increased in tau and phospho-tau in AD patients and other dementias (Sunderland et al., 
2005; Hansson et al., 2006; Kasuga et al., 2010; Mulder et al., 2010). Despite the 
promising outcome from the CSF biomarkers, their applications have not successfully 
shown that AD diagnosis and progression can be monitored with these biomarkers.  The 
CSF biomarkers are also expensive, rarely available and difficult to control repeated 
sampling for regular monitoring of AD. This makes peripheral source such as plasma 
and serum better biomarker options. 
5.2 Plasma biomarkers 
Biomarkers in blood are good diagnostic maker which allows for disease monitoring 
and therapy initiation at the early stages of the disease. Biomarker molecules in blood 
such as plasma are less challenging and readily applicable. Blood Plasma contains  lots 
of dissolved proteins such as albumin, immunoglobulin, fabrinogen and other neuronal 
cell line proteins such as tau protein, amyloid beta protein (Hye et al., 2006). These 
proteins or groups of proteins undergo changes in concentration or structural 
composition as a result of the physiological state in normal or diseased conditions.  
Blood plasma is also a rich source of CSF since CSF is readily adsorbed in the blood 
and can also be used as biomarker for CSF monitoring. The presence of amyloid beta 
proteins (Aβ 40 and 42) in plasma, makes plasma a good diagnostic marker for 
monitoring AD progression compared to the relatively invasive lumber puncture 
procedure involve in CSF biomarker procedures or the use of radio tracers which are 
technically challenging. 
The use of plasma as biomarkers also faces some challenges due to the wide range in 
protein concentration in plasma, making diagnosis assays for the very low concentration 
proteins difficult. Research has shown that as blood circulates around the brain, small 
hydrophobic and lipophilic molecules from the CSF and large amount of specific 
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molecules and metabolites are absorbed in the blood (Bell and Zlokovic, 2009). This is 
due to the activity of the blood brain barrier (BBB) which restricts diffusion of 
macroscopic pathogens to the brain. This indicates that relevant markers in the plasma 
which reflects what is happening in the brain will be in low concentration in normal 
humans (Bell and Zlokovic, 2009).  
These have led to the removal of uninformative or non-diagnostic proteins in the plasma 
through depletion processes in order to enhance the detection of low abundant proteins 
as biomarkers. The process also has disadvantages in that it removes some proteins that 
might be potential biomarkers for AD (Yocum et al., 2005; Zolotarjova et al., 2005). 
Despite the disadvantage, depleted or non-depleted plasma can yield potential 
biomarkers (Hye et al., 2006). 
Depleted and non-depleted forms of plasma has been used for AD diagnostic assays and 
the result has shown increases in the Aβ 42 levels for plasma obtained from AD patients 
at early onset and late onset compared to normal control subjects (Scheuner et al., 1996; 
Hye et al., 2006; Ertekin-Taner et al., 2008). Resent research on plasma biomarker for 
AD has been focused on antibody based detection through the use of enzyme link 
immunosorbent assay (ELISA). 
ELISA method detects the proteins in plasma using antibodies and colour change. 
Increases in plasma Aβ 40 and Aβ 42 levels with ageing for AD patients have been 
reported by Van and co-workers (van Oijen et al., 2006; Ertekin-Taner et al., 2008) 
using ELISA method. Detecting plasma and platelet immunoglobulin (Ig) levels in 
patients instead of amyloid beta proteins (Aβ 40 or Aβ 42) have shown to be a useful 
way for diagnosing and monitoring AD. Mukaetova-Ladinska and co-workers, reported 
an increase in plasma and platelet immunoglobulin in AD patient not treated with 
cholinesterase inhibitor compared to control subjects using indirect  ELISA method 
(Mukaetova-Ladinska et al., 2012). Their method used polyclonal rabbit Anti-human 
IgA, IgG, IgM as primary antibody specific to platelet or plasma immunoglobulin to 
bind the immunoglobulin (Ig) deposited in microliter plates and polyclonal Goat Anti-
rabbit Immunoglobulin/horseradish peroxidase (HRP) as secondary antibody bound to 
the primary antibody to amplify the detection of the immunoglobulin. The 
concentrations of the plasma immunoglobulin were detected through the formation of 
colour read by a UV-Vis spectroscopy reader. 
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ELISA method despite its sensitivity and ability to detect plasma proteins for AD 
diagnosis is found to be time consuming, expensive and a complex process that might 
give false result due to light sensitive chemicals applied during analysis. This makes 
electrochemical detection of plasma proteins as biomarkers for AD better option. 
Electrochemical immunoassays are highly sensitive, less time consuming, easy to 
handle and also easily integrated into portable devices. Currently there is no 
electrochemical detection of plasma immunoglobulin as biomarker for AD. 
5.3 Aims 
The aim of this chapter is to develop a direct immunosensor electrode for detecting 
plasma immunoglobulin as a biomarker for AD patients and control subjects. The 
sensor will make use of depleted plasma immunoglobulin as antigen conjugated to 
polyclonal rabbit Anti-human IgA, IgG, IgM, as the specific antibody on the surface of 
a gold electrode. Also iron oxide core-Au shell nanoparticles will be used as 
immobilization substrate for the polyclonal rabbit Anti-human IgA, IgG, IgM/plasma Ig 
conjugation to enhance plasma detection. Secondary antibody (Goat Anti-rabbit 
Immunoglobulin/horseradish peroxidase) will not be used in the development of the 
electrode because of the immobilization technique employed which is different from the 
ELISA technique, and also due to the non-conducting properties of HRP which obstruct 
electron transfer of the redox solution. Electrochemical techniques (CV and EIS) will be 
used for the detection of changes in the immuno-complex in AD and control subjects.  
 
5.4 Experimental  
5.4.1 Materials and chemicals 
3-mercaptopropionic acid (MPA), cysteamine hydrochloride (cys) >97%, N-(3-
Dimethylaminopropyl)-N-ethylcarbodimide hydrochloride (EDC),  N-
Hydroxylsulfosuccinimide sodium salt (NHS), Tween 20, TNB (3.3.5.5 
tetramethylbenzadene) and potassium chloride (KCI) were purchased from Sigma 
Aldrich (Dorset UK), Polyclonal rabbit Anti-human IgA, IgG, IgM, and Polyclonal 
Goat Anti-rabbit Immunoglobulin/horseradish peroxidase (HRP) were purchased from 
Dako (Denmark), Depleted plasma immunoglobulin (1000 ppm ) were obtained from 
Institute for Ageing and health Newcastle University, hydrogen peroxide 30% were 
purchased from VWR (Leicestershire UK). Skimmed milk (marvel) was purchased 
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from Lidl (UK). All chemicals were used as received without further purification. 
Solutions were prepared using Millipore deionised water. 
5.4.2 Immobilization of polyclonal rabbit Anti-human immunoglobulin and depleted 
plasma immunoglobulin on Gold (Au) electrode. 
Gold electrode (1.6mm diameter) was polished in 0.05 and 0.3 microns polish kit and 
rinse with distilled water. The electrode was further cleaned by running cyclic 
voltammetry in 0.1M H2SO4 at potential 0-1.5V, at scan rate 100mV/s for 20 cycles. 
The electrode was dipped in 200 µl ethanolic solution of 3-mercaptopropionic acid 
(40mM) for 2hr 30minutes sealed with parafilm for self-assembly monolayer (SAM) of 
thiol functional groups on the electrode.  The electrode was drop washed immediately 
with 200µl of ethanol. The gold electrode was immediately dipped into 200 µl mixture 
of NHS (0.05M) and EDC (0.2M) for 30minutes to activate the carboxylic group of the 
MPA. Immediately electrode was dipped in 50µl polyclonal rabbit Anti-human 
immunoglobulin with constant concentration (1000 ppm) in 2ml eppendorf tube, sealed 
with parafilm and stored at 4
o
C overnight. 
The gold electrode immobilized with primary antibody was rinsed with 200µl phosphate 
buffer (pH 6.26) containing 0.05% of tween 20 (PBST) and dipped in 200µl of 1% 
marvel (skimmed milk) in an eppendorf tube and seal with parafilm and heated in water 
bath or oven at 37
 O
C for 1hr.The electrode was drop washed with 200µl of PBST and 
dipped in 50µl of depleted plasma Ig (500 ppm or1:2000 dilution) prepared from stock 
plasma Ig solution (1000 ppm or 1:1000 diluted) in an eppendorf tube sealed and stored 
at 4
o
C in fridge for 1hr. The electrode was finally rinsed with 100µl of PBST. The 
process was repeated for depleted plasma Ig double dilutions 1:4000, 1:8000, 1:16,000, 
1:32,000, 1:64,000.00, 1:128,000, and 1:256,000 respectively. The dilutions where 
made by first placing 100µl depleted plasma immunoglobulin stock solution (1000 ppm 
or 1:1000 diluted) in the first cell of a 96 cell micro-plate, and pipetting 50µl of the 
100µl stock into the second cell and then diluting the stock in the second cell with 50µl 
PBST to get 1:2000 dilutions. The process was then repeated with the second cell to get 
the third cell (1:4000 dilutions) etc. 
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5.4.3 Immobilization of polyclonal rabbit Anti-human immunoglobulin and depleted 
plasma immunoglobulin on iron oxide-gold shell nanoparticles (Fe2O3-Au Nps) 
immobilized on Gold electrode. 
The immobilization of polyclonal rabbit Anti-human IgA, IgG, IgM and depleted 
plasma Ig on Fe2O3-Au nanoparticles follows similar immobilization process carried out 
by Sharma and co-workers for the detection of aflatoxin B1 (Sharma et al., 2010) with 
some modifications. 2000µl of Fe2O3-Au nanoparticles average particle size 74 nm 
synthesized in chapter four was dispersed in 3000µl PBS (pH 6.28) and agitated to mix. 
200µl of the mixed Fe2O3-Au nanoparticles in PBS was added to 800µl of 10mM of 
cysteamine solution (Cys) in 2ml eppendorf tube covered with kitchen foil and agitated 
overnight for SAM of thiol functional group on the Fe2O3-Au nanoparticles. The 
nanoparticles were separated from the cysteamine solution after overnight agitation with 
magnet and rinsed with 1000µl of distilled water. The nanoparticles where then 
dispersed in 50µl of polyclonal rabbit Anti-human IgA, IgG, IgM by agitation followed 
by the addition of 100µl mixture of NHS (0.05M) and EDC (0.2M) in ratio 1:1to 
activate the carboxylic group in the antibody for amine binding with the SAM Fe2O3-Au 
nanoparticles. The mixture was agitated for 2 hours. The Fe2O3-Au-polyclonal rabbit 
Anti-human IgA, IgG, IgM formed was separated with magnet and rinsed with PBS (pH 
6.28) and then dispersed in 50µl of PBS. 
Prior to immobilization of polyclonal rabbit Anti-human IgA, IgG, IgM on Fe2O3-Au 
nanoparticles, gold electrode (2mm diameter) was polished in 0.05 and 0.3 microns 
polish kit and rinse with distilled water. The electrode was cleaned by running cyclic 
voltammetry in 0.1M H2SO4 at potential 0-1.5V, at scan rate 100mV/s for 20 cycles. 
The Au electrode was dipped into 200µl of MPA (40mM) in 2ml eppendorf tube sealed 
and left for 2.30 hours for SAM of thiol on the electrode. The electrode was drop 
washed with 500µl of ethanol and dipped in 100µl mixture of NHS (0.05M) and EDC 
(0.2M) for 30 minutes. The electrode was then removed from the NHS and EDC 
solution after 30 minutes and immediately 20µl of Fe2O3-Au nanoparticles-polyclonal 
rabbit Anti-human IgA, IgG, IgM solution was dropped on the surface of the electrode 
and stored at 4
o
C for 4 hours for amide bond formation between the activated carboxylic 
end terminal of the electrode and the amine end of the polyclonal rabbit Anti-human 
IgA, IgG, IgM. The non-binding site of the polyclonal rabbit Anti-human IgA, IgG, 
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IgM was blocked by dropping 20µl of 1% marvel on the modified electrode and 
incubating at 37
o
C for 1hour. The electrode was rinsed with 100µl of PBST and dipped 
in 50µl depleted plasma Ig (500 ppm or1:2000 dilutions) and left overnight at 4
o
C 
before measurement. The process was repeated for plasma immunoglobulin dilutions 
1:4000, 1:8000, 1:16,000 and 1:32,000 respectively. Figure 5.1 and 5.2 shows the 
schematic diagrams for the gold electrode and Fe2O3-Au nanoparticles gold electrode 
modification steps with polyclonal rabbit Anti-human IgA, IgG, IgM and plasma 
immunoglobulin respectively. 
5.4.4 Conjugation of depleted plasma immunoglobulin, polyclonal rabbit Anti-human 
immunoglobulin and polyclonal Goat Anti-rabbit Immunoglobulin/horseradish 
peroxidase for ELISA detection with UV-Vis spectroscopy reader. 
The conjugation of depleted plasma Ig, polyclonal rabbit Anti-human immunoglobulin 
and Goat Anti-rabbit immunoglobulin/horseradish peroxidase was carried out by 
following similar method used by Mukaetova and co-workers (Mukaetova-Ladinska et 
al., 2012). First 50µl of 50mM ammonium bicarbonate buffer (pH 9.6) was added to the 
12 cells of the first and second rows (experiment 1 and 2) of a 96 cell microliter plate as 
diluent for coating microliter plates. Then 50µl of depleted plasma immunoglobulin 
(1000 ppm) was added to the first cells of the two rows and mix twice with pipette and 
50 µl removed and added to the next cell and the process repeated to the 12th cell to 
obtain 1:2000, 1:4000,1:8000,1:16,000, 1:32,000,1:64,000,1:128,000 
1:256,000,1:512,000,1:1024,000,1:2048,000,1:4096,000 dilutions. The microplate was 
then covered and incubated overnight at 4ºC. The plates where then washed twice with 
PBS containing 0.05% tween 20 and blocked with 1% of marvel at 37ºC for another 1 
hour. After blocking for 1 hour the solution in the plates where poured out and washed 
thrice with PBS containing 0.05% tween 20 by turning the cells upside down to pour off 
the liquids and the cells dried with hand cleaning tissue. 50µl of 1000 ppm (1:1000 
dilutions) polyclonal rabbit Anti-human immunoglobulin was then added to all the 12 
cells of the first two rows (24 cells) of the microliter plate and incubated for 1 hour. The 
plates where then washed three times with PBS containing 0.05% tween 20 and dried by 
hand cleaning tissue.  
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After drying, 50µl of 1000 ppm (1:1000 dilutions) Goat Anti-rabbit 
immunoglobulin/horseradish peroxidase prepared by adding 1µl of Goat Anti-rabbit 
immunoglobulin/horseradish peroxidase solution in 999µl PBST was then added to the 
12 cells of the 2 rows and incubated for 1 hour at 37ºC. After incubating the plates 
where washed three times with PBST and soak in water for 5 minutes and dried using 
hand cleaning tissue. Next 50 µl of freshly prepared substrate regent for ELISA was 
added to the cells and the reaction allowed to progress for 10 minutes. As the colour of 
the reaction starts changing to blue, the reaction was quenched with the addition of 50µl 
of H2SO4 (2N) to the cells which results in the formation of yellow colour indicating the 
concentration of antigens that has reacted with antibodies. The colours were read in a 
UV-Vis spectroscopy reader at 450 nm wavelength. The substrate reagent for the 
ELISA was prepared by adding 90ml of distilled water in a tube, followed by the 
addition of 10ml of 0.5M sodium acetate (pH 5.0) and swirl to mix, then 1ml of 
dimethyl sulphoxide containing 0.01g TNB (3.3.5.5 tetramethylbenzadene) was added 
and swirl to mix. Finally 10 µl of 30% hydrogen peroxide was added and swirl to mix 
before use. 
5.5 Electrochemical characterization of modified electrodes 
Cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) were used 
for the electrode characterization. The CV was obtained in 10mM of phosphate buffer 
(pH 6.26) containing 5mM of ferrocyanide/ferricyanide [Fe (CN) 6]
4-/3-
 at a scan rate of 
50mV/s. EIS analysis were carried out in 10mM of phosphate buffer (pH 6.26) 
containing 5mM of ferrocyanide/ferricyanide [Fe (CN) 6]
4-/3-
 in ratio 1:1 by applying an 
open circuit potential with amplitude 1mV in frequency range 0.01Hz-10kHz. Three 
electrode cell with modified gold electrode as working electrode, Ag/AgCl (3M NaCl, 
0.208V vs. SHE) as the reference electrode and a platinum wire as the counter electrode 
was used for the analysis. 
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Figure 5.1Schematic diagram showing the stepwise modification of gold electrode with plasma Ig 
and polyclonal rabbit Anti-human Ig 
The schematic diagrams in Figure 5.1 shows the polished gold electrode treated with 
MPA (40mM) for two and half hour then followed by treating with a mixture of EDC 
and NHS for thirty minutes to activate the carboxylic group in the MPA attached to the 
gold electrode. Polyclonal rabbit Anti-human Ig (antibody) was then immobilized on 
the electrode overnight. After the immobilization the electrode was blocked with marvel 
followed by the immobilization of depleted plasma Ig (antigen) before experimentation 
as explained in section 5.4.2. Table shows the symbols and what they represent.  
 Symbols                    Meaning 
  
 
  
               
           
Table 5.1 symbols for immobilization diagrams 
           
             
Polyclonal rabbit Anti-human Ig (antibody) 
  Depleted plasma Ig (antigen) 
Iron oxide-gold shell nanoparticles 
Marvel 
  Gold electrode 
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 (1)                                                                                                                                                                                                                
 
           
(2)  
 
 
 
 
 
 
 
 
Figure 5.2 Schematic diagrams showing the stepwise modification of gold electrode with depleted 
plasma/antibody and Fe2O3- Au nanoparticles  
The schematic diagram in Figure 5.2 shows the stepwise functionalization of the iron 
oxide –Au shell nanoparticles and its subsequent immobilization on gold electrode. Step 
1is the formation of the iron oxide gold shell nanoparticles-Polyclonal rabbit Anti-
human Ig (antibody) composite and the step 2 is the immobilization of this composite 
on the surface of a gold electrode for depleted plasma immunoglobulin conjugation. In 
step 1 iron oxide gold shell nanoparticles was treated with cysteamine (10mM) 
overnight to attach thiol groups on the electrode, followed by dispersing the electrode in 
Polyclonal rabbit Anti-human Ig (antibody) solution and treating with EDC and NHS 
for two hours to form iron oxide-Au shell- Polyclonal rabbit Anti-human Ig composite. 
Step 2 shows the cleaned gold electrode treated with MPA followed by mixture of EDC 
and NHS and the immobilization of iron oxide-Au shell- Polyclonal rabbit Anti-human 
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Ig composite on the electrode and blocking the non-binding site of the antibody with 
marvel before immobilization of depleted plasma Ig as explained in section 5.4.3.    
5.6 Results and discussion 
5.6.1 Immobilization of MPA, polyclonal rabbit Anti-human immunoglobulin and 
Marvel on gold electrode 
 
Figure5.3 Cyclic voltammograms of bare Au electrode (a), Au-MPA (b), Au-MPA-Polyclonal rabbit 
Anti-human Ig (c), Au-MPA- Polyclonal rabbit Anti-human Ig -1% marvel (d) 
Figure 5.3 shows the stepwise assembly of polyclonal rabbit Anti-human 
immunoglobulin (antibody) and depleted plasma Ig (antigen) on gold electrode using 
cyclic voltammetry (CV). The cyclic voltammogram shows well-defined oxidation and 
reduction peaks of  redox probe ([Fe (CN) 6]
4-/3-
) observed at the bare gold electrode (a), 
gold electrode with SAM of MPA (b), gold electrode with MPA-polyclonal rabbit Anti-
human Ig (c) and gold electrode modified with MPA-polyclonal rabbit Anti-human Ig 
and blocked with 1% marvel (d). The peak current decreases after coating the gold 
electrode surface with 3-mercaptopropionic acid (MPA). This indicates that the surface 
of the gold electrode was covered with SAM of MPA which in turn resulted in the 
decrease in the peak current observed. Further decreases in the peak current were 
observed when the electrode was modified with polyclonal rabbit Anti-human Ig 
(Fig.5.3c), and polyclonal rabbit Anti-human Ig blocked with 1% of marvel (Fig5.3d). 
The large decrease in peak current observed in Fig5.3d is attributed to the blocking 
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property of marvel which prevents the flow of electrons between the redox probe and 
electrode surface. 
The result further shows that increased immobilization on the bare gold electrode 
blocked the flow of electrons between the surface of the electrode and the redox 
solution. The bare gold electrode had the highest oxidation and reduction peaks at 
0.27V and 0.17V, followed by gold electrode modified with SAM of MPA. The lowest 
oxidation and reduction peaks at 0.29V and 0.16V were observed when the electrode 
was blocked with 1% marvel (skimmed milk).  
 
Figure5.4 EIS (Nyquist plot) of bare Au electrode (light blue line), Au-MPA (dark blue line), Au-
MPA- Polyclonal rabbit Anti-human Ig (green line), Au-MPA- Polyclonal rabbit Anti-human Ig -
1% marvel (dark red line) 
These results was further verified with the electrochemical impedance spectroscopy 
analysis for the modified electrodes in PBS (10mM, pH 6.26) containing  0.1M 
potassium chloride and 5mM Fe(CN)6
3-
/Fe(CN)6
4-
 (ferric/ferrocyanide solution) ratio 
1:1 by applying an open circuit potential with amplitude 1mV at frequency range 
0.01Hz-10kHz shown in Figure 5.4. 
The Nyquist plot shows that bare gold electrode (light blue line) had the lowest charge 
transfer resistance of 240Ω indicating that the gold electrode acted as electron pathway 
for the flow of electrons between the redox probes. The charge transfer resistance 
increased with each modification steps with the highest resistance at (1820Ω) for 
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electrode modified with MPA-polyclonal rabbit Anti-human Ig and blocked with 1% 
marvel (dark red line) because of the blocking property of marvel. 
5.6.2 Immobilization of MPA, polyclonal rabbit Anti-human immunoglobulin -
Marvel and depleted plasma immunoglobulin (control) on gold electrode 
 
Figure5.5 CV of Au-MPA- Polyclonal rabbit Anti-human Ig -1% marvel –plasma for control 
patient at dilutions (1:2000), (1:4000), (1:8,000), (1:16,000), (1:32,000), (1:64,000), (1:128,000), 
(1:256,000) 
Figure 5.5 shows the cyclic voltammogram for the immobilization of constant 
concentration (1000 ppm) of polyclonal rabbit Anti-human Ig with double diluted 
depleted plasma immunoglobulin (control) samples (1:2000, 1:4000, 1:8000, 1:16,000, 
1:32,000, 1:64,000, 1:128,000, 1:256,000 ) with corresponding concentrations 500, 
250,125, 62.5, 31.25, 15.62, 7.81 and 3.91 in parts per million respectively on gold 
electrode. The method in which the dilutions where carried out is described in section 
5.2.4.  
The CV was carried out in PBS (10mM, pH 6.26) containing KCI (0.1M) and 5mM of 
ferric/ferrocyanide solution [Fe(CN)6
3-
/Fe(CN)6
4-
] at scan rate 50mV/s. The result 
shows a well-defined redox peaks for each double dilutions. Increased dilution 
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decreases the plasma immunoglobulin concentration and results in decreasing peak 
currents observed in Figure 5.5. The highest peak current 19.95µA was observed at 
0.31V for plasma Ig dilution 1:2000 (500 ppm) (dark blue line) and the lowest peak 
current 14.82µA was observed for dilution 1:256,000 (3.91 ppm) (dark red line). 
 
Figure5.6. EIS (Nyquist plot) of Au-MPA- Polyclonal rabbit Anti-human Ig-1% marvel –plasma 
for control patient at plasma dilutions (1:2000), (1:4000), (1:8,000), (1:16,000), (1:32,000), 
(1:64,000), (1:128,000), (1:256,000) 
The result from the CV analysis was corroborated with the EIS analysis carried out on 
the samples as shown in the Nyquist plot in Figure 5.6. The Nyquist plot showed that 
plasma Ig dilution 1:2000 (500 ppm) with high plasma immunoglobulin concentration 
had the lowest charge transfer resistance (Rs) of 2648Ω indicating that high 
concentration of polyclonal rabbit Anti-human Ig/plasma immunoglobulin conjugate on 
the surface of the gold electrode acts as an electron accelerator (Sharma et al., 2010). 
The charge transfer resistance increases with increasing plasma Ig dilutions and the  
highest charge transfer resistance of 7751Ω was observed for plasma Ig at the 8th 
dilution (1:256,000) with low plasma Ig concentration (3.91 ppm).  
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This result also confirms the findings from the CV that less diluted plasma (high 
concentration) conjugated with polyclonal rabbit Anti-human Ig increases the electron 
accelerating capabilities of the polyclonal rabbit Anti-human Ig /plasma conjugates 
resulting in the reduced charge transfer resistance observed for the high concentrations. 
The CV and EIS analysis could not detect plasma immunoglobulin concentration 
beyond the 8
th
 dilution (1:256,000) (3.91 ppm). The reason for this might be due to the 
constant concentration of polyclonal rabbit Anti-human Ig (1000 ppm) used for 
conjugating the different plasma Ig dilutions. The concentration of the polyclonal rabbit 
Anti-human Ig might not be sufficient enough to bind the very low concentrations of 
plasma Ig and results in no further electrochemical response beyond the 8
th
 dilution. A 
repeat experiment for the control plasma showed similar findings and error bars where 
plotted as shown in Figure 5.7. The error bar analysis showed minimal errors in the 
experiment as indicated by the appearance of small upper and lower error bars away 
from the average peak current data for the 1
st
 and 2
nd
 runs. This indicates that the 
experiment is reproducible if repeated. . 
 
Figure5.7 Error bar analysis for first and second run depleted plasma concentration (control 
subject) for (A) [1:2000)(500ppm)], (B) [(1:4000) (250 ppm)] (C)[ (1:8000) (125 ppm)], (D) 
[(1:16,000), (62.5 ppm)], (E) [(1:32,000) (31.25 ppm)], (F) [(1:64,000) (15.62ppm)], (G) [(1:128,000) 
(7.81ppm)] and (H) [(1:256,000) (3.91ppm)] 
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Figure5.8 plot of peak currents against plasma immunoglobulin (control) for (A) 
[1:2000)(500ppm)], (B) [(1:4000) (250 ppm)] (C)[ (1:8000) (125 ppm)], (D) [(1:16,000), (62.5 ppm)], 
(E) [(1:32,000) (31.25 ppm)], (F) [(1:64,000) (15.62ppm)], (G) [(1:128,000) (7.81ppm)] and (H) 
[(1:256,000) (3.91ppm)] 
The relationship between the different plasma Ig dilutions and its effect on the peak 
current when conjugated with constant concentration of polyclonal rabbit Anti-human 
Ig was plotted as shown in Fig. 5.8. The plot shows that the peak current decreases in a 
logarithmic pattern as indicated by the logarithmic trend line (black line) with 
increasing plasma Ig dilutions. The increasing plasma Ig dilution decreases the 
concentration of the plasma immunoglobulin available for conjugation with polyclonal 
rabbit Anti-human Ig. The result in Fig. 5.8 shows that two linear trend were observed, 
one at higher plasma concentration (31.25 to 500 ppm) indicated by point A to E with 
level off point at E (31.25 ppm ) and the other at lower concentrations points (H to E). 
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Figure 5.9 Calibration plot of peak currents against plasma immunoglobulin dilutions (control) for 
(A) [1:2000)(500ppm)], (B) [(1:4000) (250 ppm)] (C)[ (1:8000) (125 ppm)], (D) [(1:16,000), (62.5 
ppm)], (E) [(1:32,000) (31.25 ppm)] 
Figure 5.9 shows the calibration curve for the depleted plasma Ig at high concentration 
(500-31.25 ppm) with a linear regression equation                      
    
      and sensitivity of                    The calibration curve has a coefficient of 
determination (  ) of 0.9628 which shows that the data point fit above 95% closely to 
the calibration line at high plasma immunoglobulin concentrations compared to    of 
0.7507 (75%) for the lower concentrations as shown in Figure.5.10. This indicates that 
the plasma immunoglobulin biomarker electrode is more sensitive to less diluted (high 
concentrations) of the plasma Ig than the more diluted low concentration (H-E) for the 
control subjects. 
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Figure 5.10 Calibration plot of peak currents against plasma immunoglobulin double dilution 
(control) for (E) [(1:32,000) (31.25 ppm)], (F) [(1:64,000) (15.62ppm)], (G) [(1:128,000) (7.81ppm)] 
and (H) [(1:256,000) (3.91ppm)] 
5.6.3 Immobilization of MPA, polyclonal rabbit Anti-human Ig-Marvel and depleted 
plasma immunoglobulin (AD case) on gold electrode 
 
Figure5.11 CV of Au-MPA- Polyclonal rabbit Anti-human Ig -1% marvel –plasma for AD patient 
at plasma dilutions (1:2000), (1:4000), (1:8,000), (1:16,000), (1:32,000), (1:64,000), (1:128,000),  
(1:256,000)  
y = 0.0988x + 14.928 
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Figure 5.11 shows the cyclic voltammogram of depleted plasma immunoglobulin 
obtained from AD patient. A well-defined oxidation and reduction peaks of the redox 
probe was also observed as compared to the control samples in Figure 5.5. Highest peak 
current of 20.39µA was observed for plasma immunoglobulin for the first double 
dilution 1:2000 (500 ppm) (dark blue line) obtained from the plasma stock solution and 
the lowest peak current of 15.75 µA was observed at the 8th double dilution 1:256,000 
(dark red line). This follows similar trend observed for the control subjects in Fig.5.5 in 
which the higher the concentration of plasma immunoglobulin the more plasma Ig 
available for polyclonal rabbit Anti-human Ig conjugation which in turn acts as an 
electron accelerator between the redox probe and the electrode surface. 
 
Figure 5.12 EIS (Nyquist plot) of Au-MPA- Polyclonal rabbit Anti-human Ig -1% marvel –plasma 
for AD patient at plasma dilution (1:2000), (1:4000), (1:8,000), (1:16,000), (1:32,000), (1:64,000), 
(1:128,000), (1:256,000) 
The result is further corroborated with the Nyquist plot obtained from EIS experiment 
shown in Figure 5.12. The result shows that 1
st
 double dilution (1:2000) with 
concentration (500 ppm) of the depleted plasma Ig had the lowest charge transfer 
resistance of 1961Ω. This indicates that high concentration of the antibody/plasma Ig 
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conjugate on the electrode acts as an electron accelerator, which in turn reduces the 
charge transfer resistance (Rs).  As the double dilution increases the charge transfer 
resistance increased with  the highest charge transfer  resistance of 5069Ω observed for 
the 8
th
 plasma immunoglobulin dilution (1:256,000). This also indicates that increase in 
plasma immunoglobulin dilution decreases the electron accelerating capabilities of the 
polyclonal rabbit Anti-human Ig (antibody)/plasma Ig conjugate for the AD case which 
gives rise to increased charge transfer resistance observed at the 8
th
 dilution. 
 
Figure5.13 Error bar plot of peak currents against plasma immunoglobulin dilution for (A) 
[1:2000)(500ppm)], (B) [(1:4000) (250 ppm)] (C)[ (1:8000) (125 ppm)], (D) [(1:16,000), (62.5 ppm)], 
(E) [(1:32,000) (31.25 ppm)], (F) [(1:64,000) (15.62ppm)], (G) [(1:128,000) (7.81ppm)] and (H) 
[(1:256,000) (3.91ppm)] 
Figure 5.13 shows the error bar analysis of the first and second experimental runs for 
the plasma immunoglobulin obtained from AD patient. The error bar analysis showed 
slightly high positive and negative errors in peak currents as indicated by the upper and 
lower error bars away from the average peak current for the high concentrations of 
plasma immunoglobulin (point A, B and C). The error bars becomes minimal as dilution 
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of plasma immunoglobulin increases. This result shows that the experiment is also 
reproducibility if repeated. 
 
Figure5.14 plot of peak currents against plasma immunoglobulin (AD case) for (A) 
[1:2000)(500ppm)], (B) [(1:4000) (250 ppm)] (C)[ (1:8000) (125 ppm)], (D) [(1:16,000), (62.5 ppm)], 
(E) [(1:32,000) (31.25 ppm)], (F) [(1:64,000) (15.62ppm)], (G) [(1:128,000) (7.81ppm)] and (H) 
[(1:256,000) (3.91ppm)] 
Figure 5.14 shows the plot of peak currents against plasma immunoglobulin dilutions 
for AD patient. The figure shows similar logarithmic trend (black line) observed for the 
control subjects in Figure 5.8. It also indicates two linear zones in the graph, first at the 
high concentration zones (A-E) and the second at the low concentration zone (H-E). 
Figure 5.15 shows the calibration plot of the peak currents against the plasma 
immunoglobulin at high concentrations (31.25-500 ppm) for the AD. The result shows 
the relationship between the current and plasma has a linear regression equation 
                     
           with sensitivity of                   It also 
has a coefficient of determination (  ) of 0.9719 which indicate that the data point fit 
(97 %) closely to the line compared to    of 0.888 (88 %) obtained from the calibration 
curve for low plasma immunoglobulin concentrations (E-H) as shown in Figure 5.16. 
This indicates that the plasma immunoglobulin/ polyclonal rabbit Anti-human Ig 
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electrode can detect the plasma concentration linearly at high concentration better than 
at low concentration. 
 
Figure5.15 Calibration plot of peak currents against plasma immunoglobulin double dilution for 
AD patient at (A) [1:2000)(500ppm)], (B) [(1:4000) (250 ppm)] (C)[ (1:8000) (125 ppm)], (D) 
[(1:16,000), (62.5 ppm)], (E) [(1:32,000) (31.25 ppm)] 
 
Figure5.16 Calibration plot of peak currents against plasma immunoglobulin double dilution for se 
AD patient at (E) [(1:32,000) (31.25 ppm)], (F) [(1:64,000) (15.62ppm)], (G) [(1:128,000) (7.81ppm)] 
and (H) [(1:256,000) (3.91ppm)] 
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Figure 5.17 shows the comparison between the peaks current against plasma Ig at high 
concentrations point A to E (500-31.25 ppm) for control subject and AD case with error 
bars for the 1
st
 and second run experiment. The result shows that the conjugation 
between polyclonal rabbit Anti-human Ig and plasma immunoglobulin for AD patient 
had higher peak current values compared to the control subjects. The high peak current 
might be due to the availability of large amount of plasma immunoglobulin in AD 
patients that conjugates with polyclonal rabbit Anti-human Ig and thus acts as an 
electron accelerator between the probe solution and the surface of the electrode. 
Research have shown that AD patients not treated with cholinesterase inhibitors have 
high plasma immunoglobulin in their body than control subjects (Mukaetova-Ladinska 
et al., 2012).  Similar result is obtained for lower plasma immunoglobulin concentration 
point E to H (31.25-3.91 ppm) shown in Figure 5.18.These results shows the sensitivity 
of the electrochemical method in detecting changes between control and plasma 
immunoglobulin from AD patient. The error bars in Figure 5.17 and Figure 5.18 
showed minimal upper and lower errors showing that the results are reproducible. 
 
Figure.5.17 Comparing peak currents between control and plasma immunoglobulin from AD 
patient at dilutions (A) [1:2000)(500ppm)], (B) [(1:4000) (250 ppm)] (C)[ (1:8000) (125 ppm)], (D) 
[(1:16,000), (62.5 ppm)], (E) [(1:32,000) (31.25 ppm)] 
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Figure.5.18 Comparing peak currents between control and plasma immunoglobulin from AD 
patient at dilutions (E)[(1:32,000) (31.25 ppm)], (F)[(1:64,000) (15.62ppm)], (G)[(1:128,000) 
(7.81ppm)], (H)[(1:256,000) (3.91ppm)], 
5.6.4 ELISA detection of plasma immunoglobulin/polyclonal rabbit Anti-human Ig- 
polyclonal Goat Anti-rabbit Immunoglobulin/horseradish peroxidase conjugation for 
AD case 
Figure 5.19a show the result obtained for the different dilution of plasma 
immunoglobulin for AD patient using ELISA method. This experiment was carried out 
in order to compare this result with the electrochemical technique and see which 
technique is better for detecting plasma immunoglobulin as biomarker for AD. The 
optical density for the plasma immunoglobulin/ polyclonal rabbit Anti-human 
Ig/polyclonal Goat Anti-rabbit Immunoglobulin/horseradish peroxidase conjugation 
was measured using a UV-spectrometer reader.  
ELISA incorporates polyclonal Goat Anti-rabbit Immunoglobulin/horseradish 
peroxidase to amplify the conjugation of plasma immunoglobulin/polyclonal rabbit 
Anti-human Ig for detection by the UV-Vis reader. Plotting the optical densities against 
the depleted plasma immunoglobulin concentrations (Fig 5.19a) showed the possibility 
of two linear segments at low plasma immunoglobulin concentration (3.91-0.244 ppm) 
points H to L and high plasma concentration (3.91-500 ppm) point E to A. A 
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logarithmic relationship exists from point F to L at the low concentration region. A 
repeat of the experiment showed similar findings. Error bar plots of the average optical 
densities against plasma Ig concentrations as shown in Figure 5.19b, showed negligible 
errors at high concentration points (A-E) indicated by the presence of small upper and 
lower error bars. The upper and lower error bars increased for the more diluted plasma 
concentration at point F to L. The result shows that the optical method is also a 
reproducible technique for detecting plasma immunoglobulin concentrations. 
 
 
Figure5.19 (a) Plot of Optical densities (OD) against plasma immunoglobulin dilution (b) Error bar 
plot for A[1:2000)(500ppm)], B[(1:4000) (250 ppm)] C[ (1:8000) (125 ppm)], D[(1:16,000), (62.5 
ppm)], E[(1:32,000) (31.25 ppm)], F[(1:64,000) (15.62ppm)], G[(1:128,000) (7.81ppm)], 
H[(1:256,000) (3.91ppm)], I[(1:512,000) (1.95ppm)], J [(1:1024,000) (0.98ppm)], K [(1:2048,000) 
(0.49ppm)], L [(1:4096,000) (0.244ppm)] 
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Figure.5.20 Calibration plot of peak currents against plasma immunoglobulin dilution for AD 
patient (a) [High conc. Point A-E], (b) [Point H-L] and (c) logarithmic curve [Low conc. Point F-L] 
Plotting calibration curve of the average optical densities against high concentration 
points (A-E) and low concentration points (H-L) of the plasma immunoglobulin showed 
that none of the segment fits closely to the calibration line as shown in Figure 5.20a  
and b. Figure 5.20a has coefficient of determination      of 0.7936 (79 %) and Figure 
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5.20b of 0.9106 (91 %) which are very low. The coefficient of determination determines 
the degree of closeness of an experimental data in linear regression analysis. The higher 
the value of    the closer the experimental data fits linearly. Figure 5.20c shows that 
logarithmic relationship exist at points F to L indicating that point E (31.25 ppm) is the 
detection limitation point for linearity at high concentration. Comparing these results 
with AD case from the electrochemical method in Figure 5.13 and calibration curves in 
Figure 5.15, shows that both methods has limiting detection point for linearity at high 
concentration at point E. But the electrochemical method detects better linearly at the 
high plasma immunoglobulin concentrations than the optical method.  The optical 
method based on the calibration curve analysis in Figure 5.20a and b, can neither detect 
better linearly at low or high concentration of plasma immunoglobulin. 
5.6.5 Immobilization of polyclonal rabbit Anti-human Ig /depleted plasma 
immunoglobulin on Fe2O3-Au Nps/Gold electrode surface. 
 
Figure 5.21 CV of bare Au (light blue line), Au-MPA (dark blue), Au-MPA-cysteamine- Fe2O3-Au 
Nps-polyclonal rabbit Anti-human Ig (green line), and Au-MPA-cysteamine- Fe2O3-Au Nps- 
polyclonal rabbit Anti-human Ig -Marvel (red line) 
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Figure 5.22 EIS of bare Au (light blue line), Au-MPA (dark blue), Au-MPA-cysteamine- Fe2O3-Au 
Nps-polyclonal rabbit Anti-human Ig (green line), and Au-MPA-cysteamine- Fe2O3-Au Nps- 
polyclonal rabbit Anti-human Ig -Marvel (red line) 
Figure 5.21 shows the cyclic voltammogram of bare gold electrode (light blue line), 
gold electrode modified with MPA (dark blue line), gold electrode modified with Fe2O3-
Au Nps- polyclonal rabbit Anti-human Ig (green line) and gold electrode modified with 
Fe2O3-Au Nps- polyclonal rabbit Anti-human Ig -marvel (red line). The result shows a 
gradual decrease in the oxidation and reduction peaks of the redox probe. The bare Au 
electrode had the highest oxidation and reduction peaks of 49.25µA and -49.68µA at 
0.25V and 0.19V respectively. This shows the ability of gold to act as an electron 
conductor for the flow of electrons between its surface and the redox solution. The 
oxidation and reduction peaks decreases when SAM of MPA was formed on the surface 
of the gold electrode. Further decrease in the oxidation and reduction peaks was 
observed when the gold electrode was modified with Fe2O3-Au Nps-polyclonal rabbit 
Anti-human Ig. The Fe2O3-Au nanoparticles act as immobilization substrate for the 
polyclonal rabbit Anti-human Ig with increased surface area and also aid the 
acceleration of electron transfer between the probe solution and the electrode surface. 
The lowest oxidation and reduction peaks of 42.3 µA and -35.7 µA were observed at 
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0.27V and 0.08V respectively when the Fe2O3-Au Nps-polyclonal rabbit Anti-human Ig 
was blocked with 1 % of Marvel.  
The result is corroborated with the Nyquist plot in Figure 5.22 which shows that gold 
electrode had the lowest charge transfer resistance of 96.75Ω and the Fe2O3-Au Nps- 
polyclonal rabbit Anti-human Ig blocked with Marvel electrode had the highest charge 
transfer resistance of 1199Ω. This showed that indeed the gold electrode was 
successfully modified with polyclonal rabbit Anti-human Ig/plasma immunoglobulin 
immune-complex and that the marvel blocked the flow of electrons. 
 
Figure 5.23 CV of Au-Cys-Fe2O3-Au Nps- polyclonal rabbit Anti-human Ig -Marvels –Plasma 
(control) at double dilution (DD) 1:2000 (dark blue line), 1:4000 (sky blue line), 1:8000 (light blue 
line), 1:16,000 (green line), 1:32,000 (red line) 
Figure 5.23 shows the cyclic voltammogram of gold electrode modified with Fe2O3-Au 
Nps-polyclonal rabbit Anti-human Ig-Marvel for depleted plasma Ig (control) for 
1:2000,1:4000,1:8000, 1:16000 and 1:32000 dilutions respectively. The result showed 
that as plasma dilution increases, the oxidation and reduction peaks of the redox 
solution decreases and shifts towards the right. The decrease in the oxidation and 
reduction peaks results from low plasma Ig available for polyclonal rabbit Anti-human 
Ig conjugation due to the increased dilution of the plasma Ig stock. But less dilution 
results in high amount of plasma Ig available for conjugation with the polyclonal rabbit 
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Anti-human Ig and thus acts as electron accelerator, resulting in increased oxidation and 
reduction peaks.  
The result in Figure 5.23 showed that gold electrode modified with Fe2O3-Au Nps- 
polyclonal rabbit Anti-human Ig-Marvel-Plasma (1:2000 dilution (1DD)) had the 
highest oxidation and reduction peak current of 34.27µA and -30.83µA at 0.26V and 
0.16V respectively (dark blue line). The lowest redox peak of 22.10µA and -22.20µA 
where observed at 0.41V and 0.040V respectively when the electrode was modified 
with plasma Ig (1:32,000 (5DD)) (red line). The electrode could not measure further 
changes in the redox peaks beyond plasma 5
th
 double dilution (5DD) due to the shift 
towards the right as observed in the cyclic voltammogram. 
The shift in the redox peaks might be as a result of the depletion of Fe2O3-Au Np from 
the surface of the electrode as the Fe2O3-Au Nps gradually diffuses into the redox 
solution with time as experimentation proceeds. This might be due to poor bonding of 
the Fe2O3-Au nanoparticles on the surface of the electrode, and also due to low plasma 
immunoglobulin available for conjugation with polyclonal rabbit Anti-human Ig as 
result of increased dilution of the plasma Ig stock solution.  
 
Figure 5.24 CV of Au-Cys-Fe2O3-Au Nps- polyclonal rabbit Anti-human Ig -Marvels –Plasma (AD) 
at double dilution (DD) 1:2000 (dark blue line), 1:4000 (sky blue line), 1:8000 (light blue line), 
1:16,000 (green line), 1:32,000 (red line) 
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Figure 5.24 shows the CV of the modified electrode with Fe2O3-Au Nps-polyclonal 
rabbit Anti-human Ig-Marvel-Plasma Ig for AD patient. The result is similar to the one 
obtained for control subjects in Figure 5.23. The highest oxidation and reduction peak 
current of 37.74µA and -34.76µA at 0.25V and 0.18V respectively (dark blue line) was 
observed for the 1
st
 double dilution (1:2000) and the lowest redox peak of 23.35µA and 
-23.40µA where observed for the 5
th
 double dilution (1:32,000) at 0.41V and 0.042V 
respectively (red line). The EIS experiment carried out shown in Figure 5.25 shows the 
Nyquist plot for the different dilutions. 
The result shows that as the plasma Ig dilution increases, the charge transfer increases. 
The electrode modified with Fe2O3-Au Nps-polyclonal rabbit Anti-human Ig-Marvel-
Plasma (1:2000 dilution) had the lowest charge transfer resistance of 8241Ω (dark blue 
line) and the highest charge transfer resistance of 10774Ω was observed at the 5th 
plasma Ig dilution (1:32,000). This result further verifies the effect of the different 
plasma Ig dilutions on the electrochemical response of the Fe2O3-Au Nps-polyclonal 
rabbit Anti-human Ig modified electrode. The experiment was repeated for the AD 
plasma Ig and similar result with slight variation was obtained.  
 
Figure 5.25 EIS of Au-Cysteamine-Fe2O3-Au Nps- polyclonal rabbit Anti-human Ig -Marvels –
Plasma (AD) at double dilution (DD) 1:2000 (dark blue line), 1:4000 (sky blue line), 1:8000 (light 
blue line), 1:16,000 (green line), 1:32,000 (red line) 
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Error bar analysis was carried out on the first and second run for the AD case as shown 
in Figure 5.26. The result showed minimal errors as indicated by the upper and lower 
error bars.  Although the error bars are slightly high at high plasma concentrations 500 
and 125 ppm (point A and C), the result in general does not show much deviation from 
the average peak current data indicating that the experiment is reproducible if carried 
out. 
 
Figure 5.26 Error bar analysis for first and second run depleted plasma concentration from AD 
patient at (A) [1:2000)(500ppm)], (B) [(1:4000) (250 ppm)] (C)[ (1:8000) (125 ppm)], (D) [(1:16,000), 
(62.5 ppm)], (E) [(1:32,000) (31.25 ppm)] 
Based on the CV results obtained for the control subjects (Fig.5.23) and AD case 
(Fig.5.24) using Fe2O3-Au Nps-polyclonal rabbit Anti-human Ig modified electrode, the 
difference between the AD case and control is that there is an increase in the redox 
peaks currents in the AD case compared to the control subjects as shown in Figure 5.27. 
This is true because research have shown that patients with AD have increased plasma 
immunoglobulin in their blood plasma. Therefore the increase in peaks currents 
observed for the AD case results from the presence of high amount of plasma Ig that 
conjugates with polyclonal rabbit Anti-human Ig immobilized on Fe2O3-Au Nps 
modified gold electrode. This in turn acts as an electron accelerating platform for 
electrons to flow between the redox probe and the surface of the electrode. The error 
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indicates minimal errors in the first and second run experiment for the control and AD 
case respectively as shown by the upper and lower error bars. This shows that the 
experiment is reproducible. 
 
Figure 5.27 Comparing peak currents between control and plasma from severe AD patient at 
double dilution (A) [1:2000)(500ppm)], (B) [(1:4000) (250 ppm)] (C)[ (1:8000) (125 ppm)], (D) 
[(1:16,000), (62.5 ppm)], (E) [(1:32,000) (31.25 ppm)] 
The experimental results have shown that it is possible to develop an immunosensor 
electrode for detecting plasma immunoglobulin as biomarker for AD. The experiment 
needs further studies and improvements on the immobilization and stabilization of 
Fe2O3-Au nanoparticles, and polyclonal rabbit Anti-human Ig on the electrode surface 
to prevent diffusion of particles in solution during experimentation and also to improve 
on the sensitivity of the immunosensor electrodes. 
5.7 Conclusion 
In conclusion the result shows that plasma immunoglobulin can be detected directly as a 
biomarker for AD first by immobilization of the polyclonal rabbit Anti-human Ig and 
depleted plasma Ig on gold electrode and secondly through the use of Fe2O3-Au Nps as 
immobilization substrate . For the immobilization on gold electrode, it was observed 
that the depleted plasma Ig from AD patient had higher peak currents compared to 
control subjects indicating that more plasma immunoglobulin was available for 
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conjugation with polyclonal rabbit Anti-human Ig in AD patient. This in turn increases 
their tendencies to act as electron accelerator between the redox probe and electrode 
surface. The modified gold electrode was able to detect plasma concentration up to the 
8
th
 plasma Ig dilutions (1:256,000) (3.91 ppm) in a combination of linear and 
logarithmic patterns. The linear detection was observed at high plasma Ig concentrations 
31.25-500 ppm (1-5
th
 DD) with a level off point at concentration 31.25 ppm. Although 
linear detection was observed at the lower concentrations, indications from the 
calibration curve at the lower concentrations show less linearity in detection compared 
to the higher concentrations. Comparing the result with the ELISA method showed that 
the electrochemical method is more sensitive and reproducible in detecting plasma Ig 
concentrations within linear range for the less diluted plasma Ig (high concentrations). 
Although the ELISA method detected the plasma Ig concentration up to the 12
th
 double 
dilutions (0.244ppm), calibration analysis showed that it had less linearity in detecting 
plasma Ig both in high and low concentrations. 
The results also showed that Fe2O3-Au Nps can be used as immobilization substrate for 
the detection of varying plasma Ig concentrations. Higher peak current values were also 
observed for plasma obtained from AD patients compared to the control subjects. 
Although the modified electrode could not measure further changes in the redox peaks 
beyond plasma 5
th
 double dilution (31.25 ppm). This is attributed to the shift observed 
in the cyclic voltammogram which result as the Fe2O3-Au Np gradually diffuses into the 
redox solution with time and also low plasma immunoglobulin available for conjugation 
due to dilution. Both methods still require further studies to improve on their sensitivity, 
detection of the depleted plasma Ig samples from early and late stages of AD in patients, 
and stabilization of the nanoparticles on the surface of the electrode for better 
immobilization. 
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Chapter 6 -Conclusions and recommendation for future work 
In conclusion the main work of this thesis was to synthesis and characterise iron oxide 
nanoparticles (magnetite and maghemite), iron oxide core-gold shell nanoparticles and 
their application in the development of immunosensor electrodes for the detection of 
depleted plasma immunoglobulin as biomarker for Alzheimer’s disease (AD). The iron 
oxide nanoparticles (magnetite) were successfully synthesized through oxidative 
alkaline hydrolysis of ferrous salt (FeSO4) and the effect of synthesis parameters on the 
morphology and nature of the nanoparticles were analysed. The conclusions drawn from 
the synthesis of magnetite are as follows: 
1. Increasing iron salt concentration affects the nanoparticles sizes and shape and 
higher salt concentration of up to 2M and above reduces the paramagnetic 
properties of the magnetite and the formation of rod shape β-iron oxy hydroxide 
(alkaganeite). 
2. Changes in hydroxyl ion concentration affect the nanoparticles size, shape and 
morphology. Smaller hydroxyl ion concentration (0.005M and 0.01M) results in 
the formation of super-paramagnetic nanoparticles with broader size 
distribution. The nanoparticles sizes increases with less size distribution at 
higher hydroxyl ion concentrations with the formation of hematite (α-Fe2O3) at 
2M as impurity. 
3. Synthesis temperature did not affect the nanoparticles sizes but higher synthesis 
temperature up to 150
o
C results in the formation of hematite (α-Fe2O3) as 
impurity with the magnetite. 
4. Synthesizing the magnetite nanoparticles under the influence of revolution per 
minutes showed that the nanoparticles sizes decreases with increasing revolution 
per minute and the formation of small amount of hematite (α-Fe2O3) and iron 
oxy hydroxide (γ-FeOOH) as impurities at 500 rpm and 1500 rpm. 
Iron oxide core-gold shell nanoparticles were successfully formed first by oxidizing 
magnetite to maghemite by heating the magnetite (50 nm) in nitric acid solution while 
stirring at temperature 90-100
o
C till solution turns brown. Gold shell 24 nm average 
particles size was formed as shell on the iron oxide (Fe2O3) nanoparticles through the 
131 
 
iterative reduction of chloroauric acid with hydroxylamine as reducing agents. The total 
average particles size of the iron oxide core-gold shell nanoparticles formed is 74 nm. 
During the formation of iron oxide core-gold shell nanoparticles, the effect of 
temperature and agitation on PEI adsorption on the nanoparticles were studied and the 
following conclusions were drawn: 
1. Temperature and agitation affects the adsorption of PEI molecules onto the 
surface of iron oxide nanoparticles which in turn affects the attachment of gold 
shells on the iron oxide nanoparticles. 
2. 40oC was found to be most favourable for the electrostatic attachment of gold 
shell on iron oxide nanoparticles since more PEI molecules are available. Also 
the polycationic nature of PEI was observed to diminish as the heating 
temperature increases which results in the reduced electrochemical properties 
observed at 100
o
C compared to 40
o
C. 
3. Agitation also affects the attachment of PEI molecules on iron oxide 
nanoparticles in the formation of iron oxide core-gold shell nanoparticles. It was 
found that agitating PEI solution with the iron oxide nanoparticles at room 
temperature favoured the electrostatic attraction between the positively charged 
PEI cation and the negatively charged iron oxide nanoparticles. This also 
favours the electrostatic attachment of gold shell on the nanoparticle indicative 
of the better electrochemical properties observed compared to the unstirred 
process at room temperature.  
The iron oxide core-gold shell nanoparticle (74 nm) was used in the development of 
an immunosensor electrode for the detection depleted plasma Ig as biomarker for 
Alzheimer’s diseases. Firstly the immunosensor electrode was developed with gold 
electrode as the immobilizing and sensing surface for the depleted plasma 
immunoglobulin biomarker and antibody (polyclonal rabbit Anti-human IgA, IgG, 
IgM). The immunosensor electrode was able to detect depleted plasma Ig 
concentration for both control subject and severe AD case up to the 8
th
 double 
diluted plasma (1:256,000) (3.91 ppm) in both linear and logarithmic pattern. 
Depleted plasma Ig from AD patient showed higher peak currents compared to 
control subjects indicating the presence of more plasma immunoglobulin in the AD 
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patient compared to control subject available for conjugation with antibody. This 
also increased the tendencies of the immune-complex in AD patient to act as 
electron accelerator between the redox probe and electrode surface compared to the 
control subject. The result compared to the ELISA method showed that the 
immunosensor electrode has better sensitivity and reproducibility in detecting 
plasma Ig at high concentrations linearly compared to the ELISA method. 
Secondly the iron oxide core-gold shell nanoparticle (74 nm) was used as the 
immobilizing substrate for the formation of immunosensor electrode for the 
depleted plasma immunoglobulin biomarker and antibody (polyclonal rabbit Anti-
human IgA, IgG, IgM). The result also showed higher peak current values for 
plasma obtained from AD patients compared to the control subject. Although the 
modified electrode could not measure depleted plasma concentrations beyond the 5
th
 
plasma double dilution (1:32,000) (31.25 ppm) which might be attributed to shifts 
observed in the cyclic voltammogram due to the gradual diffusion of iron oxide-
gold shell nanoparticles (Fe2O3-Au Np) into the redox solution with time. This is 
attributed to the poor nanoparticles binding and stability on the surface of the 
electrode.  
In both cases the results have shown that the immunosensor electrode developed 
with modified gold electrode and nanoparticles can differentiate between the 
concentrations in plasma Ig for both AD patients and control subjects. This shows 
that the immunosensor electrodes are highly sensitive and reproducible based on the 
results obtained and also answers the hypothesis question raised on AD biomarkers 
as supportive measures for AD diagnosis and monitoring. This also shows that the 
fabrication of plasma Ig biomarker immunosensor electrode for AD is feasible.  
6.1 Recommendations for Future work 
The following are recommendations that would help in future research work on iron 
oxide nanoparticles synthesis, and the use of gold electrode and iron oxide core-gold 
shell nanoparticles for the fabrication of immunosensor electrode for the detection of 
plasma immunoglobulin as biomarker for AD monitoring and detection: 
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1. In synthesizing iron oxide nanoparticles (magnetite or maghemite), the 
nanoparticles should be well stabilized with good stabilizing agents (PEI) to 
prevent the aggregation of the nanoparticles with time which also affects the 
formation of gold shell.  . 
2. The nanoparticles characterization should be carried out as soon as possible after 
synthesis to prevent false results which might result if the nanoparticles 
aggregate with time. 
3. Synthesizing magnetite nanoparticles of specific sizes and shapes for specific 
purposes using the oxidative alkaline hydrolysis of ferrous salt, care should be 
taken in altering the synthesis parameters to avoid the formation of impurities or 
side products which might affects the application of the nanoparticles. 
4. In using PEI for stabilizing iron oxide nanoparticles and as capping agent for the 
formation of gold shell nanoparticles on iron oxide nanoparticles, heating the 
iron oxide nanoparticles at 40
o
C is most favourable for PEI attachment or 
stirring the nanoparticles at room temperature (25
o
C). 
5. In the fabrication of immunosensor electrode, the Fe2O3-Au Np should be 
properly and strongly immobilized on the surface of the detecting electrode 
(gold electrode) using good chemical immobilization techniques to prevent the 
diffusion of the nanoparticles into the redox solution with time during 
experimentation. This will allow for the maximum detection of the plasma 
immunoglobulin concentration by the nanoparticles. Other sizes of nanoparticles 
should be used in the development of the immunosensor electrodes and to 
determine the sizes that is most favourable for the detection of plasma Ig 
concentrations. 
6. The use of multiple electrode detecting system that can measure multiple 
electrodes modified with depleted plasma immunoglobulin and polyclonal rabbit 
Anti-human IgA, IgG, IgM at a go. This will prevent discrepancies often 
observed when the plasma concentrations are run at different times. 
7. The depleted plasma Ig should be double diluted into different concentrations at 
the same time and used the same time or period. This will be prevent the 
changes that might occur on the samples if stored for a long time in the freezer 
due to experimentation time table.  
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8. The sensing electrode should be properly cleaned to avoid giving false results. 
9. The polyclonal rabbit Anti-human IgA, IgG, IgM should be freshly prepared and 
used once for all depleted plasma concentration during conjugation. This will 
prevent discrepancies that might result from using differently prepared 
polyclonal rabbit Anti-human IgA, IgG, IgM or polyclonal rabbit Anti-human 
IgA, IgG, IgM stored for a long time in the fridge. 
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